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i. ABSTRACT 
 
Chinese herbal medicines are used by women across the world to treat infertility in 
natural and assisted reproductive cycles. Randomised control trials and systematic 
reviews have shown the clinical efficacy of these medicines, but there remains a 
paucity of information as to the mechanisms by which they exert their effect. The 
herbal formula in this study, Gui Shao Di Huang Wan comprises eight herbs and is 
used to treat infertility. It is a base formula from which practitioners create a 
personalised medicine. The observed fertility benefits may be due to improvements 
in the receptivity of the endometrium, and a key aspect of this is haematology. The 
blood is a concept where the western and Chinese perspectives on fertility converge.   
Aqueous extracts of the whole formula and the individual herbs were used. 
Prothrombin time and activated partial thromboplastin time were used to evaluate 
time to clot formation. An MTT assay was used to look at proliferation of human 
umbilical vein endothelial cells.  A 2D differentiation assay was performed on matrigel 
using human umbilical vein endothelial cells and human uterine microvascular 
endothelial cells. Lysates of Ishikawa endometrial cells exposed to the herb extracts 
were used in immunoblotting to explore changes in oestrogen and progesterone 
receptor expression. 
 
Haemostasis, proliferation and differentiation of endothelial cells and expression of 
steroid receptor proteins on an endometrial cell line have all been shown to be 
affected by the herb extracts in in vitro assays modelling these functions. Prothrombin 
time (Welch’s F (8,14.57) =50.21, p<0.0005) and activated partial thromboplastin time 
(Welch’s F (8,13.77) =38.79, p<0.0005) were both increased. The whole formula led to 
an increase in proliferation at concentrations between 0.68 and 5.47 µg/mL at 48 and 
72 hours.  
 
Metrics of tubule number, length, junctions, and mesh size were increased in 
endothelial cells. All parameters of Human Umbilical Vein Endothelial Cells were 
statistically significantly increased by the whole formula but not the individual herbs. 
The Human Uterine Microvascular Endothelial Cell mesh was increased by all herb 
extracts, total length, and segment number by Radix Paeoniae Alba, Sclerotium Poria 
    
  
Cocos, Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Fructus Corni, and 
Rhizoma Alismatis, total length and junction number for Fructus Corni 
Modifications to expression of ERα and PRβ were observed. Downregulation of 
Estrogen receptor alpha after 24 hour exposure to the herbs for Radix Paeoniae Alba, 
Radix Angelicae Sinensis, Sclerotium Poria Cocos, and Cortex Moutan. Progesterone 
receptor beta was upregulated by treatment with Radix Paeoniae Alba, Radix 
Angelicae Sinensis, Sclerotium Poria Cocos and Radix Rehmanniae Preparata after 48 
hours exposure to the herb extract.  
trials currently available." 
 
This study adds a new perspective to the limited evidence available through clinical 
trials which examine Chinese herbal medicines and their potential for use in treating 
female infertility. The observed effects of the herbs may be mediated by the influence 
on the identified haematological and vascular processes related to endometrial 
receptivity. 
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vii. LIST OF TRADITIONAL CHINESE MEDICINE TERMS 
Taken from “The web that has no weaver” (1). Capital letters are used in the text to 
denote a term which has specific meaning in Chinese medicine. Where the word is in 
use in the English language it will generally have a different meaning from the 
scientific understanding of it. 
 
Traditional Chinese Medicine (TCM) is a term that encompasses several branches of 
medicine including Chinese Herbal Medicine (CHM), acupuncture, and dietary 
therapy. 
 
Yin and Yang – the concept originated from observation of the Yin or shady side of 
the mountain and Yang the sunny side. Everything has a Yin and Yang aspect, Yin and 
Yang create each other, control each other, and transform into one another. Yin is 
conserving and nourishing, Yang is dynamic and moving. 
 
Qi – often translated as energy or primordial matter. It is the common thread between 
all things, mineral to man. It is the source of all movement and accompanies all 
movement. There are many categories of Qi and its movements which affect health. 
Deficient Qi – when there is insufficient Qi of to perform the required functions. 
Spleen Qi deficiency, the Spleen Qi is unable to perform all the functions associated 
with the Spleen. Stagnant Qi – Qi does not move through the body leading to aches, 
pains, failure to digest food or to move Blood. 
 
Blood – Blood is the compliment to Qi. It originates from the transformation of food 
via the Spleen, is propelled through the Lungs to receive Qi from air and becomes 
Blood which is able to nourish the body and organs. Blood may also be deficient or 
stagnant. 
  
Heart – the Heart stores the Shen and responsible for consciousness and volition. It 
ensures appropriate behaviour and responses. 
 
    
Kidney – the Kidney stores essence, governs birth, growth, and reproduction. Kidney 
function declines with age. 
 
Spleen – The organ most closely associated with Qi but also closely related to Blood. 
It transforms and transports and its failure leads to a lack of nourishment. 
 
Liver – the Liver is most closely connected with Blood which it is said to store, but 
ensures the smooth movement of Qi. 
 
Shen – the spirit, a fundamental that defines humans. It is mind, consciousness, self-
awareness. 
 
Damp – is a pathological manifestation of healthy Yin, it accumulates and stagnates, 
can create heat, and often originates from disharmony of the Spleen. 
 
Heat -  is a pathological manifestation of the healthy Yang of the body, empty heat 
from a lack of Yin. 
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1 
1 Introduction 
 
1.1 Why investigate Chinese herbal medicine and its influence on fertility? 
 
There is a need for improvements in the assistance that can be offered to infertile 
couples whether they are trying to conceive naturally or using Assisted Reproductive 
Techniques (ART) such as In Vitro Fertilisation (IVF). In 2014 in the UK 52,288 women 
had a total of 67,708 cycles of IVF (2). There is little research into how Chinese herbs 
can be of assistance, particularly produced by researchers in the West, but what exists 
is positive, showing that herbs can be clinically effective (3, 4). Research into 
pharmacological mechanisms that underlie these positive effects is almost exclusively 
undertaken in China and published in Chinese. This lack of accessible evidence 
creates an appropriate reserve in biomedical practitioners when asked to recommend 
herbal medicines or permit them alongside conventional treatments. This is in part 
due to lack of information on how they work and so their likely interactions with 
pharmaceutical medicines. 
 
In the United Kingdom (UK) both the supply and the practice of herbal medicine 
remains without statutory regulation. European Union (EU) legislation, which passed 
into law in 2004 and whose transitionary period ended in 2011, overrode the 1968 
Medicines Act under which legal directive herbalists had previously practiced (5). 
This change to the way in which herbalists were permitted to practice led to many 
years of discussion and government reports, predominantly concerned with the safety 
of supply and practice. Although not the central purpose of the discussions, inevitably 
questions of efficacy are raised. Concerns have been expressed in debate that 
Introduction 
 
2 
statutory regulation might infer efficacy of herbal medicines, as well as ensuring the 
safe supply of herbs by qualified practitioners (6). The practice of herbal medicine 
would benefit from research generated in the west to assess possible efficacy of herbal 
medicine to back up arguments around regulation. 
 
One of the two research studies cited above on Chinese Herbal Medicine (CHM) and 
fertility (4), was conducted in Australia; it was a meta-analysis of existing studies 
covering 1851 women with a range of fertility disorders. These studies all used 
pregnancy as the primary outcome. They found that pregnancy was three and a half 
times more likely using Chinese herbs and pharmaceuticals over four months than 
pharmaceuticals alone. The second study measured markers of endometrial 
receptivity in women receiving herbal treatment for whom IVF had previously failed. 
All six measured markers of endometrial receptivity were significantly improved and 
there was a 34% pregnancy outcome (3).  
 
IVF is both expensive and invasive and should not be considered as one of the first 
solutions to infertility either for the benefit of the individual, or in the UK, for the 
National Health Service (NHS).  There are many factors that affect fertility; age, 
weight, diet, and lifestyle, all of which have their effect on the endocrine system, 
immunity, oocyte quality, and uterine environment (7). IVF is generally successful in 
oocyte retrieval, fertilisation and the production of embryos for transfer, but has only 
an average 30% live birth rate (8). When oocyte quality is apparently acceptable then 
failures may be attributable to the implantation environment.  One aspect of the 
receptivity of the endometrium to implantation is uterine perfusion and blood vessel 
development (9). Haematology was chosen for this study as a meeting point of 
western and Chinese thought, both sharing the understanding that sufficient blood 
supply is essential for preparing the uterus for embryo implantation and for 
maintenance of a pregnancy.  
 
The Traditional Chinese Medicine (TCM) understanding of Blood or “xue" includes, 
but is not limited to, that of blood circulating within the vessels and delivering Qi 
(which in this context could equate to hormones, oxygen, glucose etc.) to the cells. 
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Several herbal formulae have been studied in China for their effects on endometrial 
receptivity, expression of oestrogen receptors, and angiogenesis promoting factors. A 
Chinese herbal formula called Zhu Yun1 has been shown to improve endometrial 
receptivity in induced implantation dysfunction in mice. It is thought to reinforce the 
expression of endometrial Leukaemia Inhibitory Factor (LIF) and integrin β3 which 
are adhesion molecules active in the secretory phase of the menstrual cycle to 
promote implantation of the blastocyst (10). Also looking at expression of LIF, another 
formula called Bu Shen An Tai, showed an increased expression of LIF mRNA in the 
endometrium of mice with embryo implantation dysfunction (11). A third formula Jian 
Tai Ye has been shown to increase endometrial receptivity by increasing oestrogen 
receptor proteins and mRNA in mice with embryo implantation dysfunction (12).  Er 
Zhi Tian Gui was found to reduce the need for administered gonadotropins, increase 
deoxyribonucleic acid (DNA) methyltransferase protein expression in the 
endometrium, increase oocyte number and increase pregnancy rate in infertile 
women diagnosed with Kidney Yin deficiency who were undergoing IVF (13).  
 
Most of the studies on Chinese herbal medicine and fertility including those 
investigating endometrial receptivity and angiogenesis have been conducted in 
China, and few are translated for publication in English.  There has been little 
research in relation to fertility and the biological effects of Gui Shao Di Huang Wan 
(GSDW)2, the formula chosen for this investigation. There are many studies in the 
literature for a range of conditions on the related formulae Liu Wei Di Huang Wan. 
This research will be discussed in more detail in Section 1.7. The studies here expand 
upon the Chinese medical theory actions of “nourishing Blood and Yin3” thereby 
supporting the rationale of this study.  
 
There is also very limited research undertaken on whole formulae here or in China. 
The trend is for the reductionist analysis of individual compounds.  Pharmacological 
 
1 Details of the herbs that make up this formula can be found in Table 1-4  
2 Details of the herbs that make up this formula can be found in Table 1-1 
3 Chinese medicine terms are capitalised to distinguish them from their western use, explanations of their meaning can be found in vii 
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research tends to be reductionist, searching for compounds which in isolation may 
be modified and patented to provide a marketable drug, but techniques and attitudes 
are changing (14). Recognition of the importance of polypharmacy, polyvalence and 
the developing -omics techniques all provide a framework to investigate health and 
drugs using an interdependent, systems biology approach (Section 5.12.1). This 
resonates with the premise of researching Chinese herbs as part of formula instead of 
the pharmaceutical route of breaking it down to seek the specific “active” compound. 
 
Whilst a reductionist approach can provide information on the mechanisms of the 
therapeutic effect, it does not provide information on how the whole herbs or 
components within it can act, let alone the whole formula. Radix Panax Ginseng 
(Panax ginseng C.A. Mey) has multiple compounds which show opposing effects on 
vascular pathophysiology (15), any extracted individual compound would give 
different results to that of using the whole herb. Just as there is interaction between 
the compounds within a herb, so too between the herbs in a formula. Gui Shao Di 
Huang Wan contains eight herbs and a current review of literature finds 289 
identified individual compounds (Appendix III). Some of the compounds have only 
been isolated and characterised, others have been investigated for their roles in a 
range of physiological functions. 
 
In clinical practice, herbs are mainly prescribed as a formula and it is important that 
approaches are developed to evaluate the actions of the herbs in the way they are 
prescribed. The evidence base needs to reflect clinical practice. Investigating whether 
polyvalence can be detected between the herbs in a formula will help to inform its 
future use as a medicine, determining whether an individual compound or herb 
should be used in preference to a whole formula or whether the whole provides more 
than the parts. 
 
The proposed research takes the Chinese herbal formula Gui Shao Di Huang Wan, 
which is commonly modified for prescription in the UK for fertility, and seeks to 
elucidate some of the mechanisms by which it has been seen to produce positive 
effects on endometrial receptivity and pregnancy rates seen in clinical studies (3, 4, 
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16). Established in vitro techniques are used to investigate the effect on haemostasis, 
angiogenesis, and ovarian steroid receptor expression to inform our understanding of 
their mechanisms of action. This is vital for the public in receiving herbal treatment 
and other healthcare professionals in providing concurrent conventional care.  
 
Studying a Chinese herbal formula within a western paradigm requires some difficult 
parallels to be drawn. The principles of the two systems are diverse and the 
background to the investigation in this study necessitates enquiry into both realms 
of thinking. 
 
1.2 Natural products and the -omics 
Pharmaceutical drugs can be lifesaving and their development a testimony to the 
ingenuity of researchers. They can also be ineffective and subject to side effects. They 
can be used incorrectly, and may be unavailable or unaffordable to large proportion 
of the world population. Herbal medicines are also subject to these problems and are 
largely unregulated which leads to issues with quality. Pharmaceutical medicines 
require approval for use following trials of safety and efficacy but the majority of 
herbal medicines have not been scrutinised in this fashion. 
 
There is a long history of the drug discovery from the plant sources. Only since the 
industrial revolution has the approach of isolating pure compounds with the intent 
of having more active and safer drugs been prevalent. Of the two hundred and fifty 
two drugs considered essential by the World Health Organisation, 11% are exclusively 
of plant origin, and many more are derived from natural plant precursors (17). 
Diosgenin is an extract of Rhizoma Dioscoreae (Dioscoreae opposita Thunb.), one of 
the herbs in Gui Shao Di Huang Wan, and was used as the precursor to many of the 
common steroids in use today such as cortisone and progesterone. Of fourteen drugs 
used for chemotherapy in 2001, five drugs originate from plants (18).  Natural products 
are the origin for the vast majority of the pharmaceutical drugs introduced over the 
last fifty years. Despite the focus on biotechnology synthesis, genetic engineering and 
meta-genomic approaches to product development, natural products remain a rich 
source for novel antibiotics, oncology and other therapeutic compounds (19). 
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Plants used as medicine may be dried or fresh, whole or parts of plants, alone or in 
combinations. Extractions for internal use are typically prepared with water, and used 
as decoction, granules, powder, pills, or capsules. They may be prepared in alcohol as 
tinctures, in sugars as syrups, or for external application. Purification of plant 
materials can be used to isolate specific compounds which are precursors of 
therapeutic pharmaceutical drugs such as diosgenin from Rhizoma Dioscoreae, or be 
the therapeutic compound itself such as morphine (17). It has been shown repeatedly 
that the entire extract of a plant can have a greater effect than an isolated constituent. 
In his paper on -omic technologies in phytotherapy, Ulrich (20) describes 16 
medicinal plants for which this has been shown to be the case including several 
Chinese medicines. Gingko biloba L. affects platelet aggregation, two gingkosides 
interact synergistically in a dose dependent manner; Radix Glycyrrhizae (Glycyrrhiza 
glabra L.) is both anti-inflammatory and amplifies the activity of hydrocortisone. 
Rhizoma Paris Polyphylla (Paris polyphylla Sm.) contains saponin glycosides and is 
used to treat abnormal uterine bleeding. Twenty two glycosides were purified and 
were shown to be contractile agonists for the uterus and to work synergistically (21).  
 
A formula called Sheng Mai San was examined as a whole formula, as a single herb 
Fructus Schisandrae (Schisandra arisanensis Hayata), which is one of the constituent 
herbs, and an isolated compound from it called schizandrin. Three of the lignans 
found in Fructus Schisandrae were quantified in this experiment. It was found that 
higher levels were present in the decoction of the three herb formula Sheng Mai San 
than when it was decocted alone. The presence of the two additional herbs in the 
decoction process increased liberation of the compounds into the water. The 
schizandrin, a compound present in all three preparations, was detected in rat 
plasma. It was found that the absorption levels were increased, as was time to 
elimination, when administered as a three herb formula in comparison to 
administration as an isolated compound or as a single herb (22). 
 
Fan et al. (23) summarises the challenges of developing a western drug from a TCM 
formula. There are many compounds in each herb and the synergy and antagonism 
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between them is largely unknown. Individual compounds may be less potent that the 
total extract, compounds may be pro-drugs, active only after metabolism, and the 
actions tend to be slower than that of pharmaceuticals (23). Plant extracts containing 
a variety of bioactive compounds have the possibility of being within themselves a 
combination therapy, targeting multiple systems which is not the case with single 
compound based drugs. It will require research and embracing new methodologies to 
characterise the herbs and assess their therapeutic potential.  
 
1.3 East to west, bridging the gap 
 
The theory of Chinese medicine like Chinese philosophy is less reductionist and more 
focussed on whole world observation. Western medicine over the past few centuries 
has become increasingly micro focussed from organism to organ, cell to organelle, to 
the binding of specific molecules to cellular receptors, and the expression of DNA. 
Isolation of single protein targets has provided many drugs; particularly effective for 
the treatment of acute disease, but these strategies when used over long periods for 
chronic conditions may lead to epigenetic changes which can cause serious side 
effects (24).  
 
Identifying molecular targets is a critical step in the validation of a biological effect 
but the complexity of Chinese herbal medicines makes this a challenging approach 
(25). Focus on the details can lead to neglect of an appreciation for the whole. This is 
where Chinese medicine theory takes the opposite view, the effects on whole system 
are prioritised over the detail at a cellular level. Greel (26) suggests that western 
medicine in its use of systems biology is moving back from the reductionist 
investigations towards a more systematic view. Pharmacological investigation using 
the -omics technologies and systems biology approach applied to traditional products 
may be used to validate the traditional use of a herb or formula without threatening 
the philosophy of formulae and polyvalent prescribing. New approaches are needed 
for drug discovery as fewer and fewer new pharmaceutical drugs are making it to 
market each year (26). There is a crisis in areas such as antibiotics, and Chinese herbs 
are a huge potential resource for these substances; a first trial for Chinese herbs for 
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recurrent urinary tract infection treatment by general practitioners in the NHS has 
begun (27).  
 
1.4 History and context of the formula Gui Shao Di Huang Wan  
 
Chinese medicine has a long history of treating fertility and first discussions of it are 
found in the classic text the Shan Han Lun (Treatise on Febrile Disease) from 200CE. 
Gui Shao Di Huang Wan (GSDW), Dang Gui and Peony Rehmanniae pill. is an ancient 
formula based on one called Liu Wei Di Huang Wan, the Six Gentleman’s decoction, 
which treats Yin deficiency, and was first recorded in Qian Yi’s work Xiao Er Yao 
Zheng Zhi Jue (The Correct Execution of Paediatric Medicinals & Patterns) which was 
published in 1119CE. The addition of Radix Angelicae Sinensis and Radix Paeoniae 
Alba to make the formula Gui Shao Di Huang Wan provides additional support for 
the Blood, so creating a Yin and Blood tonic. There are many formulae that could have 
been chosen for this study; many herbs that are considered to be of therapeutic use 
for fertility. According to Traditional Chinese Medicine (TCM) theory the main 
causes of infertility are Kidney Yin deficiency, Liver and Blood stasis (28). Gui Shao 
Di Huang Wan is often used in practice and it comes up frequently as a guiding 
formula throughout a leading book on treating infertility with Chinese medicine by 
Jane Lyttleton (29). It is also one of the key formulae that were used in the study 
looking at markers of endometrial receptivity. Patients were treated using a four 
week, four formula phased approach; in week two an unmodified Gui Shao Di Huang 
Wan was used and in weeks three and four, six of the eight ingredients were used in 
a modified formula. Fifty patients, who had two previous failed IVF cycles, received 
treatment with herbs. All six physiological parameters on ultrasound known to affect 
endometrial receptivity were improved, and 34% of patients conceived (3).   
 
Traditionally Chinese herbs are prescribed in a formula, this is typically two to twelve 
herbs simmered together in a “tea”. Occasionally a herb will be used alone but this is 
unusual. This combining of herbs is used to address the multifactorial nature of most 
illness, both in origins and in manifestations. In addition, it is generally considered 
that some herbs will potentiate efficacy or ameliorate toxicity.  A definition of synergy 
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by Evans (30) suggests that synergy is frequently misapplied to describe potentiation 
and attenuation of therapeutic effects which would more accurately be described as 
polyvalence. Yang et al. (31) states that the term synergistic may be applied to a 
broader range of interactions such as regulation of the same or different pathways, 
regulation of enzymes and transporters in metabolic processes, overcoming 
resistance pathways in microbes and cancers, or by eliminating adverse effects.  
 
Compounds which may not contribute directly to the therapeutic effects may bind to 
those that do and potentiate their actions through increasing availability, transport 
into the cell, or across the blood brain barrier. Many herbal medicines contain 
terpenoids which have a strong affinity for cell membranes so can permeate cells to 
exert their effects (32). Rhizoma Coptis (Coptis chinensis Franch.) has been shown to 
have stronger anti hyperglycaemic actions in its whole form than just the alkaloid 
fraction (33). Also, in this same plant is 5′-methoxyhydnocarpin, an amphipathic weak 
acid which has no antimicrobial action. In combination with berberine, which is 
antimicrobial and is present in the same plant, it effectively disables the bacterial 
resistance mechanism potentiating the antimicrobial effect of the berberine (34). 
Epigallocatechin gallate present in green tea enhances the therapeutic effect of 
temozolomide in treating glioblastoma by crossing the blood brain barrier and 
causing chemo sensitisation (35).   
 
1.5 Fertility and Traditional Chinese Medicine 
 
In 2010 a review of  herbal medicine in IVF treatment found that there were no RCT’s 
on the use of Chinese herbs and no conclude there is no evidence to support their use 
(36). Since this review there have been several clinical studies which have shown 
positive results with the use of Chinese herbal treatment used as an adjunct to IVF, 
and with natural conception One of the most recent is a trial where patients with 
previous failed IVF cycles had either three months of Chinese herbal treatment and 
then an IVF cycle, or the control which was a three month wait and then IVF 
treatment. The Chinese herbs treatment group had significantly higher pregnancy 
rate, higher numbers of fertilised oocytes and lower numbers of biochemical 
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pregnancies (28). A review of 21 RCT’s using a range of herbal formulae was 
undertaken and although a number of limitations were identified such as no blinding, 
small sample sizes they do all show increased pregnancy rate (37).  
 
A survey was undertaken to assess levels of Chinese herbal medicine use by patients 
at fertility clinics; in the UK it was 10%, Australia 8% and the USA 18% (4) and this is 
despite opposition from many clinic doctors and a poor understanding of the effects 
of herbal medicines. In an Irish IVF unit, a study showed that 48% of patients had 
used herbal medicines and 38% of those in the 3 months prior to treatments and the 
concern raised by the study was that none had discussed this with their IVF physician 
(38).  
 
 
A meta-analysis using stringent selection criteria, within a Cochrane framework were 
completed in 2011 (39) of eight randomised control trials with 1005 women that 
showed that there was a pregnancy rate of 50% over four months using Chinese herbal 
medicine compared to 30% with IVF alone. An updated meta-analysis in 2015 (4) 
reviewed forty randomised control trials with 4200 women and suggested that in the 
treatment of female infertility, Chinese herbal medicine alongside pharmaceutical 
treatments, including IVF, increased pregnancy rate from 30 to 60% over a three to 
six month period. Further analysis of this data was performed looking at the 
pregnancy rate for women treated with Chinese herbs alone. Data was from only 
seven studies, but they were high quality and included 616 women, there was a 49% 
pregnancy rate.  
 
A meta-analysis undertaken in the UK of studies examining the use of Chinese herbal 
medicines for support during IVF cycles showed a significantly increased clinical 
pregnancy rate (40), a subset of the studies showed an increase in implantation rate. 
Only in one study were herbs continued post conception, this study involved 81 
women and did show a decreased miscarriage rate. The conclusions of the authors 
were that the methodologies of the studies were poor, results were subject to high 
risk of bias, and that the significant differences found in the meta-analysis were 
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unlikely to be accurate. In the US a retrospective analysis was performed using 
records of 1231 IVF patients and they found IVF with a whole system IVF which 
included acupuncture and Chinese herbal medicines specific to the patient was 
associated with greater odds of live birth in both donor and own gamete cycles (41). 
 
 
One clinical trial undertaken in the UK, by a Chinese herbal specialist, looked at 
influence of herbs on six parameters affecting endometrial receptivity using 3D 
ultrasound and blood tests (3). The measures were serum Follicle Stimulating 
Hormone (FSH) and progesterone levels, thickness of endometrium and sub 
endometrial uterine perfusion (three measures). Participants were women with at 
least two previous IVF failures as its test group who all received treatment, the control 
groups were normal healthy women without fertility problems. The control group 
were not trying to achieve pregnancy but were treated and all other parameters 
measured. The control group were randomised and double blinded as to whether they 
received treatment, the test group were not. The treatment duration was three 
menstrual cycles and the treatment group showed significant improvements in all six 
measures and had a 34% pregnancy outcome. The control group who were treated 
showed no changes in uterine perfusion or hormone levels (3). This is of particular 
interest when considering the debated premise of adaptogenic herbs, which are able 
to return an organism to a state of balance rather than having a specific inhibitory or 
potentiating effect (42). 
 
A Japanese study used a seven Chinese herb combination with women aged 38.5±0.7 
with previous failed intracytoplasmic sperm injection (ICSI) assisted IVF cycles and 
found improvements in oocyte development and pregnancy rate (43). A prospective 
RCT in 2014 of 432 patients under 42 years old were given IVF plus Chinese herbs or 
the control without and found that the endometrium was thicker, and the number of 
high quality embryos was higher as was the biochemical pregnancy rate. This did not 
translate into a statistically significant higher birth rate (44). 
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Despite a growing number of studies that indicate possible advantages to treatment 
with Chinese herbs for fertility or alongside IVF, there are methodological concerns 
of these studies including low numbers of patients, lack of blinding, diverse 
methodologies, and treatment protocols, all of which make it difficult to draw firm 
conclusions. Patients fail to discuss the use of these therapies to their clinicians and 
a clinician lack the research to advise their patients on adjunctive use. 
 
1.6 Traditional Chinese Medicine actions of Gui Shao Di Huang Wan 
 
The formula in this study is a ‘Yin and Blood tonic’ (Section vii for an explanation of 
TCM terms). Liu Wei Di Huang is a classic Yin tonic formula commonly modified to 
Gui Shao Di Huang Wan which makes it a Yin and Blood tonic. Yin and Blood are key 
to female fertility. In order for ovarian follicles to develop the Yin “needs to be strong”, 
especially in the first half of the menstrual cycle which is under influence of FSH. 
During this time, the follicles secrete oestrogen which promotes the development of 
the endometrium which, according to Chinese medicine theory needs to be nourished 
by Blood. Once Yin has reached its peak an oocyte is released and the follicle 
transforms to become the corpus luteum, which releases progesterone the hormone 
associated with Yang. Disorders of fertility more specific related to the Yang include 
early luteal failure, polycystic ovary syndrome and hypothyroidism. Although Yang is 
not directly treated with this formula, Yin and Yang are interrelated and transform 
into one another; treating the Yin improves the Yang.  A poor follicle creates less 
oestrogen, this causes lower inhibin so that FSH is raised. The duration of the 
development phase of the follicle is correspondingly reduced (45). High FSH leads to 
abnormal FSH to LH ratios, and both this and the decreased inhibin, impairs the 
corpus luteum and serum progesterone (46).  A classic Yang tonic for fertility shares 
many of the same herbs as the Gui Shao Di Huang Wan with additional warming 
herbs added to increase the Yang. Adequate uterine perfusion must continue under 
the influence of progesterone to maintain the endometrium and for it to continue to 
become optimally receptive during the implantation window (47). Gui Shao Di Huang 
Wan is not a personalised formula as would be used in a clinical situation, but is a 
suitable base formula for many types of female infertility.  
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In TCM theory organs involved with the creation and storage of Yin and Blood include 
the Kidney, Liver, and Spleen. The Kidneys store the Jing, which is the origin of the 
Yin and reproductive energy. The Liver both stores and moves the Blood and the 
Spleen governs the transformation of nutrients which are used for the production of 
Blood. The original formula Liu Wei Di Huang Wan is composed of two sets of three 
herbs. The first set are the three tonics which have their primary action on the Kidney, 
Liver and Spleen, the organs responsible for producing Yin and Blood. The second set 
of three herbs drain Damp and Heat which are common pathologies associated with 
Yin and Blood deficiency (29). A TCM formula is structured to have a chief, deputy, 
assistants and sometimes an envoy. The chief is the primary herb and defines the 
purpose of the formula. Additional herbs will work together with the chief to 
strengthen the main effect but will have their own effects, prevent against unwanted 
effects or to guide the direction of the formula. Table 1-1 lists the eight herbs in Gui 
Shao Di Huang Wan. Radix Rehmanniae Preparata tonifies Yin and Blood of the Liver 
and Kidney and is the chief herb of this formula. The first of the deputies is Fructus 
Corni, it is an astringent but also tonifies the Liver and Kidney. It is an astringent in 
that it retains Jing and body fluids which nourish the Yin. The second deputy is 
Rhizoma Dioscoreae which is a Qi tonic and nourishes the Yin of the Kidney and 
Spleen. Deficiency of the Kidneys often results in poor water transformation leading 
to an accumulation of Damp, which can lead to Heat and the assistants treat this. 
Sclerotium Poria Cocos drains Damp as well as being a gentle Spleen tonic. Rhizoma 
Alismatis clears Damp as well as Heat, and Cortex Moutan clears deficient Heat. Radix 
Angelicae Sinensis and Radix Paeoniae Alba are both primarily Blood tonics. 
Angelicae Sinensis tonifies the Blood of the Heart and Liver whilst also moving Blood 
stasis. Paeoniae Alba tonifies the Blood of the Liver and preserves the Yin. Table 1-1 
presents the names of the eight herbs in the formula under investigation, as well as 
its purpose within the formula. 
  
Introduction 
 
14 
 
Table 1-1 The names and functions of herbs in the formula Gui Shao Di Huang Wan 
 
 
1.7 Review of literature on the formula Liu Wei Di Huang Wan  
 
A number of studies have been undertaken examining Liu Wei Di Huang Wan, the 
antecedent formula to the one used in this study. From a review of titles alone it 
appears that papers written in Chinese journals are extensive. Where the title of the 
paper appeared particularly pertinent, the papers were obtained and translated, but 
for the most part papers reviewed are those for which the full text in English was 
available. The following demonstrates some of systems influenced by the formula and 
a few of the many mechanisms by which it may treat disease. 
 
1.7.1 Administration 
 
Some of the studies provide valuable information about the use of the formula. It was 
shown to have no adverse effects on rats at 200mg/kg/day (50). The length of time 
these herbs are decocted may be important as it was shown that mineral content 
varied according to decoction time (51). One of the measured effects of the formula 
was modification of caffeine metabolism by altering enzymes cytochrome 
P450(CYP)1A2, CYP2A6 and N-acetyltransferase (NAT)2. There are many prescribed 
Pharmaceutical name 
(48) 
Scientific name Plant Family Chinese Pinyin Role of herb in the formula 
(49) 
Radix Rehmanniae 
Preparata 
Rehmannia glutinosa 
(Gaertner) De Candolle 
Orobanchaceae 熟地黄 Shu Di 
Huang 
Kidney Yin and Blood tonic 
Fructus Corni Cornus officinalis Siebold 
& Zuccarini 
Cornaceae 山茱萸 Shan Zhu Yu Kidney and Liver Yin tonic, 
astringent 
Rhizoma Dioscoreae Dioscorea oppositifolia  
Carolus Linnaeus 
Dioscoreaceae 山药 Shan Yao Kidney and Spleen Yin tonic 
Sclerotium Poria 
Cocos 
Wolfiporia extensa 
(Peck) Ginns 
Polyporaceae 茯苓 Fu Ling Spleen tonic, clear damp 
Rhizoma Alismatis Alisma plantago-
aquatica subsp. orientale 
(Sam.) Sam 
Alismataceae 泽泻 Ze Xie Drain damp, clear heat 
Cortex Moutan Paeonia ostii T. Hong & J. 
X. Zhang 
Paeoniaceae 牡丹皮 Mu Dan Pi Clears deficient heat 
Radix Angelicae 
Sinensis 
Angelica sinensis (Oliv.) 
Diels 
Apiaceae 当归 Dang Gui Blood tonic, moves Blood 
stasis 
Radix Paeoniae Alba Paeonia lactiflora Pallas Paeoniaceae 白芍 Bai Shao Blood and Yin tonic 
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drugs whose metabolism would be affected by these pathways including the 
antibiotic Ciprofloxin and the anti-depressant Fluvoxamine. This demonstrates the 
potential for interactions with other drugs administered in combination with the 
formula (52). The formula must be prepared correctly, and care must be taken during 
prescribing to understand the potential interactions with other medications. 
 
Synergy has been demonstrated within Liu Wei Di Huang Wan. In one study three 
compounds, 5-hydroxymethyl-2-furoic acid, loganin, and paeonol, were used as 
plasma markers of absorption. It concluded that the pharmacokinetics of these three 
compounds within the formula led to more rapid absorption and slower elimination 
than administration of each individual herb (53).  
 
Si Wu Tang contains three of the same Blood tonifying herbs as GSDW (Table 1-1, p14) 
with the addition of Rhizoma Ligustici Chuanxiong, a study shows how these herbs 
stimulate haemopoiesis by promoting erythropoietin and granulocyte-colony 
stimulating factor (G-CSF) gene expression (54).  A study using microarrays to analyse 
gene expression induced by this formula has shown that it upregulates nuclear factor 
erythroid 2 related factor (NFE2L2), signalling a cytoprotective pathway resulting in 
increased antioxidant response. This is not the system targeted by oestradiol or ferulic 
acid, but another mechanism. It was also demonstrated that the gene expression 
induced by Si Wu Tang closely aligned to that obtained from oestradiol treated cells, 
which is consistent with the use of this formula to treat women’s reproductive health 
(55). Eight pairs of Chinese herbs, including an ethanolic extraction of Radix 
Angelicae Sinensis and Radix Paeoniae Alba, were tested for their antioxidant 
properties, all of the pairs when decocted together were shown to have greater radical 
scavenging abilities than the sum of the individual herbs (56). 
  
A study examined the pharmacokinetics of three triterpene acids in Sclerotium Poria 
Cocos following oral administration to rats. The formula Gui Zhi Fu Ling Wan which 
contains Poria was seen to have more effective absorption and slower elimination of 
the triterpenes when administered within the formula than the Poria extract alone 
(57). 
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1.7.2 Neuronal 
Cognitive enhancement and reversal of induced amnesic behaviour was seen in 
rodents after administration of Liu Wei Di Huang Wan (58). The formula was able to 
modulate neuronal and synaptic function in rats (59), and improve synaptic plasticity 
in a cell model (60). Both functions suggested a mechanism for the cognition 
enhancing effect. It also has positive effects on demyelination in experimental 
autoimmune encephalitis in mice (61). 
 
1.7.3 Haematology 
Microcirculatory blood flow was measured using spectral analysis of skin surface laser 
doppler at the Kidney acupuncture point Tai Xi. It was shown that in patients, 
following administration of Liu Wei Di Huang Wan, microcirculation was increased 
(62). Bone marrow suppressed mice showed improvements in progenitor cell 
proliferation following administration of Liu Wei Di Huang Wan when measured 
using flow cytometry (63). 
 
1.7.4 Endocrine 
Insulin sensitivity in rats was increased and insulin resistance was delayed with 
administration of the formula (64). Plasma glucose was reduced in a dose dependent 
manner even when there was insulin resistance (65). In a Cochrane review of Chinese 
herbs and glucose metabolism, impaired glucose tolerance and fasting glucose were 
both improved with Liu Wei Di Huang Wan. However, there were concerns about the 
methodologies. There was the lack of data on the herbs, risk of bias, and no account 
taken of likely reversion to normal glucose considered in the studies (66). 
 
Liu Wei Di Huang Wan used with antihypertensive drugs was more effective in 
reducing blood pressure and associated symptoms than antihypertensive drugs alone 
in an analysis of 6 trials (67). 
 
Menopausal symptoms in women either through natural decline or following surgery 
were given Liu Wei Di Huang Wan for one year, showed improvements in FSH, LH 
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and E2 levels (68). Liu Wei Di Huang Wan granules were shown to improve a range 
of markers of bone quality in ovariectomised rats (69). 
 
1.7.5 Genetic 
Looking for the geno-protective effects of Liu Wei Di Huang Wan in human cells in 
vitro by using the COMET (single-cell gel electrophoresis) assay, it was found that the 
whole formula did not protect DNA from breaking under hydrogen peroxide 
mediated stress but Cortex Moutan and Rhizoma Dioscoreae individually did (70). 
 
It is a somewhat disparate group of studies that have been found on Liu Wei Di Huang 
Wan. In TCM, Liu Wei Di Huang Wan is seen as a Yin nourishing formula; it is 
frequently used to treat older people and particularly older women. It is not 
prescribed for age, or for women, but when a diagnosis of Yin deficiency is made at 
any age. Yin deficiency is most common in the very young, and the old. The incidence 
of hypertension, insulin resistance, cognitive decline, and errors in DNA transcription 
all increase with advancing age. Many of these studies are the first of their kind, but 
they do employ standard assays and techniques. 
 
1.8 Fertility, the endometrium, and uterus 
 
Infertility is an increasing problem worldwide. Infertility can have many identifiable 
physical causes such as blocked fallopian tubes, polycystic ovaries, endometriosis or 
fibroids but in 24% of cases the cause is idiopathic (8). IVF has provided window into 
infertility; historically research into how a system works frequently begins by looking 
at dysfunction. IVF allows us to examine many of the usually concealed steps of the 
conception process. In the US five million couples are affected by infertility (71), and 
many perceive it as a stigmatising condition. Technology has provided interventions 
for those who can pay, but for many of these it simply extends the crisis and turns a 
private pain into a public one (71). Couples experiencing infertility talk of their 
sadness, depression, anger, confusion, desperation, hurt, embarrassment and 
humiliation (72). It is argued that the medicalisation of infertility leads to a disregard 
for the emotional response (73), and that therapies such as TCM, which are able to 
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acknowledge and support the emotional, as well as physical, needs may be vital to a 
successful outcome. Statistically, the limited number of herbal medicine studies so 
far, show similar success rates to IVF intervention (3, 4, 40) and the financial burden 
is significantly less. The NHS suggests a private IVF cycle costs in the region of £5000 
(74), it is in the authors experience that treatment with herbal medicines, taken over 
a 3 months period is likely to cost in the region of £1000. The emotional burden of 
infertility and IVF is often overlooked in conventional treatment and is exacerbated 
by the medications (73).  
 
 
Increasingly we are seeing women trying to conceive later in life, so age and reduced 
oocyte quality play a role. The use of IVF has increased in the thirty years since its 
inception. In 1991, 14,057 women underwent IVF, and in 2011 this number had risen to 
48,147 (2). Success rates have not improved for the majority of clinics remaining at 
around 30% (2). This is thought to be largely due to the implantation environment, 
an incredibly complex process which is poorly understood. The complete picture of 
the changes that must occur in the uterus for implantation to occur are unknown. 
The newest technique for assessing endometrial receptivity uses RNA sequencing 
from a uterine biopsy to assess the levels of expression of 236 genes which may be up 
or downregulated during the implantation window (75). 
 
One of the disadvantages to the IVF stimulation phase is supra physiological 
oestradiol concentrations which causes a pro-coagulable state. This is likely to be 
detrimental to the implanting embryo (76). It has been shown the extracts from 
Chinese herbs improve endometrial receptivity in mice that have been subjected to 
ovarian stimulation. In a mouse model of the stimulation phase of IVF, it was shown 
that the Chinese herbs reversed the downregulation of LIF and integrin β3 subunit 
which contribute to poor endometrial receptivity (10). To address the pro-coagulable 
state induced by IVF treatment, fertility clinics may use pharmacological 
interventions such as aspirin, enoxaparin, and sildenafil, which are used despite an 
inconclusive evidence base (77, 78). This provides an opportunity for further research 
on Chinese herbs to assess possible effects on haematological parameters. 
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In his book entitled “The endometrium”, Aplin (79) describes in detail the angiogenic, 
apoptic and immune processes that occur in the endometrium during the four phases 
of the female cycle. 
 
The uterus is comprised of three main layers the perimetrium, myometrium and 
endometrium. The endometrium has two distinct layers the basilis, which is 
permanent, and the functionalis which forms and sheds cyclically.  
Figure 1.1 shows how the blood vessels emerge from the arcuate vessels dividing and 
penetrating the layers of the uterus. The two uterine cell types used in the assays of 
this paper are shown in this figure for reference. 
 
1st Phase:  
The early proliferative phase follows the shedding of the functionalis during 
menstruation so repair must be initiated from the baslilis. Under the influence of 
oestrogen, mediated by insulin like growth factors, epidermal growth factor and 
transforming growth factors endometrial glands begin to transform. During this time, 
the endometrium is hostile. Endometrial arteries develop from the radial artery at the 
endometrial-myometrial border (Figure 1.1). 
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Figure 1.1 Structure of the uterus and endometrium  
showing three distinct layers and the penetrating blood vessels. The cell types of the endometrium are 
described as reference for the cell types used in the assays in this paper. 
 
2nd Phase:  
New blood vessels develop from existing mature vessels in several different processes. 
Vasculogenesis, when the vascular plexus forms angioblasts from which emerge 
primitive blood vessels. Arteriogenesis, when there is both creation of new arterial 
vessels but also enlargement of collaterals and lymphangiogensis, the formation of 
new lymph vessels. Many hormones, growth factors and cytokines have an effect on 
angiogenesis but the most well-known are the Vascular Endothelial Growth Factor 
(VEGF) family. VEGF also regulates lymphangiogensis. Oestrogen driven 
angiogenesis in the mid proliferative phase causes elongation of endometrial vessels. 
Oestrogen is considered to be a promoter of angiogenesis but it may also be 
antiangiogenic, it acts directly on the endometrial vasculature and indirectly on other 
cell types.  
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3rd Phase:  
After ovulation follows the secretory phase when, under the influence of 
progesterone, there is growth of the spiral arteries. During this progesterone phase, 
apical cellular protrusions occur in the endometrium called pinopods. These are 
thought to be involved in implantation as they are only present for a short period 
during the implantation window. Expression of apoptosis related genes B-cell 
lymphoma 2 (Bcl2) and BCL2 Associated X (Bax) are likely regulated by ovarian 
steroid hormones and are involved in remodelling as well as cell destruction. The 
Bcl2/Bax ratio alters in favour of apoptosis as the cycle progresses. Lymphomyeloid 
cells contribute to remodelling and at their most abundant may be 40% of the cellular 
content of the tissues. Eosinophils, macrophages, neutrophils, uterine natural killer 
cells, dendritic B cells, T cells and mast cells are all present. Decidualisation occurs 10 
days after the rise in progesterone levels, when fibroblast cells become more like 
epithelial cells, and well known markers such as relaxin, prolactin, insulin like growth 
factor binding protein-1 are raised. Once pregnancy is established these decidualised 
cells persist and become uniform. 
 
4th Phase:  
Menstruation is due to a loss of steroidal support. Since decidualisation is a non 
reversible differentiation, these cells must be shed if no implantation occurs. 
Withdrawal of progesterone leads to inflammation. Proinflammatory and vasoactive 
mediators lead to tissue destruction and shedding; prostaglandin F2 alpha, 
cyclooxygenase-2 and endothelin 1 are all involved. 
 
The blood supply enters the uterus through a branched structure and the vessel size 
decreases as it passes through the myometrium and into the endometrium. These 
vessels are transformed into the spiral arteries of the secretory phase which persist 
into pregnancy and are present in both basilis and functionalis (80).  The spiral 
arteries are a unique blood vessel found only in the uterus and are highly sensitive to 
the ovarian steroids. Haemodynamics have a significant effect on endothelial cells, 
and their interaction with the smooth muscles cells in the remodelling of the spiral 
arteries (81). It is the decidualisation of the spiral arteries occurring prior to 
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trophoblast invasion, which facilitates implantation and necessitates menstruation in 
the absence of the fertilised oocyte (82).  
 
Implantation of an embryo in the endometrium is a key step in establishing a 
pregnancy. It is possible only during the implantation window, which occurs 6 to 10 
days after ovulation. This is when the embryo reaches attachment competence and 
the endometrium also reaches a receptive state. A complex molecular dialogue then 
occurs between embryo and endometrium (83).  The endometrium is only receptive 
in these 4-5 days when the blastocyst can anchor to the basal lamina, and stromal 
extracellular matrix (84). Comparing gene expression in the endometrium in the 
receptive window, 172 genes were upregulated and 20 downregulated in comparison 
to the pre receptive state (85). Ovarian stimulation in IVF treatment is considered to 
be detrimental to luteal phase function, it creates an altered endocrine environment 
with dyssynchronous glandular and stromal differentiation. Pinopods, integrins and 
LIF are all prematurely expressed and this is likely to contribute to IVF failures (86).  
 
Adequate perfusion in the endometrium at embryo transfer is associated with high 
pregnancy success in IVF (87). Endometrial perfusion was seen to have greater 
predictive value of pregnancy following IVF than endometrial thickness or 
morphology (88). The high oestradiol associated with many follicles in IVF creates a 
pro-coagulable state which reduces uterine perfusion (76). Significant correlations 
with successful IVF embryo transfers were shown between a lower pulsatility index of 
the uterine artery on day 14, and increased oestrogen receptor protein (analysed from 
biopsy). This correlation was not seen with increased endometrial thickness. It was 
also observed that prolongation of unopposed oestrogen in downregulated IVF cycles, 
where a gonadotrophin releasing hormone agonist is used prior to commencement 
of stimulation, also results in a lower pulsatility index (89).The endometrial processes 
investigated through in vitro assays in this study, and the known influences of the 
herbs in Gui Shao Di Huang Wan, are expanded upon in the following sections; 
haemostasis (Section 1.9, p23), angiogenesis (Section 1.10, p31) and the steroid 
receptors (Section 1.11, p37). 
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1.9 Endometrial haemostasis and effects of GSDW component herbs 
 
1.9.1 Haemostasis and the endometrium 
 
Haemostasis is the process by which blood is kept as a fluid, and how bleeding is 
arrested after damage to a blood vessel. If a vessel is damaged, collagen in the vessel 
wall is exposed and promotes clot formation (Figure 1.2, p25). Von Willebrand factor 
present in the blood binds to collagen and to the platelets which then aggregate. 
Platelets alone are not robust enough to maintain a clot against arterial pressure and 
so a series of reactions leads to the creation of thrombin, which converts soluble 
protein into insoluble fibrinogen. This forms a mesh which imparts structural 
integrity to the aggregation of platelets. Inhibitors exist to modulate this process and 
shut down the coagulation cascade once the bleeding is stopped. Once the vessel has 
been repaired the clot is broken down by plasmin in a similar process to thrombin 
formation of the clot but with different activators and inhibitors (90). 
 
There are a number of in vitro assays used to examine the haemostatic process. 
Prothrombin Time (PT) is considered to measure the time to clot formation via the 
extrinsic pathway (Figure 1.2) and detects changes relating to factors II, V, VII, X or 
fibrinogen. The intrinsic pathway measured by the Activated Partial Thromboplastin 
Time (aPTT) may be due to modifications of factors II, V, VII, IX, X, XI, XII, or 
fibrinogen. These changes may be due to such alterations in the levels or availability 
of these factors, to drugs, vitamin K and autoantibodies. Thrombin Time (TT) assesses 
any influence of the conversion of fibrinogen to fibrin only (90). 
 
Endometrial bleeding affects the capillary and vascular structures of the functionalis, 
which comprises a layer of endothelial cells wrapped in pericytes on a basement 
membrane. Coagulation in the endometrium is different from the rest of the body as 
the process is under the regulation of the ovarian steroids (81). Normal menstrual 
bleeding is the result of enzymatic auto digestion of the functionalis. The proteolytic 
enzyme plasmin is thought to be responsible for preventing the thrombi typical in 
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blood exposed to the collagen of damaged vessels. Lysosomes containing proteolytic 
enzymes are present in epithelial, stromal, and endothelial cells. During the secretory 
phase progesterone stabilises lysosomal membranes, but as the corpus luteum 
disintegrates, this support is withdrawn and the lytic enzymes are released (91).  
 
Factor VII binds to tissue factor, which mediates haemostasis via thrombin 
generation, and plasminogen activator inhibits fibrinolysis, both of which are 
regulated by progesterone (92). Successful implantation requires the trophoblast to 
penetrate maternal uterine circulation whilst the endometrium retains haemostasis.   
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Figure 1.2 The cascade model of haemostasis 
showing the fundamental activations and conversion leading to cessation of bleeding. This is presented as 
two pathways, intrinsic and extrinsic, which in vivo occur simultaneously but are used to evaluate clotting 
disorders and anti-coagulants in vitro by the aPTT and PT tests.  
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A condition known as antiphospholipid syndrome is when the immune system 
creates antibodies against a range of phospholipids involved in the haemostatic 
cascade. It is known to cause problems in pregnancy such as implantation failures in 
IVF, early pregnancy loss, placental insufficiency, and pre-eclampsia (90). Although 
the pathogenic mechanisms of this syndrome are not fully understood, aspirin, and 
enoxaparin are used for their treatment. Enoxaparin is a low molecular weight 
heparin. Heparin has been suggested to inhibit the binding of phospholipids with 
antibodies (93). Both heparin and enoxaparin bind to antithrombin III inactivating 
factors Xa and IIa. Heparin has a greater inhibition on factor Xa and enoxaparin on 
factor IIa (94). Therapeutically heparin is less often used as it binds with plasma 
proteins, platelets, macrophages, and endothelial cells which enoxaparin does not 
(95). Aspirin inhibits platelet aggregation which may prevent hyper coagulation once 
implantation has occurred (96). A Cochrane review in 2005 examined studies 
including combinations of therapies; aspirin, heparin, enoxaparin, prednisone, and 
intravenous immunoglobulin. This review concluded that use of the combination of 
enoxaparin and aspirin may reduce pregnancy loss by 54% (97). Contradictory 
opinions have been published since (77, 78).   
 
Inflammation and haemostasis are closely interlinked. Inflammation repairs tissue 
damage due to infection, haemostasis damage to vessels. The mediators of 
inflammation increase platelet activation, impair anti-coagulant pathways, supress 
fibrinolysis and downregulate tissue factor (98). In GSDW 34 of the compounds do 
have anti-inflammatory functions although these links are not explored here. 
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1.9.2 The effects of GSDW herbs on haemostasis 
 
A summary of the actions of the herbs within the formula can be found in Table 1-2, 
p31, but here they are discussed in more detail with references to the literature. 
1.9.2.1 Radix Paeoniae Alba and Cortex Moutan 
A study into the ethanolic whole herb extract of Radix Paeoniae Alba has been shown 
to extend the aPTT, possibly by inhibition of thrombin and fibrin polymerisation, and 
endogenous blood coagulation (99, 100). Within Radix Paeoniae Alba and Cortex 
Moutan, which are both peonies, are a range of compounds which are thought to 
mediate the improved blood circulation and inhibit platelet aggregation. This 
includes paeonol, paeoniflorin, benzoylpaeoniflorin, and benzoyloxypaeoniflorin In 
addition, methylgallate, catechin, paeoniflorigenone, galloylpaeoniflorin, and 
daucosterol may contribute to these actions (101).  
 
Paeonol and a three synthesized derivatives of paeonol were tested in an automated 
platelet aggregation analyser, and have been shown to inhibit platelet aggregation 
(102). Paeonol has a potent vasodilatory effect, it attenuates intracellular Ca2+ by 
impairing the Ca2+ channels in vascular smooth muscle, and thereby interrupting the 
excitation-contraction coupling process (103). Both vasodilatory and anti-
inflammatory effects were found for the 1,2,3,4,6-penta-O-galloyl-β-D-glucose which 
is present in Paeoniae. It is thought to dilate smooth muscle and suppress 
inflammation via endothelium dependent nitric oxide / cyclic guanosine 
monophosphate signalling (104). 
 
Paeoniflorin has a series of anti-thrombotic effects which have been shown in vitro in 
HUVECs. It increases tissue plasminogen activator, an enzyme, and so increases 
fibrinolysis.  In platelets, it has been shown to decreases thromboxane A2 (TXA) 
production and so reduces platelet aggregation and inhibits production of new 
platelets. (105). Two acetophones 2,5-dihydroxy-4-methoxyacetophenone and 2,5-
dihydroxy-4-methylacetophenones were shown to inhibit the aggregation of platelets 
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in vivo in rabbits, and these were found to be more potent than the major compound 
paeonol (106).  
1.9.2.2 Radix Angelicae Sinensis  
Radix Angelicae Sinensis, used in a 5:1 ratio with Radix Astragali in a formula known 
as Dang Gui Bu Xue Tang, has long been used to “tonify the Blood” in TCM. A study 
of the effects of these herbs traditionally decocted in combination showed that Hep3B 
cells, exposed to the formula, demonstrate that it regulates erythropoietin mRNA 
expression, and secretion of erythropoietin protein (107). Erythropoietin stimulates 
the production of erythrocytes.  Angelicae Sinensis has been shown to be anti-
thrombotic in a rat model of in vivo thrombosis, significantly increasing prothrombin 
time and TT (108). Polysaccharides of Radix Angelicae Sinensis have also been shown 
to have both haematopoietic and thrombopoietic actions. Peripheral blood cells from 
a mouse model of thrombocytopaenia, treated with the polysaccharides of Radix 
Angelicae Sinensis, showed increased recovery of erythrocytes, leukocytes, and 
platelet numbers (109).  
 
(Z)-ligustilide, in Radix Angelicae Sinensis, is a monomeric phthalide that has been 
investigated for its neuroprotective effects in ischaemia. Part of this protection may 
be due to its inhibition of platelet aggregation thus preventing thrombosis. The 
effects do not appear to be mediated through the intrinsic or extrinsic pathways as 
time to clot formation was not prolonged when looking at PT or aPTT (110). N-
butylphthalide has antiplatelet and antithrombotic effects when administered to 
mice with collagen and epinephrine induced thromboembolism (111). Radix Angelicae 
Sinensis contains p-cresol a phenolic compound which reduces thrombosis by 
inhibiting platelet aggregation, reactive oxygen species production, extracellular 
signal-regulated kinase /p38 activation and TXA2 production (112). Oleic acid is a fatty 
acid in Radix Angelicae Sinensis found in the membranes of erythrocytes (113). It may 
serve as an intracellular messenger in human platelets (114). α-pinene found in Radix 
Angelicae Sinensis has been shown to be antithrombin and anti platelet aggregatory 
(115). 
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Radix Angelicae Sinensis extract was fractioned and the parts investigated for their 
anticoagulant activity. It was found that the petroleum ether soluble fraction had the 
highest anti-coagulant activity on TT using rat plasma. They identified 26 compounds 
in this fraction and found 38 metabolites of these in vivo. Additional compounds 
identified as anticoagulant include senkyunolide I, senkyunolide D and senkyunolide 
F (116). 
 
Compounds in Radix Angelia Sinensis do have serotoninergic actions, binding to 5-
HT7 receptors in vitro (117) and this receptor affects haemodynamics by acting as a 
vaso-relaxant (118). Platelets do have serotonin binding sites and serotonin is involved 
in platelet aggregation (119). 
 
1.9.2.3 Radix Rehmanniae Preparata 
Radix Rehmanniae Preparata was found to contain a bis-furan derivative 1,5-bis(5-
methoxymethyl)furan-2-yl-penta-1,4-dien-3-one which inhibits in vitro platelet 
aggregation (120). Salidroside which is also present, has been shown to protect human 
erythrocytes from H2O2 induced haemolysis in vitro (121). Catalpol which is present 
in Radix Rehmanniae, administered to a rat stroke model was shown to upregulate 
erythropoietin expression, when sections of brain tissue were probed (122).  
 
1.9.2.4 Rhizoma Dioscoreae  
Diosgenin is a steroidal saponin found in Rhizoma Dioscoreae. This compound has 
been isolated from other plants and found to have antithrombotic effects, it produces 
elongated PT, aPTT, TT, and inhibition of platelet aggregation in vitro. In vivo inferior 
vena cava ligation in rats showed inhibition of thrombus formation. Increases in in 
vivo tail bleeding and time to clot formation were shown in mice.(123). 
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1.9.2.5 Fructus Corni 
Fructus Corni contains eugenol and elemicin (124) and these have been shown to have 
anti platelet action through inhibition of TXA2, TXAB2, and of cyclooxygenase2 in a 
manner similar to that of aspirin (125). 
 
No evidence of research into the haemostatic properties of Sclerotium Poria Cocos 
and Rhizoma Alismatis was found. 
 
In Radix Paeoniae Alba and Cortex Moutan are a range of compounds which inhibit 
platelet aggregation, modify Ca2+ channels to vasodilate smooth muscle cells, and 
increase fibrinolysis. Radix Angelicae Sinensis regulates erythropoietin, is anti 
thrombotic, haematopoietic and thrombopoietic. In Radix Rehmanniae compounds 
inhibit platelet aggregation, protect against oxidative stress, and upregulate 
erythrocyte production. Rhizoma Dioscoreae is antithrombotic and thrombolytic.  
 
Overall, the combination of herbs in the formula GSDW would be expected to reduce 
platelet aggregation, more rapidly break down clots, increase production of 
erythrocytes and be vasodilatory. Twenty compounds within five of the eight herbs 
in GSDW have been researched for their mechanisms of influence on haemostasis 
both in vitro and in vivo. It is expected that the whole formula would have a significant 
effect on blood clot formation and on breaking down clots which form. Table 1-2 
summarises the effects on haemostasis of the herbs or compounds within them. It is 
important to note when looking at any compounds whether they are soluble in water 
and therefore extracted from the plant material in an aqueous decoction. This also 
influences whether they will be bioavailable once ingested. _Solubility of organic 
compounds is dependent on their polar group e.g. hydroxyl and amine function 
groups and the extent to which they interact with water. Saponin type entities in 
herbs can behaving like surfactants solubilising the more lipophilic compounds. 
Listed in Table 1-2 and Table 1-3 are the predicted solubilities based on the structure 
of the molecule (126) at pH 7.2 and 25°C with those closest to 0 being the most soluble 
and -10 being least soluble in water (127). These are approximations based on the 
chemical structure and will vary from expected due to the pH of the solution, 
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temperature, and other compounds present during extraction. Z-ligustilide for 
example has been considered to be insoluble in H2O, but despite having low solubility 
it has been detected by HPLC in aqueous extraction of Radix Angelicae Sinensis (128).  
 
Table 1-2 Compounds known to occur in the herbs included in the formula which influence on haematology 
 
 
1.10 Endometrial angiogenesis and effects of GSDHW component herbs 
 
1.10.1 The endometrium and angiogenesis 
 
Herb Compound / Herb  Aqueous 
solubility 
LogS 
Action 
Radix Angelicae Sinensis  Whole herb  Antithrombotic, haematopoietic and 
thrombopoietic 
 With Radix Astragali  Regulate erythropoietin 
 (z)-ligustilide -2.58 Inhibits platelet aggregation 
 p-cresol -0.67 
 
Inhibits platelet aggregation, ROS production, 
ERK/p38 activation and TXA2 production 
 Oleic acid -6.37 
 
Intracellular messenger in human platelets 
 α-pinene -2.94 Antithrombin and anti platelet aggregatory 
 N-butylphthalide -3.46 Antiplatelet and antithrombotic 
Radix Paeoniae Alba and 
Cortex Moutan 
Whole herb  Inhibition of thrombin and fibrin polymerisation 
and endogenous blood coagulation 
 Benzoylpaeoniflorin 
Benzoyloxypaeoniflorin 
Methylgallate 
Catechin 
Paeoniflorigenone, 
Galloylpaeoniflorin 
Daucosterol 
-2.97 
-2.93 
-1.65 
-2.65 
-1.85 
-2.74 
-5.31 
Improve blood circulation, inhibit platelet 
aggregation 
 Paeonol -1.75 Inhibit platelet aggregation, vasodilatory 
 Paeoniflorin -1.96 
 
Inhibit platelet aggregation, reduce production of 
platelets, increase fibrinolysis. 
 1,2,3,4,6-penta-O-galloyl-β-D-
glucose 
-3.14 
 
Vasodilatory and anti-inflammatory 
 2,5-dihydroxy-4-
methoxyacetophenone 
-1.68 
 
Inhibits platelet aggregation 
Sclerotium Poria Cocos n/a   
Radix Rehmanniae 
Preparata  
1,5-bis(5-methoxymethyl) 
furan-2-yl-penta-1,4-dien-3-
one 
-4.33 
 
Inhibit platelet aggregation 
 Salidroside -1.36 Protects erythrocytes 
 Catalpol -0.19  Upregulates erythropoietin expression 
Rhizoma Dioscoreae Diosgenin -5.88 
 
Antithrombotic, thrombolytic, inhibits platelet 
aggregation, increases time to clot formation 
Fructus Corni Eugenol 
Elemicin 
-2.06 
-3.16 
 
 
Inhibit platelet aggregation 
Rhizoma Alismatis n/a   
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New blood vessel formation such as that seen in the endometrium is uncommon in 
the adult body. The arcuate arteries in the myometrium end in arterioles, which pass 
into the basalis of the endometrium where they are initially straight, but become 
spiralled as the cycle progresses (129). Vasculogenesis is the creation of new vessels 
from precursor cells, and angiogenesis is the process of new vessels forming from the 
existing network by elongation, sprouting, or intussusception. These are multi step 
processes which include proliferation and migration of endothelial cells through the 
extracellular matrix under the influence of multiple regulators and growth factors 
(130).  
 
There has been debate over the proliferation of endothelial cells in the endometrium, 
an early study states that the number of vessels does not change through the cycle, 
but this study was looking at the endometrium as a whole (131). Another study 
suggests that significant proliferation occurs at all stages of the menstrual cycle in 
humans (132). It has been found that the number of vessels does not change 
dramatically but the proportion surrounded by vascular smooth muscle cells does 
(133) and also that little changes in the basalis but there is proliferation in the 
functionalis (134). 
 
The cycling endometrium is a highly angiogenic tissue and defects in this process 
could to contribute to implantation failure and recurrent miscarriage. Angiogenesis 
in the functionalis during the proliferative phase, occurs through elongation. In the 
late proliferative and early secretory phase the complex branched capillary sub 
epithelial network occurs through intussusception from the vascular stumps that 
remain in the basal layer of endometrium following menstruation (135).  
Intussusception is described as the process of increasing capillary complexity through 
the insertion of trans-capillary pillars which divide the existing vessel. Conventional 
sprouting angiogenesis is where a new vessel is formed, often extending across gaps 
in the vasculature. Intussusception permits rapid expansion of the capillary network 
(136). 
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Migration of endothelial cells occurs predominantly post menstruation but there is a 
mid to late proliferative rise in migratory activity and some evidence of migration mid 
secretory which may be associated with spiral artery development. As each of these 
occur under variable prevailing hormonal influences the mechanisms are likely to be 
different (137). Migration of endothelial cells is in part regulated by sheer stresses 
influenced by the blood flow (138). A representation of these interactions can be seen 
in Figure 1.3. 
 
Vascular endothelial growth factor (VEGF) mediates endometrial angiogenesis and is 
in part controlled by the oestrogen receptors, Oestrogen Receptor alpha (ERα) and 
Oestrogen Receptor beta (ERβ) (88). Oestrogen and progesterone regulate uterine 
vascular function upregulating VEGF and fibroblast growth factor2 messenger 
ribonucleic acid (mRNA) and protein expression (89). Endothelial cell migration, 
viability, tube formation and haematopoietic functions are all in part regulated by 
VEGFR2 and integrin αvβ3 (139). In the proliferative phase, endothelial cells express 
VEGFR2, but after ovulation these receptor levels decrease and VEGFR1 increases. 
When VEGF binds to VEGFR1 it causes endometrial cells to migrate whereas VEGFR2 
leads to proliferation (140).  
 
In vitro assays for the evaluation of angiogenesis have commonly been performed with 
HUVECs which are easy to obtain. But, since angiogenesis often involves the micro 
vasculature rather than the macro vasculature, these are not an ideal model (141), it is 
better to use the specific tissue type where possible. The characteristics of HUVECs 
and placental microvascular endothelial cells were shown to have phenotypical and 
physiological differences (142). 
 
Oestrogen and progesterone both upregulate angiogenesis, but these receptors are 
lost on HUVECs after six passages (143). Oestrogen and progesterone receptors affect 
vasculature in the endometrium and receptors have been demonstrated on 
endothelial and smooth muscle cells. Oestrogen has been shown to increase the 
density of the microvasculature, permeability, and vasodilation of endothelial cells. 
Increase in vascular density has been shown in response to progesterone (144).  
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1.10.2 The effects on GSDW herbs on angiogenesis 
1.10.2.1 Radix Angelicae Sinensis  
Effects of an aqueous Radix Angelicae Sinensis extract on angiogenesis showed that 
HUVEC proliferation was increased, as was migration in the wound healing assay, 
and mean tubule length in the differentiation assay on matrigel. The extract was also 
used to demonstrate changes in angiogenesis in vivo in zebra fish. All results indicated 
the extract promotes angiogenesis and that these effects are due to p38 and c-Jun N-
terminal Kinase (JNK) 1/2 phosphorylation. P38 and JNK 1/2 are mitogen activated 
kinases which are involved in VEGF signalling (145). 
 
N-Butylphthalide derived from the volatile oils of Radix Angelicae was shown to 
inhibit angiogenesis in in vitro matrigel assays and in vivo capillary sprouting of 
mouse aortic rings (146).  
 
The angiogenesis activity was seen in an aqueous extract and the anti-angiogenic in 
the volatile oils. This pattern of opposite influences on angiogenesis, in compounds 
present within a single herb, was also seen in also Radix Ginseng (15). 
 
Ferulic acid is present in Radix Angelicae Sinensis and has been shown to induce 
significant angiogenesis in HUVECs, and to promote the formation of microvascular 
networks in vivo. Ferulic acid is hypothesised to modulate VEGF, platelet derived 
growth factor and hypoxic inducible factor 1-ɑ (147). It has also been shown to 
promote proliferation of endothelial cells through upregulating cyclin D1 and VEGF 
in a dose dependent manner (148).  
 
1.10.2.2 Cortex Moutan 
Cortex Moutan contains quercetin, which is also present in many plant foods. 
Quercetin is seen in vitro to inhibit cell viability, expression of vascular endothelial 
growth factor receptor 2 and angiogenic tube formation (149). Quercetin inhibits 
tubule formation by directly inhibiting p300 histone acetyltransferase which 
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suppresses activation of the cyclooxygenase-2 pathway which stimulates angiogenic 
growth factors such as VEGF and B-cell lymphoma 2 (BCL) (150).  
1.10.2.3 Radix Rehmanniae Preparata  
Radix Rehmanniae Preparata aqueous extract was shown to promote angiogenesis in 
diabetic wound healing, although the exact compounds involved were not 
investigated (151). Catalpol in Radix Rehmanniae Preparata has been shown to 
increase brain angiogenesis, probably through its effects on erythropoietin and 
vascular endothelial growth factor (122). It was also shown to stimulate human 
mammary endothelial cells to increase tubule length, sprout formation and cell 
migration (152). Rehmanniae contains campesterol which has been isolated from 
Chrysanthemum coronarium L. and shown to inhibit angiogenesis and disrupt 
neovascularization in chick chorio-allantoic membranes (153).  
1.10.2.4 Rhizoma Dioscoreae 
A polysaccharide from Rhizoma Dioscoreae was isolated and shown to promote 
proliferation of human endometrial epithelial cells. This is attributed to the decrease 
in levels of BCL2-Associated X proteins which promote cell death and the increase in 
anti-apoptic BCL-2 protein leading to reduced cell death and a higher number of 
epithelial cells (154). 
1.10.2.5 Fructus Corni  
An ethanol extract of Fructus Corni was shown to be inhibitory to angiogenesis in 
HUVECs. Immunoblotting shows that it has the effect of suppressing vascular 
endothelial cadherin which is a component of the endothelial cell junctions and 
protein kinase B which regulates angiogenesis via VEGF (155). Cornel iroid glycosides 
from Fructus Corni have been shown to promote neurogenesis and angiogenesis after 
induced cerebral ischaemia in rats. There was upregulation of VEGF seen in the cortex 
of the rats (156).  
 
No evidence of research into the angiogenic properties of Radix Paeoniae Alba, 
Sclerotium Poria Cocos, and Rhizoma Alismatis were found. 
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Across the herbs in GSDW are a range of pro and anti angiogenic compounds and the 
effects of any compound are not quantified. It is not clear from the research what the 
overall effect of the formula is likely to be. Table 1-3 summarises the known 
angiogenic promoting or inhibiting properties of the herbs and compounds discussed 
above.  
 
Table 1-3 Herbs and compounds in GSDW known to have angiogenic promoting or inhibiting properties 
 
 
  
Herb Inhibits angiogenesis Aqueous 
solubility  
Log S 
predictions 
Promotes angiogenesis Aqueous 
solubility  
Log S predictions 
Radix Paeoniae Alba n/a    
Radix Angelicae Sinensis  N-Butylidene phthalide 
 
-3.11 Whole herb 
Ferulic acid 
N-Butylphthalide 
 
-2.33 
-3.46  
 
Sclerotium Poria Cocos n/a    
Cortex Moutan Quercetin -3.06   
Radix Rehmanniae Preparata  Campesterol -7.26 Whole herb 
Catalpol 
 
-0.19 
Rhizoma Dioscoreae   Single polysaccharide 
promotes proliferation  
unknown 
Fructus Corni    Cornel iroid glycosides 
upregulate VEGF 
unknown 
Rhizoma Alismatis n/a    
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1.11 Endometrial ovarian steroid receptors and effects of GDSW component 
herbs 
 
1.11.1 Endometrial ovarian steroid receptors 
 
Endometrial blood vessels are unique in their regulation by oestrogen and 
progesterone, and the paracrine mediation of these actions on vascular and other cells 
of the endometrium. Regulatory mechanisms are not well understood and many 
factors have been identified but are likely to have zone and cell type specific 
regulatory function (157).  
 
Both ERα and ERβ, membrane Progesterone Receptor alpha (mPRα) and 
Progesterone Receptor beta (PRβ), are all expressed in the epithelial, stromal and 
vascular cells (84). At a simplistic level, rising oestrogen levels in the secretory phase 
predominantly enhances endometrial cell proliferation, while progesterone in the 
secretory phase leads to differentiation. However ERα is thought to be necessary for 
downregulation of PR, and PR in stroma are required to inhibit oestrogen stimulated 
proliferation (158). The interactions between the hormones and receptors are 
complex, and this is compounded when the interactions of angiogenesis and blood 
flow are added, as is illustrated in Figure 1.3. All these factors influence one another, 
they do not occur in isolation. 
 
In an examination of the glandular, stromal, and vascular compartments of the 
endometrium over an entire cycle, it has been shown that ERα is more predominant 
than ERβ, but both vary through the cycle. In the proliferative phase, glandular, 
stromal, and vascular compartments express ERα and ERβ, but ERα is more 
predominant. ERβ staining peaks on the periovulatory days in epithelial cells and ERα 
in mid proliferative and periovulatory phases. In the secretory phase this expression 
of ERα is reduced as is glandular ERβ. ERα drops and ERβ increases in vascular cells, 
and in the smooth muscles of the spiral arteries in the late secretory phase (159). It 
Introduction 
 
38 
has been proposed that ERβ may be needed for uterine perfusion over the long term 
in response to oestrogen during pregnancy, and ERα for the dynamic vasodilation in 
remodelling (160). ERα is involved in the dynamic control of actin arrangement and 
cell migration through recruitment of focal adhesion kinase which regulates the 
connections of the cytoskeleton of a cell to the extracellular matrix (161).  
 
ERα increases in response to oestrogen in the proliferative phase and is diminished 
in response to progesterone in the secretory phase; so the endometrium is resistant 
to oestrogen in the implantation window. This decline in ERα is thought to be an 
important effect, signalling receptivity to begin. Inappropriately high expression of 
ERα is seen in reproductive disorders such as luteal phase defects, endometriosis, and 
polycystic ovarian syndrome (162). 
 
Progesterone selectively down regulates PR expression and is important in 
establishing endometrial receptivity. It may be that abnormal persistence of the PR is 
a contributor to infertility. It has been suggested that PRβ may remain whilst PRα 
declines (163). Progesterone in vivo shows anti proliferative effects on 
microvasculature and on decidual endothelial cells (92). Serum progesterone 
facilitates pinopod formation (164) and luminal closing, which facilitates blastocyst 
apposition (165). 
 
PRs regulate many genes for growth factors, transcription factors, and morphogens 
(165). The receptor is present exclusively in uterine blood vessels and selectively in 
uterine veins and lymphatic vessels, it is also present in the smooth muscle cells of 
the uterine arteries but not in the endothelium (166). 
 
The increase in vascular permeability that makes the endometrium receptive to 
implantation is controlled by PRs. This increased permeability is vital for the proteins 
contained in the blood to pass into the interstitial space to support the developing 
blastocyst (167). PRs also co-ordinate the molecular changes in the stroma, matrix, 
and vasculature that govern decidualisation (168) and lead to the establishment of a 
pregnancy. Progesterone receptors in the endometrium are increased in pregnancy 
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and are key to maintaining the endometrium (139). Smooth muscle cells of the spiral 
arteries have high levels of PRs, suggesting it modulates blood during pregnancy 
(169). 
 
Loss of progesterone signalling has been implicated in endometriosis when PRs are 
reduced, especially PRβ. Loss of PRβ in the stroma of the endometrium leads to 
abnormal interactions between the epithelium and the stroma and causes epithelial 
cell defects (140).  
 
Rapid responses to progesterone initiated at the cell surface have long been described, 
but only recently been characterised as due to the presence of membrane 
progesterone receptors. These have been shown to exist in three forms; alpha, beta, 
and gamma, and belong to the seven-transmembrane progesterone adiponectin Q 
receptor family (93). Membrane PRs are highly tissue specific and mPRα is the 
predominant form in reproductive tissues (170). It has been implicated in regulation 
of progesterone function in the uterus in humans and in gonadotrophin releasing 
hormone secretions in rats (171). Membrane bound receptors are present in the 
human cervix, and upper and lower myometrium (172). It is suggested the membrane 
bound progesterone ratios may be important in triggering labour (141).  
 
As with progesterone receptors there are membrane bound oestrogen receptors such 
as G protein-coupled oestrogen receptor 1 which appear to be regulated by the nuclear 
oestrogen and progesterone receptors (173).  
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Figure 1.3 Angiogenesis in endothelial cells and actions of oestrogen and progesterone receptors in the 
endometrium. 
 
1.11.2 The effects of GSDW herbs on endometrial ovarian steroid 
receptors 
1.11.2.1 Radix Angelicae Sinensis  
Administration of an aqueous extract of Radix Angelicae Sinensis led to an increase 
in ERα and ERβ, but not all activities could be attributed to these receptors as the 
response pattern was different to that of oestradiol (174).  Dang Gui Bu Xue Tang 
aqueous extract containing Radix Angelicae Sinensis was shown to phosphorylate 
ERα at Ser 167, a different location on the ER to that of oestrogen which binds 
predominantly at Ser 118 (175). Radix Angelicae Sinensis contains a flavonoid, 
calysosin, with a similar structure to oestradiol and has been suggested to impart its 
oestrogenic action in human mammary epithelial carcinoma cells in vitro (176).  
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An ethanolic extract of this herb was also shown to have anti-progesterone activities 
in a progesterone receptor-positive human mammary adenocarcinoma cell line MCF-
7, using a transfected progesterone response element-driven luciferase reporter gene 
bioassay (177). 
 
1.11.2.2 Rhizoma Dioscoreae 
The same anti-progesterone activities were seen for an ethanolic extract of Rhizoma 
Dioscoreae MCF-7 (177). In another study, an extract of Rhizoma Dioscoreae showed 
that PR was upregulated in MCF-7 breast cancer cells and ERα was downregulated 
(178). A third study showed that ERβ was upregulated by oestrogen stimulating 
proteins isolated from an aqueous extract of Dioscoreae but ERα was not (179).  
 
It is expected that ERα and β will be upregulated by Radix Angelicae Sinensis and that 
PRα and β may be downregulated. The outcomes for Rhizoma Dioscoreae is more 
unpredictable with both downregulation and no changes of ERα seen, upregulation 
of ERβ, upregulation of PR with anti-progesterone activities. For these studies, the 
details of the compounds within the extracts used in the studies are not included, 
making an understanding of the conflicting results difficult. 
 
1.12 Research into TCM formulae used in treating infertility 
 
A number of studies have been undertaken almost exclusively in China, many more 
than those discussed here, but those that will be discussed here are considered to be 
of higher quality and the most pertinent to this investigation. The studies presented 
used a range of different formulae (11 in total) and Table 1-4, p44 lists the herbs which 
are present in each of the formulae discussed.  
 
The formulae all treat the Kidneys some focussing on Yin, Yang, or both and they all 
nourish and move Blood. Table 1-4, p44 shows the herbs which are common to the 
formula used in this study and the herbs which are different. Radix Angelicae Sinensis 
is in 6 of the 11 formulae and Radix Rehmanniae is in 3 of the 11, but there are 44 
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unique herbs in the 11 formulae. The herbs and formulae that could have been chosen 
to study are extensive.  
 
The “correct” way to administer a Chinese herbal medicine is to make an 
individualised prescription according to the patient not the disorder. There is a saying 
in Chinese medicine ‘Tong Bing Yi Zhi, Yi Bing Tong Zhi’, which means same disease 
different treatment, different disease same treatment. In essence, it means each 
person and disease must be diagnosed and treated in their own way. The concept of 
personalised medicine is emerging into mainstream healthcare with evidence and 
discussion of how genomics might be part of NHS care in the UK, in particular within 
the context targeted cancer care, prevention of disease, and screening (180). 
 
Bu Shen An Tai up regulates endometrial leukaemia inhibitory factor (LIF) 
expression, which increases cyclooxygenase that enhances vascular permeability and 
angiogenesis in mice with an embryonic implantation dysfunction (11). This formula 
also regulates endometrial thickness, micro vessel density and number of pinopods 
during the implantation window in mice (181). 
 
Bu Shen Yu Gong was tested in rats and seen to increase levels of oestrogen receptors, 
increase the number of follicles, weight of the uterus, and serum oestradiol levels 
(182). 
 
Er Zhi Tian Gui increases DNA methyltransferase 1 expression in the endometrium of 
infertile women during the implantation phase, which may lead to greater receptivity 
(13). In mice it is thought to improve oocyte quality by elevating insulin like growth 
factor 1R mRNA in ovarian granular cells (183). The expression of integrin β3 and its 
ligand osteopontin in the endometrium were normalised in a mouse model of IVF 
using ovarian stimulation (184). 
 
Gui Zhi Fu Ling Wan leads to a regression of endometriotic implants in rats by 
immunological regulation (185). 
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Jian Tai Ye formula was administered to mice with an induced endometrial 
dysfunction and analysis of the endometrial oestrogen receptors and mRNA showed 
that both were up regulated (12). 
 
Nu Zhen Yun Yu was shown to improve the blood supply to the ovaries and the uterus 
as seen on Doppler in humans (186). 
 
Yi Wei Ning was administered in a rat model of endometriosis and shown to inhibit 
synthesis and secretion of tumour necrosis factor-alpha, interleukin (IL) -6 and IL8, 
molecules which may contribute to infertility (187). 
 
You Gui Wan was administered to rats following an ovariectomy. Combined 
administration of the herbs and oestrogen supplementation prevented the atrophy of 
the vaginal fold and blood vessels in the lamina propria, without causing endometrial 
hyperplasia. It did not increase oestrogen levels, but upregulated ERα and ERβ 
receptors (188). 
 
Zhu Yun aqueous extract used in a rat model has been used to improve endometrial 
receptivity and counteract the dysfunction seen as a result of the ovarian stimulation 
used in IVF cycles. It was shown to reverse the high expression of endometrial LIF 
and integrin β3 (10). 
 
Zi Shen Yu Tai has been shown to improve implantation rates in women undergoing 
IVF treatment. This formula has also been shown in a mouse model to ameliorate the 
early endometrial maturation associated with the stimulation drugs used in IVF cycles 
and improves receptivity by up regulating homeobox A10 (189). It has been shown to 
have a significant effect on threatened abortion in rats by increasing levels of 
oestradiol and progesterone, and regulating the Type 1 T helper /Type 2 T helper 
balance (190). 
 
Most of these studies are using mouse or rat models to examine the influence of the 
formulae. This incorporates both the complexity of the whole organism and of the 
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whole formula, whilst looking for specific effects. There are however substantial 
differences between different species in their menstrual cycles, fertilisation and 
implantation environments (191). Mice and rats reproduce quickly, are mammalian 
and so share many reproductive features. Additionally, obtaining ethical approval to 
work with mice and rats is easier than on human women with infertility. 
 
Table 1-4 shows the herbs which are contained each of the formulae discussed 
above, for the Latin nomenclature of the herbs see Appendix II. This provides an 
insight into the range of herbs and formulae that are investigated for their effects on 
fertility. There are both overlaps and disparities. 
 
Table 1-4 The herbs present in the formulae discussed with an effect on endometrial receptivity 
 
Formula TCM actions Herbs in formula different to Gui Shao Di 
Huang Wan 
Herbs in formula in common with Gui 
Shao Di Huang Wan 
Gui Shao Di 
Huang Wan 
Tonify Kidney Yin and 
Blood 
 Radix Rehmanniae, Fructus Corni, Rhizoma 
Dioscoreae, Sclerotium Poria Cocos, 
Rhizoma Alismatis, Cortex Moutan, Radix 
Angelicae Sinensis, Radix Paeoniae Alba 
Bu Shen An 
Tai 
 
Tonify Spleen and 
warm Kidney 
Semen Cuscutae, Radix Dipsaci, Ramulus 
Loranthi, Radix Astragali seu Hedysari Radix 
Salviae Miltiorrhizae  
Radix Angelicae Sinensis 
Bu Shen Yu 
Gong 
Tonify Kidney Yin and 
Yang, nourish Blood 
Semen Cuscutae, Cortex Eucommia, 
Fluoritum, Placenta Hominis, Cornu Cervi, 
Radix Salviae Miltiorrhizae 
Radix Rehmaniae, Fructus Corni 
Er Zhi Tian 
Gui 
Tonify Yin and Blood Fructus Ligustri Lucidi, Herba Eclipta Alba, 
Fructus Lycii, Semen Cuscutae, Radix 
Ligusticum wallichii, Rhizoma cyperi, Radix 
Glycyrrhizae Preparata 
Angelicae Sinensis, Radix Paeoniae Alba, 
Radix Rehmaniae 
Gui Zhi Fu 
Ling Wan 
 
Warm Kidney, move 
Blood and dispel stasis 
Ramulus Cinnamomi Cassiae, Semen Pruni 
Persicae 
 
 
Sclerotium Poria Cocos, Cortex Moutan, 
Radix Paeoniae Lactiflorae 
Jian Tai Ye Tonify yin, move and 
tonify Blood 
Ramulus Loranthis, Radix Salviae 
Miltiorrhizae, Rhizoma Ligustici Chuanxiong 
Radix Angelicae Sinensis 
Nu Zhen Yun 
Yu 
Tonify Kidney Yin and 
Yang, nourish Blood 
Semen Cuscutae, Fructus Ligustrum, Radix 
Salviae Miltiorrhizae, Fructus Lycii, Radix 
Bupleuri, Fructus Rubi, Radix Glycyrrhizae 
Preparata 
Radix Angelicae Sinensis, Radix Paeoniae 
Lactiflorae 
Yi Wei Ning Move Blood Rhizoma Corydalis, Rhizoma Curcumae, 
Semen Persicae, Radix Paeoniae Rubra, Flos 
Carthami, Radix Salviae Miltiorrhizae, 
Carapax et Plastrum testudines 
Radix Angelicae Sinensis 
You Gui Wan Tonify Kidney Yang, 
nourish Blood. 
Cortex Eucommiae, Semen Custcutae, 
Fructus Lycii, Cervi Cornus, Cortex 
Cinnamomi, Radix Aconiti Preparata 
Radix Angelicae Sinensis, Radix Dioscoreae 
Oppsitae, Radix Rehmaniae 
Zhu Yun  Warm Kidney Yang Herba Epimedii, Radix Morindae Officinalis, 
Semen Cuscutae, Cortex Eucommia 
 
Zi Shen Yu Tai Tonify Kidney Yin and 
Yang, nourish Blood 
and Qi 
Semen Cuscutae, Fructus Amomi, Radix 
Ginseng, Herba Taxilli, Colla Corii asini, 
Radix Polygoni Multiflori, Folium 
Artemisiae Argyi, Radix Morinda officinalis, 
Rhizoma Atractylodis Macrocephalae, Radix 
Codonopsis, Cornu cervi, Fructus Lycii, 
Radix Dipsaci, Cortex Eucommiae 
Radix Rehmanniae 
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1.13 Summary 
 
Chinese herbs have a long history of use and of success in treating fertility. A number 
of studies on various formulae looking at fertility have been undertaken 
predominantly in China, and these suggest that some of the pharmacological 
mechanisms for the success in assisting fertility can be elucidated. Research into the 
individual herbs and compounds of Gui Shao Di Huang Wang would suggest that 
finding differences to haematology, angiogenesis and ovarian steroid receptor 
expression is likely. Figure 1.4 summaries these potential areas of influence on 
haematology in the endometrium through the menstrual cycle. 
 
 
 
Figure 1.4 An overview of the haematological processes taking place in the endometrium and areas of 
possible influence for herb extracts to be investigated. 
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Traditional indications suggest that understanding of the mechanisms of action seen 
in clinical trials may be found in the ways in which these herbs can influence the 
blood in the uterus through haemostasis and angiogenesis. Gui Shao Di Huang Wan 
is an appropriate formula to study due to its use in a clinical trial, in clinical treatment 
of infertility and presence as a core formula in TCM texts on infertility. Examination 
of the details of the endometrial changes through the menstrual cycle show that 
angiogenesis and haemostasis are important aspects of a receptive endometrium and 
that both of these are influenced by the expression of ovarian steroid receptors. 
 
The use of formulae can be seen as confounding to analysis by western methods and 
it is likely that systems biology, integrated with the reductionist approach, will lead 
to greater understanding of the effects of Chinese herbs. Pharmacokinetics shows us 
that the presence of a compound in a formula does not define if and where those 
compounds can act in the body. The examination of the effects of GSDW in 
endometrial receptivity through literature, theory, clinical trials, and bioassays each 
bring their own contributions to providing answers to the question of how this 
formula can improve measures of endometrial receptivity. 
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1.13.1 Aims and hypotheses 
 
To explore the underlying biological mechanisms by which the clinically observed 
effects of a Chinese herbal formula may improve endometrial receptivity.  
 
H1 Gui Shao Di Huang Wan will increase parameters of uterine perfusion and 
angiogenesis in endothelial cell proliferation, migration, and differentiation. 
 
H2 Gui Shao Di Huang Wan will modify oestrogen and progesterone receptor 
expression. 
 
H3 The influence of the extract whole formula Gui Shao Di Huang Wan is 
greater than the individual herb extracts. 
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2 Materials and Methods 
 
2.1 Extraction procedures for individual herbs and whole formula 
 
In practice, a Chinese herbal formula is prescribed on an individualised basis 
following a consultation with a trained practitioner of Chinese herbal medicine. This 
will typically mean modifying a classic formula; adding or removing herbs to tailor it 
to the specific patient’s symptoms and presentation. The classic formula before any 
modifications are made is what is meant by a “base” formula. The formula in this 
study was chosen as it was the base formula used in a clinical study. The study 
employed ultrasound imaging, testing of serum FSH, and serum progesterone to 
investigate the influence of herbal medicines on endometrial receptivity (3). It is also 
the base formula recommended in one of the leading textbooks on infertility (29). 
This formula is used extensively as the base formula by the practitioners at The 
London Acupuncture Clinic. This is an acupuncture and herbal clinic in Harley Street, 
London which specialises in treating infertility and where the author of this work was 
in practice for 10 years. 
 
Herbs were obtained from Avicenna, a herbal supplier based in Hove, UK. This 
company is part of the approved suppliers scheme run by the professional body the 
Register of Chinese Herbal Medicine. Samples were submitted for macroscopic 
identification and species validation to the medical botanist at Kew Gardens Jodrell 
laboratory (192). They were verified as being consistent with the authenticated 
samples held for reference at Kew (Appendix I).  
 
Each herb extract was prepared individually, and as part of a whole formula, as shown 
in Table 2-1. This was to enable the investigation of individual contributions to any 
effects, interactions between the herbs, and the effects of the formula as a whole. 
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Table 2-1 Herbs and their proportions in the formula GSDW, scientific names are given in Table 1-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.1 Patient decoction 
 
This is the form used in all experiments except for the thin layer chromatography 
analysis. The herb, in grams as listed in Table 2-1, was soaked for 12h in 100mL distilled 
water. They were then brought to the boil using a hot plate (Fisher Scientific / 11-600-
49SH) and simmered for 20 min. 
 
The herb extracts were first filtered with a filter paper to remove the plant pieces and 
were then allowed to cool before undergoing centrifugation at 3500 rpm (2383g 
Heraeus Labofuge 400) for 10 min to create a pellet of fine plant residue. The 
supernatant was removed and passed through a 22µm syringe driven filter (Millex) in 
a Biological Class II laminar airflow cabinet into a sterile universal container (Thermo 
scientific) and stored at 4 °C until required. All samples were sterilised as this is 
necessary for cell culture work. 
  
Latin Pinyin % composition  
in formula 
grams in  
decoction 
Radix Rehmanniae Preparata Shu Di Huang 25 8 
Fructus Corni Shan Zhu Yu 12 4 
Rhizoma Dioscoreae Shan Yao 12 4 
Sclerotium Poria Cocos Fu Ling 9 3 
Rhizoma Alismatis Ze Xie 9 3 
Cortex Moutan Mu Dan Pi 9 3 
Radix Angelicae Sinensis Dang Gui 12 4 
Radix Paeoniae Alba Bai Shao 12 4 
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2.1.2 Water based extract 
 
The process was identical to the patient extraction, but the herbs were crushed using 
a pestle and mortar prior to boiling, and were not soaked for 12 hours. 
 
2.1.3 Ethanol extraction 
 
Herbs were ground in a pestle and mortar, then added to 100mL of ethanol in flasks 
that were placed in a water bath at 80°C for 20 min. These then underwent 
centrifugation and were filter sterilised as above. 
 
2.1.4 Data for comparative mg/mL for extracted herbs 
 
1 mL of each of the herb extracts were evaporated and the dry weight of the dissolved 
compounds was recorded, as is shown in Table 2-2, in order to calculate mg/mL to 
facilitate comparison between assays.  Of the assays in this study one utilises human 
blood plasma and the others utilise cells of three different types HUVECs, HUtMECs 
and Ishikawa. These are all seeded at different densities and assays are tested with 
varying quantities of herbs or dilution factors which are stated with the results 
reported for each of the assays. 
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Table 2-2 Concentration in mg/mL of herb extracts determined from dry weights 
 
2.2 Qualitative examination of the herb extraction methods by thin layer 
chromatographic analysis 
 
Many studies investigating the action of herbal medicines use ethanol based 
extractions. The extraction method used for Chinese herbal medicines will 
significantly alter the compounds extracted and the ratios in which they are extracted, 
and hence potentially the biological effect (193, 194). In order to maintain clinical 
relevance for these investigations, herbs were prepared as they are for administration 
to a patient. To qualitatively illustrate these differences according to the extraction 
method, thin layer chromatography was performed on three variants of the herbal 
preparation as described in 2.1 
 
2.2.1 Method 
 
Herb and formula samples produced as described previously in Section 2.1 were 
applied to silica G coated plates that were produced in house. Using glass capillary 
tubes, samples were applied in rows 2 cm up from the base of the plate and at 1.5 cm 
intervals. Herb extracts were applied to the silica of the chromatography plate and 
each application allowed to dry before this was repeated until the herb extracts 
formed a visible spot on the plate. 
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patient 
PT and APTT 
0.1053 0.0251 0.0532 0.011 0.0674 0.0451 0.0387 0.0733 0.017 
patient 
TLC 
0.133 0.0064 0.0208 0.0014 0.0072 0.0571 0.0065 0.0225 0.0064 
H2O 
TLC 
0.0851 0.0091 0.0426 0.0032 0.015 0.0048 0.0319 0.0904 0.0172 
ethanol 
TLC 
0.0234 0.0011 0.0061 0.001 0.0037 0.0029 0.0145 0.0017 0.0022 
patient 
Angiogenesis, MTT, 
migration and 
immunoblotting 0.0867 0.0365 0.0404 0.0021 0.0126 0.1204 0.0176 0.0358 0.0092 
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Once the applied samples were dry the plates were placed in chromatography tanks 
to develop the chromatograms. The mobile phase for the two water-based extractions 
was chloroform 75 mL and methanol 25 mL. The mobile phase for the ethanol-based 
extraction was chloroform 90 mL and methanol 10 mL. Plates were allowed to air dry 
before analysis. 
 
The dried plates were analysed under two UV light wavelengths, 254 and 365nm. The 
compounds on the chromatograms were then derivatized by spraying until saturated 
with a solution containing 88% (v/v) methanol, 2% (v/v) anisaldehyde and 10% (v/v) 
sulphuric acid, followed by heating for 15 min at 100°C. Photographs were taken to 
record any detected compounds and any variation between the extraction methods. 
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2.3 Haemostasis assays PT and aPTT 
 
Fresh plasma for these assays was obtained from healthy, male volunteers. Males were 
used so that ovarian steroids from cycling females would not add an uncontrolled 
variable to the results as oestrogen has been shown in cause a pro coagulable state. 
Ethical approval for the obtaining the samples is in Appendix IV. 
 
The KC10 (Amelung) is an automated clot detector as seen in Figure 2.1. It contains 
reaction chambers which are pre-warmed to 37°C and loaded with 10 cuvettes, each 
containing a steel ball. The cuvettes are rotated by the drive shafts and the reagents 
are added. When there is only liquid in the KC10 the steel ball remains stationary and 
its presence is detected by the magnetic sensor.  
 
Reagents are added and once the final reagent, the CaCl2 (100µL, 25 mM) is added a 
timer is manually started. When a clot has formed, the steel ball is moved as the 
cuvette rotates. The magnetic sensor detects that the steel ball is no longer present 
and the timer stops. 
 
Figure 2.1 The KC10 Automated clot detector 
is used to semi automatically detect the time to clot formation, a steel ball in a cuvette is rotated and the 
reagents and plasma added. At clot formation, the steel ball is moved and the magnetic sensor detects the 
missing ball to trigger the timer to stop. 
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To each assay 0 - 0.04 mL of GSDW and 0 - 0.04 mL dH20, or 0.02mL of the individual 
herb extracts were added to the plasma as shown in Table 2-3 to examine the anti-
thrombotic actions of the herb extracts over a range of concentrations in the PT and 
aPTT assays. 
 
Table 2-3 Herb to dH20 volumes used in PT and aPTT assays 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1 Prothrombin time (PT)  
 
This assay was performed according to the protocol provided by Diagnostic Reagents 
Ltd. Freeze Dried Rabbit Brain Thromboplastin (Diagen FRBT10) was made up with 
5mL dH20 and 0.1mL of this was added to the cuvettes in the KC10 and left to warm 
for 3 min. 0.06mL of fresh plasma from volunteers was added and 0.4mL of the 
herb/dH20 mixture added (Table 2-3). All reagents were allowed to warm to 37°C in 
the cuvette for a further minute before 0.01mL of CaCl2 (100µL, 25 mM) prewarmed 
to 37°C was added. The time to clot formation in seconds was then detected by the 
KC10 and recorded. Normal lab range is 11-15 s. 
  
Herb extract 
added in mL 
dH20 mL Dilution of herb 
extract in dH20 
Dilution of herb 
extract in dH20 and 
plasma 
0.000 0.040 No herb 0 in 100 
0.005 0.035 12.5 in 100 5 in 100 
0.010 0.030 25 in 100 10 in 100 
0.015 0.025 37.5 in 100 15 in 100 
0.020 0.020 50 in 100 20 in 100 
0.025 0.015 62.5 in 100 25 in 100 
0.030 0.010 75 in 100 30 in 100 
0.035 0.005 87.5 in 100 35 in 100 
0.040 0.000 No dilution 40 in 100 
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2.3.2 Activated partial thromboplastin time (aPTT)  
 
This assay was performed according to the protocol provided by Diagnostic Reagents 
Ltd. 0.06mL fresh plasma and the 0.04mL herb/H20 mixture (Table 2-3) was added to 
the cuvette in the KC10. Platelet substitute (Bell and Alton BAPS040) made up with 
5mL dH20 and 0.1mL of this was added to the cuvette and warmed for 1 minute. 0.1mL 
of liquid kaolin (5mg/mL in saline solution) was added and the mixture was left to 
warm for a further 2 min and 0.1mL warmed CaCl2 (100µL, 25 mM) was added. The 
time to clot formation in seconds was then detected by the KC10 and recorded. Normal 
lab range is 25-35 s. 
 
Heparin was used to compare the size of the effects of the herb extracts. The 
therapeutic dose of heparin was taken as 10,000 iU/5L of blood in vivo and so heparin 
was added to the assays at 10 iU/mL which for the 1 iU dose was 0.75mg/mL for the 
PT and 1.0mg/mL for the aPTT. A 10x dilution was also used as tissue levels of heparin 
will not be as high as blood levels in vivo (195). 
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2.4 Cell culture techniques 
 
2.4.1 Initiation of proliferating cultures 
 
Cells were removed from liquid nitrogen and placed on dry ice whilst the lid was 
loosened to release pressure from the vial and the cryovial was then placed with the 
bottom half in a water bath at 37°C. It was swirled until only a small piece of ice was 
left. The cells were immediately pipetted into 25cm2 culture flasks. The flasks used 
were lysine coated cell culture flasks (Thermo scientific Nucleon delta EasYFlask 
25cm2). Flasks were filled with 5mL of pre warmed media (as listed in Table 2-4) and 
swirled to distribute evenly. The flasks were left undisturbed in an incubator at 37°C 
and 5% CO2 (Nuaire, DH Autoflow) for 24 h to allow the cells to adhere. Media was 
changed every 48 hours and cells passaged when they were considered confluent as 
recommended by the supplier (Table 2-4). This table also describes the supplier 
recommended media, supplements, and specific recommendations for cell culture. 
Phenol red free media was used as phenol red has been shown to be weakly 
oestrogenic (196). 
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Table 2-4 Cells used and their cultivation specifics 
 
 
2.4.2 Splitting cells 
 
At the recommended confluence (Table 2-4) the cells were passaged. Media was 
removed and cells were washed in PBS (Gibco 1x pH 7.4 CaCl, MgCl) to remove 
residual media and then disaggregated using 1mL TrypLE Express (Gibco). Cells were 
then incubated with TrypLE Express until they were observed under a microscope to 
have become detached from the base of the flask, typically 5-10 min. Once 
disaggregated, the actions of TrypLE Express were neutralised by the addition of 3 mL 
fresh media. The suspension was split across flasks according to the ratio in (Table 
2-4, p57) and the total volume of media/flask increased to 5mL by the addition of 
fresh media. 
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Human Umbilical 
Vein Endothelial 
Cells (HUVEC) 
 
Caltag  
ZHC-2301 
Cellworks 
Human Large 
Vessel 
Endothelial Cell 
Basal Medium 
KC1015 
Cellworks Human Large Vessel 
Endothelial Cell Growth 
Supplement KC1016 
Cellworks Antibiotic 
Supplement 
(Gentamycin/Amphotericin B) 
KC1019 
 
2,500 
cells/cm2 
60-80% 1:2 
Human Uterine 
Microvascular 
Endothelial Cells 
(HUtMEC) 
 
2bScientific Promo cell 
Endothelial Cell 
Basal Medium 
MV2 (prf) 
+ Foetal Calf Serum, Epidermal 
Growth Factor, Basic Fibroblast 
Growth Factor, Insulin-like 
Growth Factor, Vascular 
Endothelial Growth Factor 165, 
Ascorbic Acid, Hydrocortisone 
10,000-
20,000 
cells/cm2 
>70% 1:2 
Ishikawa 
 
Sigma Aldrich 
99040201 (from the 
European collection 
of authenticated cell 
cultures) 
Ishikawa 
Culture 
Medium MEM 
+ 2mM Glutamine + 1% v/v 
Non-Essential Amino Acids 
(NEAA) + 5% v/v Foetal Bovine 
Serum (FBS) 
20,000-
30,000 
cells/cm2 
70-80% 1:5 
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2.4.3 Neutralising and counting cells 
 
If the cells were to be used in an experiment following passage, 3mL of media was 
added to neutralise the TrypLE Express. Following centrifugation for 5 min at 1500 
rpm (438 x g Heraeus Labofuge 400), the supernatant was removed and cells were 
resuspended in 5mL fresh media. 
 
Once re-suspended the cells were then counted manually using a haemocytometer 
(C-Chip, Neubauer improved DHC-N01). 10µl of the cell suspension was added to 
haemocytometer and, under a light microscope, the cells in the four outer corners of 
nine large squares were counted (Figure 2.2). The mean of the four large squares was 
taken as the cell count. The final concentration of the cells was then adjusted by 
centrifuging, counting, and re-suspending in media to obtain the required cell count 
for the experiment to be performed.  
 
Figure 2.2 Diagram of C-Chip, Neubauer improved DHC-N01 haemocytometer  
used for counting cells to obtain the correct seeding density for the experiments. 
 
 
Image courtesy of http://www.incyto.com/product/product02_detail.php 
 
When HUVEC and HUtMEC media is supplied, it comes with additional growth 
factors and antibiotic supplements in separate containers to be added when ready for 
use, these are required to sustain growth in primary cell lines. In order to assess the 
effects on the herb extracts on angiogenesis method development indicated that 
experiments needed to be conducted with growth factor free media, as the growth 
Cells/mL = Mean cells counted per square × 10, 000 
(104)/mL 
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factor supplements induce angiogenic activity and mask the influence of the herbs. 
Thus, media for use in setting up the experiments was kept without any additional 
supplements and only small amounts of either bovine serum albumin (BSA) (1% v/v) 
for migration experiments, or foetal calf serum (FCS) (0.1% v/v) for the angiogenesis 
which were added to the culture media for that cell type. When cells were trypsinised 
for use in angiogenesis experiments, TrypLE Express was first neutralised with media 
with growth factors, then cells were centrifuged (as detailed above) and resuspended 
in growth factor free media with either BSA/FCS. This was repeated twice to remove 
any remaining growth factors prior to counting and adjusting to the correct seeding 
density. 
 
For the MTT, and for the protein extraction for immunoblotting assays the cells were 
re-suspended in the media containing growth supplements as these experiments were 
performed over 24-72 hours. Without growth factor supplements cell survival was 
reduced to between 12 and 24 h. 
  
  
Materials and Methods 
 
60 
 
2.5 Proliferation assays using MTT and MultiTox methods 
 
The MTT assay gives a spectrophotometric measure of the mitochondrial activity of 
the cells which is considered to be correlated with cell viability. The mitochondria in 
viable cells cleave the tetrazolium ring of the 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide (MTT, Sigma Aldrich, UK) reagent to yield purple 
formazan crystals. The crystals are then solubilised in dimethyl sulphoxide (DMSO, 
Sigma Aldrich, UK) to yield a purple coloured solution the intensity of which, as 
determined spectrophotometrically, is considered to be proportional to viability 
(197). 
 
2.5.1 Method 
 
Day 1:  
This assay was performed with both HUVECs and Ishikawa cells. The HUtMEC did 
not reach a sufficient number to perform this assay. HUVECs were resuspended in 
media to 20 x 104 /mL and the Ishikawa cells in media to 7.5 x104/mL. The cells were 
added to 96 well plates (Thermo scientific 167006 Nunclon delta surface) at 100µl per 
well in the central 60 wells (Figure 2.3) 100µL of PBS was added to the outside wells 
to reduce evaporation in the central wells. Plates were then incubated at 37°C and 5% 
CO2 (Nuaire, DH Autoflow) overnight to allow the cells to adhere. 
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Figure 2.3 96 well plate plan for MTT assay 
Cells suspended in media were added to wells coloured pink/purple and PBS to uncoloured wells. In 
experiments, serial dilutions of test herb extracts were added to wells coloured blue and herb free controls 
with dH20 only, to wells coloured pink. 
 
Day 2:  
100µL of the neat herb extract (prepared as described in Section 2.1.1) was put into 
wells 2B-D and 100µL of dH20 control in 2E-G. Using a multichannel pipette, a serial 
double dilution of the herb extracts/control were prepared across columns 3 – 11 
inclusive. During dilution, solutions were mixed by evacuating and refilling the 
pipette three times at each dilution until row 11, when 100µL was removed and 
discarded so that all wells contained the same volume. This was replicated on three 
plates which were then incubated for three time periods of 24, 48 and 72 h.  
 
GSDW used was at a dry weight equivalent concentration of 0.0867mg/mL so the 
actual final dry weight equivalent of the herb extract added in serial dilution is shown 
in Table 2-5. 
 
Table 2-5 µg dry weight equivalents of the herb extract added  
 
 
  
 
µg in  
100µL 
1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:245 1:512 
GSDW 8.670 4.335 2.167 1.084 0.542 0.271 0.135 0.068 0.034 0.017 
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Day 3, 4 or 5:  
 
A 0.5% (w/v) stock solution of MTT was prepared by dissolving 0.1mg of MTT was in 
20mL of distilled water. Following the required incubation period of 24, 48 or 72 h 
and immediately prior to use, the MTT stock solution was diluted 1 in 5 with cell 
culture media and 50µL added to each well of the plate that contained cells. The plate 
was kept in an incubator at 37°C and 5% CO2 (Nuaire, DH Autoflow) for 2-4h until 
purple crystals were visible in the wells. 
 
The media, herb extract, and PBS were all removed from the wells by tipping the plate 
and then blotting on an absorbent towel. 100µL of DMSO was added to each well to 
solubilise the formazan crystals. This was assisted by agitating the plate on a plate 
mixer (Heidolph, Titramax 100) for 2 mins. 
 
The absorbance of the resulting solutions was measured using a plate reader (Biotech 
Powerwave 340) and the KC Junior software set at a wavelength of 570nm as is 
described in Sigma Aldrich MTT protocol.  
 
MTT data is written by KC Junior software into an Excel file (Table 2-6). The number 
represents quantification of the 560nm wavelength absorbance of the dissolved 
formazan crystals in DMSO. 
 
Table 2-6 Raw data colour metric quantification output from KC Junior plate reader 
 
  
Dilution from 
neat GSDW  
1.000 0.500 0.250 0.125 0.063 0.031 0.016 0.008 0.004 0.002 
Test well 0.048 0.069 0.094 0.101 0.261 0.288 0.312 0.302 0.286 0.332 
Test well 0.047 0.048 0.085 0.093 0.235 0.282 0.307 0.322 0.293 0.319 
Test well 0.045 0.056 0.087 0.109 0.226 0.303 0.333 0.301 0.275 0.234 
Control well 0.238 0.262 0.223 0.27 0.254 0.248 0.27 0.25 0.262 0.257 
Control well 0.242 0.282 0.268 0.232 0.247 0.239 0.215 0.216 0.253 0.269 
Control well 0.239 0.258 0.253 0.254 0.256 0.241 0.224 0.248 0.261 0.295 
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The calculation of viability takes the mean of each of the three test wells and the mean 
of each (Equation 1) of the three controls wells and a percentage viability is calculated 
as presented in Table 2-7. 
 
Equation 1 viability calculation 
 
𝑚𝑒𝑎𝑛 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡ℎ𝑟𝑒𝑒 𝑡𝑒𝑠𝑡 𝑤𝑒𝑙𝑙𝑠
𝑚𝑒𝑎𝑛 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡ℎ𝑟𝑒𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑤𝑒𝑙𝑙𝑠
× 100 = % 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑜𝑓 𝑡𝑒𝑠𝑡 𝑜𝑣𝑒𝑟 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
 
Table 2-7 Calculation of % viability from the raw data 
 
  
Dilution from neat 
GSDW 
1.000 0.500 0.250 0.125 0.063 0.031 0.016 0.008 0.004 0.002 
µg/mL 86.70 43.35 21.68 10.84 5.42 2.71 1.35 0.68 0.34 0.17 
Absorbance Test 0.047 0.058 0.089 0.101 0.241 0.291 0.317 0.308 0.285 0.295 
Absorbance Control 0.240 0.267 0.248 0.252 0.252 0.243 0.236 0.238 0.259 0.274 
% Viability 19 22 36 40 95 120 134 130 110 108 
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2.5.2 MultiTox-Glo Multiplex Cytotoxicity Assay 
 
100µL of HUVECs (20 x 104 /mL) were plated into 96 well plates (Greiner 96 F-bottom) 
as described above for the MTT assay (Section 2.5.1, p60) and treated with either 
GSDW/dH2O in serial dilution (Table 2-5, p61) or dH2O only, and incubated for 48 
h.  
 
The media, herb extract, and dH2O in were all removed from the wells by tipping the 
plate and blotting on an absorbent towel. Wells were washed by adding 100µL of 
HUVEC media and then agitated on a plate mixer (Heidolph, Titramax 100) for 1 min 
and then repeated. 50µL of fresh HUVEC media was then added to each well. 
 
Reagents were prepared according to the protocol provided for the MultiTox-Glo 
Multiplex Cytotoxicity Assay (Promega G9270). 50µl of GF-AFC, the live cell reagent, 
was added to all wells and mixed on plate mixer for 2 min. The cells were incubated 
at 37oC and 5% CO2 for 60 min, protected from light by wrapping in foil. 
 
The resulting live-cell fluorescence was measured using a multimode fluorescence 
plate reader (Polar Star Omega) equipped with filter sets for excitation ~400nm and 
emission ~520nm. The plate was returned to the incubator for a further 30 min and 
live-cell fluorescence was repeated as documentation states that a longer incubation 
may improve the assay sensitivity. 
 
After the second measure of live cell fluorescence, 25μl of AAF-Glo™ reagent (to 
detect non-viable cells) was added to all wells and mixed on plate mixer for a further 
2 min. The plate was kept at room temperature for 15 min protected from light by 
wrapping in foil. The resulting dead-cell luminescence was measured using a 
multimode plate reader (Polar Star Omega). 
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2.6 Differentiation assays on matrigel using HUVECs and HUtMECs 
 
An influence on angiogenesis may be one of the ways in which the haematology of 
the endometrium is affected by the Chinese herbs. Angiogenic processes can be 
investigated though several different bioassays. In vivo these processes occur together 
and are interrelated but to try and determine how the herb extracts may be 
influencing this activity it is broken down into three distinct processes; proliferation, 
migration, and differentiation. The first of these bioassays examines differentiation, 
the process of endothelial cells forming new vessels which will become the new 
vessels through which blood is carried through the tissues.  
 
2.6.1 Protocol development 
 
The development of an appropriate protocol for evaluation of the HUVEC 
differentiation was an extensive process. Initially matrigel with growth factors was 
used as was cell culture media with growth factors. No clear patterns of differentiation 
according to the test conditions was found. Variables such a seeding density, passage 
of cells, age of herb extracts were all evaluated for contributory effects. Matrigel with 
no growth factors (GF-) was used but this failed to show any consistent differences in 
the test conditions. The cells were weaned off growth factors in the culture flasks but 
this led to poor differentiation. Media without the commercial growth factors with 
the addition of 0.1% (v/v) FBS and the GF-matrigel did show differences. The cells 
were kept in media with growth factors until the final pipetting into the wells of the 
µ-slides. The cells viability once all growth factors were removed was only 12-18 h, 
whereas with the growth factors they were able to survive to 36 h. 
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2.6.2 Final Method 
 
Growth factor deficient phenol red free matrigel (Corning) was defrosted on ice at 2-
5°C for 12 h prior to use. Ibidi µ-slides were used as these have a lower well for 
containing the matrigel which prevents a meniscus forming in the gel (Figure 2.4). 
The surface on which the cells differentiate provides a flat focal plane for the 
microscope to enable clear photographs of the differentiated cells for analysis. 
 
              
Figure 2.4 Diagram of the Ibidi µ-slides 
showing the lower well containing matrigel and the cells adhering to the matrigel for differentiation on a 
flat plane to enable good focus of the entire field for the photographs used for analysis. 
 
An 18 well µ-slide (Ibidi) was placed on ice and a reverse phase pipette used to pipette 
10µL of neat Matrigel into each well. The slides were placed into an incubator at 37°C 
and 5% CO2 (Nuaire, DH Autoflow) for 1h to allow the gel to form a matrix. 
 
Cells were grown to 80% confluence and dissociated from the flask and suspended in 
media (Section 2.4.3, p58). Following centrifugation, they were re-suspended in the 
media containing 0.1% FBS (v/v) (Gibco 10270106) but no supplied growth 
supplements or antibiotics. The cells were and added to the µ-slide at a concentration 
of 3 x 105 /mL and 25µL per well. The slides were then incubated for 1h to allow the 
cells to adhere to the matrigel. 
 
The herb extracts as prepared in Section 12.1.1 for use with the HUVECs were then 
diluted 1:100 with 0.1% FBS (v/v) HUVEC media, so as to produce a final dilution of 
1:200 when added to the µ-slide. 25µL of the herb extract was added see in Table 2-8, 
p67. VEGF and suramin were used as positive and negative controls for growth 
respectively. 
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The herb extracts prepared as for the HUtMECs were then diluted 1:250 with 0.1% FBS 
(v/v) HUtMEC media, so as to produce a final dilution of 1:500 when added to the µ-
slide. Controls here were media with and without growth supplements added. 25µL 
of the herb extract was added in (Table 2-8, p67) VEGF and suramin were used as 
positive and negative controls for growth (described below). 
 
Controls of VEGF and suramin used in the HUVEC assays were obtained from the 
angiogenesis assay control kit (Cellworks ZHA-1300) and used according to the 
manufacturer’s guidance. Suramin was an effective inhibitor of differentiation, 
however, VEGF did not show significant increases in differentiation. In the HUtMEC 
assay media with supplements was used as the positive control and the supplement 
reduced media alone was used as the negative control. 
 
Table 2-8 Concentrations of herb extract added to each well for HUVECs and HUtMECs, determined from 
the dry weights of the herbal decoctions prepared. 
 
 
The µ-slides were incubated before being photographed on an inverted microscope. 
HUVECs were photographed on an inverted microscope (Zeiss Axioscope A1) coupled 
to digital camera (Zeiss Axiocam 503) at 5X and photographed at 6h and 12h but 
tubules were significantly degraded by 18 h. The microscope used for the HUtMECs 
(Nikon eclipse 80i) was coupled to a digital camera (Nikon digital sight DS-Fi2) at 4X 
magnification and slides were viewed at 6, 12 and 18 h. Marked differentiation had not 
occurred at 12 h so the slides were photographed at 18 h. 
 
Six repeats were made of each condition for HUVECs and HUtMECs. Data analysis 
was performed using the angiogenesis analyser add on to ImageJ (v1.49).   
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HUVECs 25ul added at 
1:100 
0.0217 0.00913 0.0101 0.00053 0.00315 0.0301 0.0044 0.0089 0.0023 
HUtMECs 25ul added at 
1:500 
0.0043 0.0018 0.0020 0.00011 0.00063 0.0060 0.0009 0.0018 0.0005 
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2.7 Migration assay using culture inserts 
 
Migration is the third aspect of angiogenesis, and migration assays were performed 
with both HUVECs and HUtMECs. The ability of endothelial cells to migrate can be 
assessed in a number of different assays but the assay selected was a basic migration 
assay. Boyden chambers can be used to assess chemotaxis, would healing assays assess 
the rate of migration of cells. The wound healing assay is where a scratch is made with 
a pipette tip or similar tool in a layer of confluent cells. The migration of the cells 
across the scratch is recorded and rate of migration across the “wound” and can be 
measured (138). A modification of this assay was used, the 2 well culture insert (Ibidi) 
see Figure 2.5. According to the manufacturer these have higher repeatability than 
scratch assays as the “wound” in this case is typically a more consistent gap across 
which the cells must migrate making measurements more reliable. This method of 
creating the “wound” does not damage cells can which then release molecules that 
can inhibit migration (198).  
 
 
 
Figure 2.5 Ibidi 2 well culture insert used to obtain a clean “wound” across which the migration of cells can 
be measured accurately. 
 
Cells at 80% confluence were dissociated from the flask using TrypLE Express 
(Section 2.4.2, p57). Following centrifugation at 1500 rpm (438 x g Heraeus Labofuge 
400) for 5 min, the supernatant media was removed cells were and resuspended in 
Picture courtesy of  
ibid.com/applications/ 
wound-healing-and-migration/ 
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fresh media containing BSA 1% (v/v) to a final concentration of 8 x 105 cells/mL. Using 
sterile tweezers, culture inserts were placed into each well of a 6 well plate (Corning 
tissue culture plate) and 70µL of the cell suspension was dispensed into each chamber 
of the insert, a total of 140µL cell suspension per insert.  
 
Plates were then incubated in a humidified atmosphere at 37°C and 5% CO2 for 24 h 
to allow the cells to adhere to the base of the plates. Once the cells had formed a 
confluent layer, the inserts were removed using sterile tweezers. The adhered cells 
were washed with sterile PBS (Gibco, pH 7.4) to remove any loose cells before the 
herb extract was added at dilution of 1 in 100, 500 and 1000 for GSDW and 1 in 200 for 
the individual herb extracts. Table 2-2, p51 shows the equivalent concentrations 
mg/mL based on the dry weights of the extracts. Dilutions were prepared in media 
without the standard supplements but with 1% (v/v) BSA (Fisher Chemical, 
Microbiological grade BPE9700-10.0) and were added at 5mL per well. 
 
Live cell imaging was performed using a Zeiss Axiovert 200M (inverted) microscope 
(Carl Zeiss, Welwyn Garden City, Herts, UK) contained in an incubator (37 °C, 5% 
CO2, humid atmosphere). Phase images (camera model C4742-80-12AG; Hamamatsu 
Photonics, Hamamatsu, Japan) were acquired every 15 min for 24 h with a 5x objective 
using Volocity software (V6.1.1, Perkin-Elmer, Waltham, MA, USA). Time-lapse 
movies (.avi) were compiled from the images, using the same software, at 10 fps.  
 
Images were analysed using ImageJ (v1.49) MRI wound healing tool which is used to 
calculate the area of space, in pixels, between the two areas of cells at the start of the 
experiment and then as the gap is reduced as the cells migrate.  
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2.8 Immunoblotting 
 
The herbal formula could influence the receptivity of the endometrium by altering 
the expression of hormone receptors in endometrial cells, as discussed in Section 1.11.1.  
In order to analyse the possible influence of the herb extracts on selected receptors 
expressed on an endometrial cell line, Ishikawa cells (Sigma Aldrich 99040201) were 
exposed to the herb extract before being lysed to extract total cell proteins. Lysates 
were frozen (Nuaire, -86°C Ultralow Glacier) whilst waiting for analysis.  
 
Immunoblotting was used for comparative analysis of selected proteins in the 
extracts. Proteins are separated according to molecular weight using Sodium Dodecyl 
Sulphate Polyacrylamide Gel Electrophoresis (SDS- PAGE). The proteins are then 
transferred to a Polyvinylidene Difluoride (PVDF) membrane where they can be 
probed using specific antibodies. 
 
Ishikawa cells were used in this series of experiments. These are a clone of a well 
differentiated human endometrial adenocarcinoma cell line, the cells originated from 
the glandular cells of the epithelium and express both oestrogen and progesterone 
receptors (199).  
 
Oestrogen receptors have so far been seen in five forms, three membrane bound 
receptors and two nuclear. The two nuclear forms are the most widely understood 
and are the ones which are investigated here.  Progesterone receptors are also found 
as two nuclear forms PRα and PRβ. These are very similar in structure, transcribed 
from the same gene with a different 165 amino acid terminal sequence on the beta 
isoform. Membrane progesterone receptors come in three isoforms: alpha (mPRα), 
beta and gamma. MPRα was investigated as the only one of the three cited as having 
uterine function (171). 
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2.8.1 Method for obtaining the protein extracts from Ishikawa cells 
 
Day 1:  
Ishikawa cells were cultured to 80% confluence (Table 2-4, p57) and dissociated from 
the flasks as described in Section 2.1.1 and re-suspended in media (Gibco Minimum 
Essential Medium) containing 5% (v/v) FCS (details in Table 2-4, p57) and seeded into 
6 well plates (Corning costar 3516 culture cluster flat bottom plate) at 3mL cell 
suspension containing 1x105 cells/mL. These were incubated overnight in a humidified 
atmosphere at 37°C and 5% CO2 (Nuaire, DH Autoflow). 
 
Day 2:  
On the second day 1.5mL of the media was removed and media with herb extract or 
media only control was added. The herb extracts were diluted 1:50 with media for a 
final concentration in the wells of 1:100. Table 2-2, p51 presents the equivalent herb 
concentrations (mg/mL), as determined from their dry weight. Cells were incubated 
for either 24 or 48 h.  
 
Day 3 or 4:  
Once removed from the incubator the plates were placed on ice. Media was removed 
from the wells into sterile Eppendorf tubes and, following centrifugation (Sigma 
Aldrich, Eppendorf mini spin) at 12,000 rpm (9660 x g) for 1 min the supernatant was 
removed and discarded. This was repeated for all media and for all wells to ensure 
that any cells not adhered were collected. The resulting cell pellets were then washed 
in ice cold PBS before being kept on ice. 
 
The adhered cells were washed with 3mL of ice cold PBS which was then discarded. 
100µL of Pierce RIPA buffer was added to each well, and cells removed using sterile 
cell scrapers. The resulting cell suspensions were then added to the respective cell 
pellets on ice. In a cold laboratory (4°C) all Eppendorf tubes were agitated using a 
vortex mixer (Scientific Industries, Vortex Genie 2) for 30 seconds each, repeated for 
30 min. They then underwent centrifugation for 1 minute at 12,000 rpm and the 
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resulting supernatants were placed into clean sterile Eppendorf tubes for storage at  
-80˚C until analysis. 
 
2.8.2 Quantification of proteins obtained from Ishikawa cells using 
the Pierce BCA Assay 
 
To ensure equal loading of proteins on the SDS PAGE gel the extracted cellular 
proteins were quantified using a BCA protein assay (Pierce, 23225) according to the 
manufacturer’s instructions. Samples were loaded onto a Thermo scientific 167006 
Nunclon delta surface 96 well plate. Measurements of the provided reference samples 
and the extracted proteins were compared using a colour-metric assessment of the 
protein quantity at 562nm using a Biotech plate reader and KC Junior software. The 
absorbance of the standards was then plotted onto standard curve (Appendix VIII) 
and the protein concentration of the samples could then be determined. 
 
2.8.3 Preparation of acrylamide gels 
A Bio-Rad Mini-PROTEAN Tetra Cell hand cast electrophoresis system was used as 
shown in Figure 2.6. 
 
Figure 2.6 Photograph of Bio Rad mini protean tetra cell hand cast equipment used to prepare the gels and 
perform electrophoresis. 
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A 12.5% resolving gel was prepared according to a modification of the Laemmli 
protocol (200) as detailed in Table 2-9 and loaded into the glass plates held securely 
in the clamp kit in the casting frame and allowed to polymerise. A gel of 12.5% is 
recommended by Abcam for proteins of 10-70 kilodalton (kDa) which was an 
appropriate range for the proteins of interest (201). Recipes for all of the solutions 
made up in the lab are in Appendix VI, as are the reference codes for any purchased 
reagents.  
 
 Table 2-9 Resolving and stacking gel preparation 
  
Once the resolving gel had polymerised, a 5% stacking gel was prepared see Table 2-9 
and added on top of the resolving gel. A 12 well comb was immediately inserted into 
the stacking gel which was then allowed to polymerise. 
 
2.9 Electrophoresis of Samples 
 
Protein extracts prepared from Ishikawa cells as described in Section 2.8.1, were 
thawed. 20µg of the protein sample was loaded in each lane (calculated in Excel 
spreadsheet appendix VIII). Laemmli loading buffer (Appendix VII) was added to the 
samples to make up to a final volume of 20µl and the samples were then placed into 
a heat block (Techne, Dri-Block) at 90˚C for 10 mins. 
 
The comb was removed from the polymerised gel and the gel and plates were secured 
in the electrophoresis tank. The electrophoresis tank was filled with running buffer 
(Appendix VII) and wells were flushed with running buffer before the samples were 
loaded. 20µl of sample were added along with the reference protein at their 
recommended loading concentrations (Table 2-11, p77) and the protein ladders 
(Abcam Ultra prism ladder ab116027). 
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Samples were electrophoresed at 60V for 30 min and then 150V for ~60 min until the 
dye front could be seen approaching the bottom of the gel. After electrophoresis, the 
glass plates were removed and gels were soaked in transfer buffer prior to transfer of 
proteins onto PVDF membranes.  
 
2.9.1 Electroblotting for Protein Transfer  
 
PVDF membrane was placed into methanol for 10s then equilibrated in transfer buffer 
for 10 mins, a “transfer sandwich” was then constructed (Figure 2.7). 
 
   
 
Figure 2.7 Construction of the transfer sandwich 
Layers of sponge, filter, gel, and membrane are created in order to transfer the separated proteins from the 
gel onto a membrane for probing with antibodies. 
 
Prior to completion of the “transfer sandwich”, any air bubbles between the gel and 
membrane were removed using a roller to ensure a good contact between the gel and 
the membrane. The “transfer sandwich” was then placed into a tank filled with 
transfer buffer.  A stirrer and an ice pack were placed inside the tank. The tank was 
then left overnight in a cold laboratory (4°C) on a stirrer plate and a current of 30V 
was applied to transfer proteins. To check for any protein loss, experiments were 
performed where a second membrane was placed behind the first to ensure that 
proteins were not passing through the membrane with an overnight transfer, proteins 
were not detected on the second membrane. 
  
Materials and Methods 
 
75 
2.9.2 Protein detection 
 
Following transfer, PVDF membranes were removed from the “transfer sandwich”, 
washed in distilled water and then blocked with 5% (w/v) skimmed milk powder in 
PBS for 1 h at room temperature, with constant agitation using a roller set at 35 rpm. 
They were then placed into 3mL of 5% (w/v) skimmed milk powder in PBS containing 
the primary antibody typically at a concentration of 1:1000 (Table 2-10). These were 
left for 1 h at room temperature, with constant agitation using a roller set at 35 rpm. 
The primary anybody (Table 2-10) was then removed and the membrane washed three 
times in 5mL of PBS-T before being returned to the rollers for 10 min in 30mL of PBS-
T, this process repeated a further two times. The secondary antibody was added to 
4mL of 5% (w/v) skimmed milk powder in PBS, typically at a concentration of 1: 2000 
(Table 2-10) and the membrane incubated with the secondary antibody for 1 h at room 
temperature with constant agitation using a roller set at 35 rpm. The secondary 
antibody was removed and the membrane washed with PBS-T as described above. 
Molecular weights (kDa) of the antibodies used are indicated on a protein ladder 
diagram (Figure 2.8). 
 
For analysis, the membrane was placed on an acetate sheet and 800µL of Luminata 
Forte HRP substrate (Merck Millipore, BLUF0500) was added. Analysis was 
performed on a ChemiDoc MP imaging system (Bio-Rad) using ImageLab 6.0 
software and auto detection of optimal resolution time. ImageLab software allows the 
user to quantify the relative saturation of the bands detected on a single blot for 
comparison.  
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Table 2-10 Antibody reference table 
 
 
The kDa reported in the manufacturers datasheets are in some cases reported as a 
range, an approximate value, and at other times at a specific kDa. Variations in the 
detected protein can occur due to modifications of the protein such as glycosylation 
and phosphorylation altering the predicted versus observed molecular weight. The 
charge of the molecule may be altered changing its migration rate. Cleavage or 
degradation of the protein, splice variants and multimers can all modify the molecular 
weight. Reference proteins were used to verify that the correct receptor proteins were 
being identified (Table 2-11). 
 
Antibody ref antibody 2nd 
AB 
concentration 
provided 
Concentration for 
WB 
kDa data from 
manufacturers 
datasheet 
Loading controls       
Anti-beta actin 
antibody 
ab8226 mouse 
monoclonal 
GxM 100 µg at 1 mg/mL 1/500 - 1/10000 42 
Anti GAPDH 
antibody 
ab8245 mouse 
monoclonal 
GxM 100 µg at 2 mg/mL 1/500 - 1/10000 Observed band 37, 
predicted band 40 
Anti-cyclophilin ab74173 donkey DxM 100 µL at 1 mg/mL  1/1000 - 1/2000 23 
Anti-Alas1 antibody 
(ALAS1) 
ab84962  rabbit 
polyclonal 
GxR 100ul at 0.5mg/mL 1µg/mL Observed band 65, 
predicted band 71 
Anti-Alas1 antibody 
Mitochondrial 
Marker (ALAS2) 
ab154860 rabbit 
monoclonal 
GxR 100 µL at 0.445 - 
0.63 mg/mL  
1/1000 - 1/10000 71 
Oestrogen       
Anti-Estrogen 
receptor alpha 
antibody 
(ERα) 
ab108398 rabbit 
monoclonal 
GxR 100 µL at 1.228 
mg/mL  
1/1000 - 1/10000 66 
Anti-Estrogen 
Receptor beta 
antibody (ERβ1) 
ab3577 rabbit 
polyclonal 
GxR 50 µg at 1 mg/mL  1 - 2 µg/mL ~55 
Anti-Estrogen 
Receptor beta 
antibody (ERβ2) 
ab133467 rabbit 
monoclonal 
GxR 100 µL at 0.346 - 
0.437 mg/mL batch 
dependent 
1 - 2 µg/mL 59 
Progesterone       
Anti -Membrane 
Progestin Receptor 
Alpha (mPRα) 
ab75508 rabbit 
polyclonal 
GxR 100ug at 1mg/mL 1/500-1/1000 ~40 
Anti progestin 
receptor beta 
antibody (PRβ) 
ab46535 rabbit 
polyclonal 
GxR not specified “assay 
dependent” 
1ul/mL has 
worked 
~40 
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Table 2-11 Reference proteins used on blots to verify the identity of the detected bands 
 
 
 
 
Figure 2.8 Molecular weights of antibodies used to probe membranes for ERα, ERβ, mPRα, PRβ, and the 
loading control proteins used. 
  
Receptor Reference proteins Loading volume Outcome 
Oestrogen receptor alpha 
Recombinant Human Estrogen 
Receptor alpha protein ab82606 
0.5 µL Receptor verified 
Oestrogen receptor beta 
Recombinant Human Estrogen 
Receptor beta protein ab114181 
up to 6µL Never detected 
Progestin receptor alpha 
Recombinant Human mPRα 
protein ab165766 
3µL 
Protein detected but 
receptor not seen in lysates 
Progesterone receptor beta 
Recombinant Human Progestin 
Receptor Beta protein ab164739 
3µL Receptor verified 
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2.10 Statistical analyses 
 
The data for the TLC, migration and the receptor expression were not quantitively 
analysed.  
 
Data for the haemostasis, proliferation and differentiation was analysed using a T-test 
for difference between GSDW and control and a one way ANOVA was used for 
differences between the individual herbs if the assumptions for outliers, normal 
distribution and homogeneity of variance were met. In this case the Tukey post hoc 
tests were used.  
 
In several cases the homogeneity of variance was not met and so a Welch’s ANOVA 
was performed with Games Howell post hoc tests.  
 
Where data failed to meet the assumptions for parametric testing a Mann Whitney U 
and Kruskal Wallis were used with Dunn’s post hoc tests.  
 
Analysis was performed using SPSS v22, graphs were produced in Graphpad Prism 6. 
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3 Herbal Extraction Methods 
 
The extraction methods for analysis of herbal medicines 
effects in vivo should be congruent with preparation 
methods used for patient treatment 
 
3.1 Introduction 
 
When east meets west in herbal research an early conflict in methodology arises. 
Pharmaceutical extraction methods for herbal products may involve grinding or 
crushing plant materials to a fine and uniform texture and the use of a soxhlet 
extractor with solvents such as ethanol and methanol. Hydroalchoholic solvent 
mixtures are considered optimal for investigation. They have an expanded polarity 
range so that more compounds are extracted.  More advanced techniques such as 
microwave assisted extraction, ultrasonic extraction or supercritical fluid extraction 
may be employed (202).  
 
Amino acids can be separated by TLC, for identification they are usually hydrolysed 
prior to separation. They are generally soluble in water but some require alcohol(203). 
Amino acids in GSDW include phenylalanine in Radix Paeoniae Alba, histidine in 
Sclerotium Poria Cocos and uracil in Radix Angelicae Sinensis and Radix Rehmanniae 
Preparata. 
 
Phenols, of which phenolic acids are a sub group, are the most common secondary 
metabolite (204). Phenols include tannins, flavonoids, and phenolic acids. Flavonoids 
include quercetin present in Cortex Moutan, and paeonin in Radix Paeoniae Alba. 
Tannins including gallotannin, tellimagrandin I and II are found in Fructus Corni and 
1-O-Galloyl pedunculagin in Radix Paeoniae Alba. Extraction of high molecular 
weight phenols will require aqueous acetone and low molecular weight with ethanol, 
there is no universal solvent (205).  
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Phenolic acids are aromatic secondary metabolites and have a wide variety of 
functions in the plants, location in the plant and therapeutic functions. They have 
excellent ability to scavenge free radicals, they are immune stimulants, anti-cancer, 
antimicrobial, and sedative amongst a range of other functions (203). Ferulic acid in 
Radix Angelicae Sinensis and gallic acid in Radix Paeoniae Alba, Cortex Moutan, and 
Fructus Corni are phenolic. Many of these acids are precursors to more complex 
compounds and are typically extracted in alcohol. 
 
Terpenes are ubiquitous in plants and present in all of the eight herbs including the 
triterpenes, monoterpenes, phytosterols, glycoside saponins and these compounds 
are known to have many biological functions in the plant and have many uses 
therapeutically for humans. Two very well known terpenes, that have been isolated 
from Chinese herbs and used as a pharmaceutical compound, are the antimalarial 
compound artemisinin and the anticancer drug Taxol (206). Chloroform and 
methanol on silica plates are an appropriate method for the extraction of this class of 
compounds and can be observed under UV as black quenching spots. The number of 
sugars can be as high as 10 and these determine the polarity of the compounds so a 
huge range is possible.  
 
Carbohydrates include the polysaccharides some of which are the energy storage for 
plants others are structural. These molecules are soluble in water but bind strongly 
to silica and so a highly polar mobile phase must be used. Methanol and chloroform 
the mobile phase used are highly polar (203). 
 
When herbal decoctions are prescribed to a patient in a clinical setting one traditional 
way of preparing prescribed herbs is to place the raw herbs in water for 12 h. It is then 
brought to the boil, simmered for 20 min, and strained, retaining the fluids for 
therapeutic consumption. 
 
Prior to the biological and functional assays, three extraction protocols were explored; 
ethanol, water with a pharmaceutical technique and water as a patient would prepare 
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it when prescribed clinically. Extracts from these methods were compared using Thin 
Layer Chromatography (TLC) (Figure 3-1).  Extracts were prepared (Section 2.1., p48) 
in ethanol and water (ground and whole dried plants, the latter with prior soaking). 
The method for the TLC is described in Section 2.2. The adsorbent used in these 
chromatograms is silica which is not a strong adsorbent. It was used with a 
combination of a very polar solvent, methanol, and the moderately polar chloroform. 
All plates were sprayed with an anisaldehyde 2% (v/v), sulphuric acid 10% (v/v) in 
methanol reagent spray. This is a spray used for all plates in a chromatographic study 
of Chinese herbs (207-210). 
 
3.2 Results 
 
Differences between the patient and water based extractions were minimal. 
Differences between the patient and ethanol were pronounced. There were many 
compounds seen in the patient or water based decoction which are not seen in this 
ethanol extraction. In additional there were a few compounds not seen in the patient 
or water based extraction which were visualised in the ethanol extraction. 
 
The protocols were not optimised for specific herb extracts or compounds. A simple 
technique was used which was the same for all herb samples with the exception of 
the different proportion of methanol to chloroform in the mobile phases.  Three 
methods used to extract compounds were visualised using TLC.  Qualitative 
differences are presented in photographs collated in Figure 3.1, p83 with circles to 
reference specific differences. It could be seen that differences exist in the profile of 
compounds from these extractions.  
 
In the UV 365 nm images that the circle 1 shows a fluorescing compound was 
present in both patient and water extractions with a very low (retention factor) Rf. 
The Rf is a measure of how far the compound has been eluted and this may be 
affected by the thickness of the silica on the plate, the depth of the mobile phase, 
temperature, and sample size so even with near identical conditions the Rf value 
may not be consistent.  In the patient decoction, the compound appeared less bright 
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than in the water extraction. This may be due to unequal loading of the extracts and 
cannot be assumed to represent different levels of compounds in the extracts 
themselves. They were applied until a mark was visible not by applying a measured 
quantity. Variances in mg/mL have been seen between herbs extracted at different 
times using the same process (Table 2-2, p51). Differences in loading as well as 
differences in concentration of the herb extracts mean that no quantitative 
evaluation is possible, only a qualitive presence or absence of the compound. The 
sample loading position on the ethanol plate (circle 1) is present but no compound 
was carried up the plate.  
 
There are two highly fluorescing compounds at the upper limit of the solvent front 
(circles 2 and 3) in the ethanol extraction of Radix Angelicae Sinensis also seen in 
GSDW that were not present in the patient and water based extractions.  
 
There were additionally compounds visualised in UV 254 nm (circles 6-10) where 
compounds with at least two conjugated double bonds appear dark, as they quench 
the fluorescence. The differences are pronounced. Circle 10 does appear to be 
slightly different between the patient and water based extraction and a compound 
(circle 11) is absent from the patient decoction. It may be that the different 
appearance, a longer dark smudge (circle 10), may be the same compound but the Rf 
is varying as it is on a different plate. The only way to confirm the presence is using 
a known compound on the plate with the unknown for comparison. (z)-ligustilide 
will form a noticeable band under UV 254 and it may be this that has been 
visualised (circle 10) for Radix Angelicae (207). 
 
Terpenes and steroids will show a red colour after anisaldehyde and sulfuric acid 
spray under UV 365 nm (203) For Sclerotium Poria Cocos (207) the main 
triterpenoic acids with a single carboxyl group are expected to be seen higher up the 
chromatogram and poricoic acid with two carboxyl groups to be lower but this was 
with a diethyl ether extraction. Little was visualised in these chromatograms for 
Poria except in the ethanolic extraction where slight fluorescence could be seen 
where the herb extract was applied in circle 4. 
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Figure 3.1 Thin Layer Chromatography of three forms of herb extraction for comparison 
Patient decoction which represents the methods used in a therapeutic setting, a water based extraction of 
ground herbs and an ethanol extraction of ground herbs. All plates are set up in the same order as shown in 
the enlarged text. The most prominent differences are highlighted with a red circle and numbers used for 
reference in the descriptive text. 
 
Fructus Corni will show a clear band of loganin and other triterpenoids as a pink band 
when a methanolic extract is used and an anisaldehyde spray at UV 365nm (210). This 
noticeable pink spot is also present in these chromatograms (circles 24 and 25). There 
is also a distinct grey spot below the pink which may be due to the gallotannins or 
gallocysides.  
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Radix Paeoniae Alba will show a strong band for the monoterpene glycoside 
paeoniflorin with a vanillin sulphuric acid reagent spray under visible light (207). It 
may be that this is seen in the smudge (circle 18). An optimised TLC method for 
extraction of paeoniflorin uses methanol extraction under reflux to collect any 
volatiles before drying and reconstituting with acetone (211).  
 
Rhizoma Dioscoreae diosgenin and other steroidal saponins would be expected to be 
seen in an ethanolic extraction after anisaldehyde spray with UV 365nm (209). This 
was using n-butanol mobile phase for separation. In these chromatograms, there was 
a fluorescing spot seen at UV 365nm before the anisaldehyde spray (circle 5). There 
were faint smudges present after the anisaldehyde spray in the patient and water 
extractions. These could be the steroidal saponins. 
 
Iridoids are frequently soluble in water but they are frequently unstable compounds. 
Some iridoids will quench UV 254nm but the majority are not directly detectable. 
Acids in the developing sprays tends to degrade iridoid aglycones and show as violet 
blue or grey on TLC in visible or UV 365nm. Anisaldehyde can be used for 
visualisation of iridoids.  (203). Radix Rehmanniae will show fluorescence across the 
Rf range under UV 365 (208) and this was seen for the patient and water extractions. 
In visible light with the vanillin reagent it may be possible to see the iridoids, 
glycosides and the rehmanniosides. These are not differentiated in this 
chromatogram but a very dense spot is present for this herb (circles 21 and 28). 
 
Rhizoma Alismatis (209) will typically show alisol-B and alisol-B monoacetate in an 
methanolic extraction with anisaldehyde spray under visible light. Dark spots are 
present at the bottom of the chromatogram (circle 23) with anisaldehyde in visible 
light for the patient and water extractions but only a very faint dark spot is present in 
the ethanolic extraction which is also visible under UV 365nm. 
 
In summary four compounds which fluoresce under UV 365nm are present in the 
alcoholic extraction were not seen in the water based (circles 2-5). All of these were 
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at the extremes of the mobile front, two not moved from where they were applied, 
and two at the very distal edge of the front. The aqueous extract of the herbs did 
appear to contain some organic compounds and their extraction in water may be due 
to their small size or that they have hydrophilic functional groups such as alcohol, 
thiol, or ester.  
 
 
UV 254nm showed quenching of UV from compounds (circle 6-11) which are present 
in the water based extractions but not the ethanol. Two double bonded compounds 
which quench the UV present in the ethanolic extraction were not seen in the water 
based (circles 12 and 13). It was in the anisaldehyde and sulphuric acid reagent sprayed 
chromatograms that the biggest differences are observed between the ethanol and 
water based extractions (circle 14-23). Differences between the patient decoction and 
water extraction were minor. Under UV, and with the reagent spray, (circles 24-29) 
are highlighting the differences already seen (circle 14-17) but show the pink and grey 
colours of the compounds in Fructus Corni which may be the triterpenes and 
gallotannins. Colours are present (circles 30-34) in the herbs of the ethanolic 
extraction under these conditions which are absent in the patient and water based 
extraction.  
 
3.3 Discussion 
 
Very specialised extraction protocols are used for identification of the herbs as stated 
in the People’s Republic of China (PRC) pharmacopeia, but here a single process was 
applied to all herbs in an extraction. The mobile phase contained the same solvents 
and the reagent spray used was the same. Without reference compounds, which are 
difficult to obtain and costly, it is not possible to identify compounds. This does not 
necessarily detract from the value of comparing the extraction techniques using a 
fingerprint of the herbs. Differences could be seen even though not identified as 
specific compounds or quantified.  
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According to the PRC pharmacopeia (48) verification for herb requires the following 
processes for identification of the eight herbs in Gui Shao Di Huang Wan. These are 
performed on silica G plates which use a gypsum binder or for Rhizoma Alismatis 
Silica H, which does not have a binder. Reference drugs are prepared as for the 
powdered herb, as described in herb extraction column in Table 3-1. The procedures 
are complex and very specific for the extraction of a single reference compound, 
which was not the objective in this case. It would be interesting to verify the presence 
of these compounds, but these identified compounds are not specifically those which 
are suggested to confer the therapeutic actions.  
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Table 3-1 Summary of the process for identification of the eight herbs of GSDW from the PRC Pharmacopeia 
 
 
  
Herb Herb extraction Mobile phase Spray reagent Reference 
compound 
Radix Paeoniae 
Alba 
Ethanol ultrasonicate, filter, dry and 
dilute with ethanol 
chloroform, ethyl acetate, 
methanol, formic acid 
40:5:10:0.2 
vanillin 5% in sulfuric 
acid, heat 
Paeoniflorin, 
blue purple spot 
Radix Paeoniae 
Alba 
Ethanol ultrasonicate, filter, dry and 
dilute with ethanol 
cyclohexane and ethyl 
acetate 3:1 
Ferric chloride 5% in 
ethanol and 
hydrochloric acid, 
heat until band 
appears 
paeonol 
Radix Angelicae 
Sinensis 
Sodium bicarbonate solution, adjust 
to pH2, extract with ether, 
ultrasonicate, filter, dry and dilute 
with methanol  
Cyclohexane, 
dichloromethane, ethyl 
acetate, formic acid 
4:1:1:0.1 
n/a UV 365nm ferulic acid 
(z)-ligustilide 
Radix Angelicae 
Sinensis 
Ether ultrasonicate, filter, dry and 
dilute with, ethanol 
n-hexane and ethyl 
acetate 4:1 
n/a UV 365nm reference drug 
(unspecified) 
Sclerotium 
Poria Cocos 
Ether ultrasonicate, filter, dry and 
dilute with, methanol 
toluene, ethyl acetate and 
formic acid 20:5:0.5 
vanillin in sulfuric acid 
4:1 heat to 105°C 
reference drug 
(unspecified) 
Cortex Moutan Ether no ultrasonicate, acetone cyclohexane, ethyl 
acetate, glacial ethyl 
acetate 4:1:0.1 
vanillin in sulfuric acid 
1:10 heat to 105°C 
paeonol 
Radix 
Rehmanniae 
Preparata 
Methanol, ultrasonicate, filter, dry, 
dissolve in water, extract in n-
butanol, dry, dissolve in methanol 
ethyl acetate, methanol, 
and formic acid 
Soak plate in 2,2-
diphenyl-1-
picrylhydrazyl in 
dehydrated ethanol 
air dry 
verbascoside 
Fructus Corni Ethyl acetate, ultrasonicate, filter, 
dry, dissolve in ursolic acid 
toluene, ethyl acetate and 
formic acid 20:4:0.5 
10% sulfuric acid in 
ethanol and heat to 
105°C 
reference drug 
(unspecified) 
violet red in 
daylight, orange 
fluorescent in UV 
365nm 
Fructus Corni Ethyl acetate, ultrasonicate, filter, 
dry, dissolve in ursolic acid 
Ethyl acetate, ethanol, 
glacial acetic acid 50:10:1 
5% vanillin in sulfuric 
acid and heat to 
105°C 
loganin 
violet red spot 
Rhizoma 
Dioscoreae 
Dichloromethane, heat for 2 hours, 
filter, dry, dissolve in 
dichloromethane 
ethyl acetate, methanol, 
and ammonia 9:1:0.5 
phosphomolybdic 
acid 10% in ethanol 
and heat to 105°C 
reference drug 
(unspecified) 
Rhizoma 
Alismatis 
Ethyl acetate, ultrasonicate, apply 
filtrate to alumina column, elute 
with 10mL ethyl acetate, collect 
elutes, evaporate, dissolve residue 
in 1mL of ethyl acetate 
cyclohexane and ethyl 
acetate 1:1 
silicotungstic acid 5% 
in ethanol 
23-acetate alisol-
B 
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Paeonol from the peonies is one of several “active” phenols including paeoniflorin, 
benzoylpaeoniflorin, and benzoyloxypaeoniflorin, methylgallate, catechin, 
paeoniflorigenone, galloylpaeoniflorin, and daucosterol may also be important in 
the effects on haemostasis (101). Verbascoside from Radix Rehmanniae is a glycoside 
which is antioxidant, hepatoprotective and anti-inflammatory (212). Loganin from 
Fructus Corni is an iridoid glycoside and promotes differentiation and inhibit 
apoptosis (213). Rhizoma Alismatis is identified by 23-acetate alisol-B a triterpene 
which is antimicrobial (214). The Silica G type plates were used for this analysis but 
the specific extraction methods for the herbs were not and neither were the mobile 
phases. Vanillin was not used but a related compound anisaldehyde was. The 
specific reference compounds were not purchased and so identification could not be 
made and for three of the herbs the reference drug was not specified but described 
only as the reference drug. 
 
3.4 Conclusion 
 
An ethanolic extraction used for the assays would not be representative of the 
predominant clinical use of the herbs. Tinctures are an ethanolic extraction which is 
part of the tradition of TCM but not the most commonly used in the west. Many of 
the studies on TCM herbs including those cited in this work use techniques to 
optimise extraction of compounds. Whilst this has value in exploring the full range 
of compounds present in plant material is does not represent the medicinal product 
in use. This has been explored more fully in a previous work by the author using HPLC 
to compare concentrated powders, raw herb decoction and tinctures for a specific 
herb (215). The patient style extraction was therefore used in all subsequent assays in 
order to most closely relate to the clinical used of the formula. 
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4 Effects of Gui Shao Di Huang Wan and its individual herb extracts 
on uterine perfusion and endothelial function. 
 
4.1 Haemostasis 
 
Gui Shao Di Huang Wan shows a dose dependent 
increase in time to clot formation, and evidence of 
polyvalent interaction between the component herbs in 
in vitro haemostasis assays 
 
4.1.1 Introduction 
 
Good uterine vascular perfusion in the endometrium is vital to implantation of the 
embryo to facilitate natural conception as well as being associated with successful 
outcome of IVF cycles (216). Uterine perfusion is reduced in women with infertility 
(187), and high pulsatility index is due to uterine impedance (217) and is correlated 
with poor reproductive outcome (218).  In many assisted reproductive technologies 
clexane and aspirin are used as anticoagulants to improve endometrial receptivity 
(96). Anticoagulants reduce the pulsatility index in the uterine arteries (219). 
Anticoagulants can be used to overcome increased coagulability as a result of the 
hyper oestrogenic state induced by supra physiological levels of FSH. Anticoagulants 
are also used when hypercoagulability is due to anti-phospholipid syndrome which 
can lead to infertility, IVF failures and recurrent miscarriage (96). The failure rate for 
assisted conception is circa 70% even when a visually acceptable embryo is transferred 
(8) and therefore any intervention that improves the receptivity of the endometrium 
is of high value. 3.5 million people in the UK  are struggling to conceive (2). If 
infertility is caused by poor endometrial receptivity, then it may be that IVF can 
exacerbate this pre-existing state rather than being the solution to infertility.  
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There is some evidence to support the use of Chinese herb extracts for improving 
fertility and Gui Shao Di Huang Wan is widely used as a base formula. Despite the 
clinical evidence supporting the use of Chinese herbs (3, 4, 28, 39, 40), there is little 
research to date which explains the mechanisms of action. In order to investigate the 
effects on uterine perfusion two assays which model the clotting processes (Figure 
1.2) were used. 
 
The Prothrombin Time (PT) and activated Partial Thromboplastin Time (aPTT) are 
in vitro assays which are tests of haemostasis representing the models of the extrinsic 
and intrinsic coagulation pathways respectively (Section 1.9, p23). These pathways are 
an artificially segregated sequence of events describing the in vitro activity of plasma. 
In vivo the extrinsic and intrinsic pathways are interrelated activities with feedback 
loops, inhibitors, cofactors, interaction with blood flow, vessel vasoconstriction, and 
interaction with endothelium (220). These pathways and tests do however remain 
valuable tools for assessing substances for their anti-coagulant activity (221). 
 
The following section presents the results obtained when the herb extracts, prepared 
as detailed in Section 2.1.1, were tested using the PT and aPTT assays. Methods are 
described in full in Section 2.3, p53.   
 
4.1.2 Results 
4.1.2.1 Increasing concentration of GSDW on prothrombin time  
 
Results indicate that GSDW increases the PT in a dose dependent manner. The PT 
assay tests the extrinsic pathway, results shown in Figure 4.1 show the gradual 
increase in time to clot formation as the volume of GSDW increases relative to dH2O.  
 
Concentrations for which the time to clot formation is significantly higher are 
indicated by *. This is for volumes above 0.015mL GSDW. The mean time ± Standard 
Deviation (SD) at 0.04mL was 112 s ±36.64 (n-5), compared to the next highest 
0.035mL which was 42.84 s ±2.96. The time to clot increases with increasing dosage 
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of GSDW to 0.04mL, where very high variance (SD) impacts on the reliability of 
measurements. 
 
 
 
Figure 4.1 Time(s) to clot formation in PT assay with increasing concentrations of GSDW. 
Data is presented as mean±SD, GSDW 0 (17.68 s ±1.85), 0.05 (19.38 s ±0.57), 0.10 (20.12 s ±0.52), 0.15 
(22.58 s ±1.52), 0.20 (21.86 s ±1.32), 0.25 (26.22 s ±1.81), 0.30 (33.70 s ±2.71), 0.35 (42.84 s ±2.96), 0.040 
(112.0 s ±36.64). A Welch’s ANOVA was used to analyse differences between group and those which were 
significantly different to the control of dH2O are marked with an *. 
 
Time to clot formation in PT assay was significantly different Welch’s F (8,14.57) =50.21, 
p<0.0005.  
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Games Howell post hoc analysis revealed that the increases were significant  
as shown in Table 4-1, values stated are those where p<0.05. Above 0.015mL of GSDW 
added to the assay, the increase in time to clot formation was significant. 
 
Table 4-1 Summary of significant (p<0.05) pairwise comparisons of PT with increasing concentration of 
GSDW from Games-Howell post hoc tests 
 
 
  
mL herb 0 0.005 0.010 0.015 0.020 0.025 0.030 
0              
0.005        
0.010              
0.015 0.025             
0.020 0.048       
0.025 0.001 0.006 0.010 0.099 0.036     
0.030 0.000 0.002 0.002 0.002 0.002 0.016   
0.035 0.000 0.000 0.000 0.000 0.000 0.000 0.013 
0.040 0.039 0.042 0.043 0.047 0.046   
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4.1.2.2 Increasing concentration of GSDW on activated partial 
thromboplastin time (aPTT) 
 
Results indicate that GSDW increases the aPTT in a dose dependent manner. This 
assay tests the intrinsic pathway, results shown in Figure 4.2 shows the gradual 
increase in time to clot formation as the volume of GSDW relative to dH2O is 
increased in the assay (n=5).  
 
The graph shows those concentrations for which the time to clot formation is 
significantly different indicated by * and this is for volumes between 0.015mL and 
0.030mL. Above these levels the time to clot formation becomes highly variable. 
 
 
Figure 4.2 Time (s) to clot formation in aPTT assay with increasing concentrations of GSDW.  
Data is presented as mean ± standard deviation, GSDW 0 (63.74 s ±1.19), 0.005 (64.56 s ±3.5515), 0.010 
(75.28 s ±6.37), 0.015 (112.52 s ±11.47), 0.020 (150.9 s ±15.51), 0.025 (217.16 s ±34.96), 0.030 (312.28 s 
±116.31), 0.0350 (465.46 s ±174.94), 0.040 (439 s ±220.50). A Welch’s ANOVA was used to analyse 
differences between group and those which were significantly different to the control of dH2O are marked 
with an * 
 
Time to clot formation in aPTT assay was significantly different Welch’s F (8,13.77) 
=38.79, p<0.0005.  
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Games Howell post hoc analysis revealed that the increases were significant as shown 
in Table 4-2, values stated are those where p<0.05. 
 
Table 4-2 Summary of significant (p<0.05) pairwise comparisons of aPTT from Games-Howell post hoc tests 
 
  
 
 
 
 
 
The extrinsic pathway tested by the PT, and the intrinsic pathway tested using the 
aPTT assay both show a pattern of increase in coagulation time as the volume of the 
herbal formula increases, but standard deviations show that this difference becomes 
less consistent at higher concentrations. 
 
Having established that the formula did significantly increase coagulation time over 
a no herb control of dH2O, and that the effect was seen in both pathways, each herb 
was tested individually. This was to see if the changes could be attributed to a 
particular herb. The volume added was 0.02 mL chosen as the midpoint of the 
concentrations tested for the whole formula and at a concentration where the herb 
extracts showed a significant change from no herb control but were still showing 
consistent results in the time to clot formation. 
  
mL herb 0 0.005 0.010 0.015 
0         
0.005         
0.010         
0.015 0.005 0.004 0.007   
0.020 0.002 0.001 0.001 0.031 
0.025 0.005 0.005 0.006 0.015 
0.030 0.066 0.067     
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4.1.2.3 Effects of the individual herb extracts on prothrombin time (PT) 
 
Results shown in Figure 4.3 shows that for GSDW and for Fructus Corni the difference 
in PT was significantly higher than for a dH2O control only, and that there was a 
difference between GSDW and Cortex Moutan. Data here did not meet the 
assumptions for parametric testing and so a Kruskal Wallis was used. Complete 
pairwise comparisons from Dunn’s post hoc can be found in Appendix XII. 
 
  
Figure 4.3 Time (s) to clot formation for individual herb extract using prothrombin assay.  
Mann Whitney U was used as the assumptions for a parametric test were not met. It showed GSDW (mean 
rank=8) was statistically higher than for dH2O (mean rank=3), U=25, z=-2.62, p=0.008. Kruskal Wallis 
showed significant differences between individual herb extracts χ2(9) = 38.11, p < 0.0005. Dunn’s post hoc 
analysis revealed statistically significant differences between dH2O (11.40) and GSDW (42.10) (p=0.039); 
dH2O (11.40) and Fructus Corni (47.00) (p=0.005); GSDW (42.10) and Cortex Moutan (11.90) (p=0.047). 
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4.1.2.4 Effects of the individual herb extract on activated partial 
thromboplastin time 
 
aPTT with the individual herb extracts (Figure 4.4) show that for GSDW and for 
Fructus Corni the difference in time to clot formation was significantly higher than 
for a dH2O control, and that GSDW was significantly higher than all of the 
contributory herbs.  
 
Figure 4.4 Time (s) to clot formation for individual herb extract using activated partial thromboplastin time 
assay.  
T-Tests showed was a statistically significant difference between media and GSDW for aPTT, data is shown 
here as mean±SD, dH2O (63.74 s ±1.19), Gui Shao Di Huang Wan (167.74 s ±14.52) t (8) =15.94, p<0.0001 
the effects size Cohen’s D is 10.1. Radix Paeoniae Alba (65 s ±1.19), Radix Angelicae Sinensis (77.4 s ±3.69), 
Sclerotium Poria Cocos (57.1 s ±2.15), Cortex Moutan (62.68 s ±1.45), Radix Rehmanniae Preparata (62.68 s 
±1.45), Rhizoma Dioscoreae (61.2 s ±2.68), Fructus Corni (107.86 s ±9.32), Rhizoma Alismatis (59.12 s 
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±3.19). A Welch’s ANOVA was used to analyse differences between group and those which were 
significantly different to the control of dH2O are marked with an * 
 
 
Activated thromboplastin times for the individual herb extracts did significantly change 
time to clot formation, Welch's F (9, 16.135) = 42.64, p < .0005.  
 
Games-Howell post hoc analysis revealed significant differences between dH20 and 
the individual herbs and significant differences also existed between GSDW and every 
other herb as is shown in Table 4-3. 
 
Table 4-3 Games Howell post hoc tests for individual herb aPTT 
 
There were further significant differences between the individual herb extracts, but 
these are not directly useful in answering the hypotheses here. The full table of all 
post hoc tests can be seen in Appendix XIII. 
 
  
Control/formula Herb extract Mean difference 95% CI p 
dH2O GSDW -104.0 -139.78 to -68.22 0.001 
dH2O Radix Angelicae Sinensis -13.66 -22.37 to -4.94 0.008 
dH2O Sclerotium Poria Cocos 6.64 1.67 to 11.61 0.012 
dH2O Fructus Corni -44.12 -66.96 to -21.28 0.004 
GSDW dH2O 104.0 68.22 to 139.78  0.001 
GSDW Radix Paeoniae Alba 102.74 66.96 to 138.52 0.001 
GSDW Radix Angelicae Sinensis 90.34 55.57 to 125.11 0.001 
GSDW Sclerotium Poria Cocos 110.64 75.17 to 146.11 0.001 
GSDW Radix Rehmanniae  105.06 69.35 to 140.77 0.001 
GSDW Rhizoma Dioscoreae 106.54 71.29 to 141.79 0.001 
GSDW Fructus Corni 59.88 26.00 to 93.76 0.002 
GSDW Rhizoma Alismatis 108.62 73.61 to 143.63 0.001 
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4.1.2.5 Comparison of the effect of Gui Shao Di Huang Wan with Heparin 
 
To compare the effects of GSDW with a commonly used pharmaceutical 
anticoagulant medication the assays were repeated. The whole formula heparin and 
heparin PT and aPTT were performed and time to clot formation was compared. The 
therapeutic dose of heparin was assumed to be 10,000 iU/5L (v/v) of blood in vivo and 
so was used at an equivalent concentration in the assay and at 10x dilution. The 
dilution was used because heparin has a very short half-life of only 90 min, and binds 
to a range of plasma proteins (195) and so a direct therapeutic dose is unlikely to 
represent in vivo plasma concentrations (222). Heparin binds to antithrombin in the 
plasma and so inactivates thrombin and factor Xa which are both on the common 
pathway and so will inhibit both assays (94).  
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4.1.2.5.1 PT Heparin 
 
Figure 4.5 shows PT for GDSW as compared to the effect with a 1U dose of heparin 
calculated for this assay to be 0.075mL of heparin. Heparin at this dose and GSDW 
both have a significant difference (GSDW p<0.005, Heparin p<0.005) over dH2O but 
the difference between them is not significant (p=1.0). 
 
 
Figure 4.5 Time (s) to clot formation for GSDW and heparin using prothrombin time assay. 
Kruskal Wallis showed PT was significantly different χ2(4) 41.27, p < .0005. Dunn's (1964) procedure with a 
Bonferroni correction for multiple comparisons using adjusted p values, data shows ranks and 
demonstrates statistically significant differences between dH2O (7.85) and GSDW 0.04mL (39.20) (p<0.005); 
dH2O (7.85) and heparin 0.075mL (41.80) (p<0.005) but not between GSDW 0.04mL (39.20) and heparin 
0.075mL (41.80) (p=1.000). 
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4.1.2.5.2 aPTT Heparin 
 
The previous assay used heparin at 1U dose but in the assay no clot formed after 15 
min. In this assay, GSDW was compared to the effect with a 1/10U dose of heparin 
calculated for this assay to be 0.001mL Figure 4.6 shows aPTT for GDSW as of heparin. 
Heparin at this dose and GSDW both have a significant difference over dH2O (GSDW 
p<0.005, Heparin p<0.005, but the difference between them is not significant(p=1.0). 
 
 
 
Figure 4.6 Time (s) to clot formation for GSDW and heparin using activated partial thromboplastin time 
assay.  
Kruskal Wallis showed that aPTT time were significantly different χ2(3) 32.25, p < 0.005. Dunn's (1964) 
procedure with a Bonferroni correction for multiple comparisons using adjusted p values, data shows ranks 
demonstrates statistically significant differences between dH2O (5.50) and GSDW 0.04 (16.50) (p<0.005); 
dH2O (5.50) and heparin 0.075mL (33.10) (p<0.005) but not between GSDW 0.04mL (16.50) and heparin 
0.075mL (33.10) (p=1.000). 
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The graphs show the results for the PT for the 1 iU dose, 1/10 iU was tested and a small 
effect was seen, similar to a 0.02mL dose of GSDW (mean±SD 1/10 iU heparin 
26.33±5.26, GSDW 0.02mL 29.91±0.96, dH2O 22.71±0.57).  A 1/10 iU equivalent only is 
shown for the aPTT as a 1 iU heparin did not form a clot within 15 min.  
 
4.1.3 Discussion 
 
GSDW increases time to clot formation in both the PT and aPTT assays, and it does 
so in a dose dependent manner which is statistically significant (p<0.05) at volumes 
above 0.015mL added to the assays. The effect on PT appears to be similar for both 
GSDW and Fructus Corni suggesting the effects originate from that herb alone. A 
derivative of Fructus Corni containing malic acid, succinic acid and citric acid has 
been shown to be anti-thrombotic but this is suggested to be mediated by 
interference in ADP activated signalling in platelets and regulation of endothelial 
function (223) none of which are tested in these assays. Fructus Corni is a peony and 
contains many of the same compounds Radix Paeoniae Alba which has been shown 
to have antithrombin effects, but no effect was seen in Radix Paeoniae Alba (100). 
 
In the aPTT assay, GSDW, Radix Angelicae Sinensis and Fructus Corni all showed a 
significant increase in time to coagulation over the dH2O control. H1 Gui Shao Di 
Huang Wan will increase parameters of uterine perfusion and angiogenesis in 
endothelial cell proliferation, migration, and differentiation and H3 the influence of 
the extract whole formula Gui Shao Di Huang Wan is greater than the individual herb 
extracts are accepted the time to clot formation is increased and the different herbs 
have different contributions. Radix Angelicae Sinensis does contain (z)-ligustilide 
which has been shown to inhibit clot formation and platelet aggregation (110) but in 
another study time to clot formation via the PT and aPTT assays were not extended 
with (z)-ligustilide alone. N-butylphthalide is also found in Radix Angelicae Sinensis 
and has been show to increase coagulation times; the mechanism of its anti-
thrombotic and anti-platelet activity is related to its regulation of cAMP level and 5-
Effects of Gui Shao Di Huang Wan and its individual herb extracts on uterine perfusion and endothelial function. 
 
102 
HT release (111), these effects will not lead to the extended clotting times observed. 
The compound α-pinene (115) found in Radix Angelicae Sinensis has been shown to 
be weakly antithrombin and ferulic acid (224) it has been shown to inhibit tissue 
factor. Fructus Corni is closely related to Radix Paeoniae Alba which has antithrombin 
effects. 
 
Many of the anticoagulant effects seen in herb extracts are due to their effects on 
inhibition of platelet activation and aggregation, by antithrombin activity, or by 
inhibition of tissue factor (225).  
 
4.1.3.1 Polyvalence 
 
The mean aPTT of GSDW was 167.74 s, Radix Angelicae Sinensis was 77.4 s and 
Fructus Corni 107.86 s. If clot formation in dH2O control is 63.74 s then effect of Radix 
Angelicae Sinensis over control is 13.66 s and for Fructus Corni is 44.12 s, the combined 
effect is 55.78 s assuming the effects are additive. The increase in time to clot 
formation for GSDW over dH2O is 104 which suggests that the effects is not merely a 
cumulative effect of the two herbs. N=5 repeats in the analysis but time to clot 
formation of 150-250 s was seen in 25 repeats over the course of the experiments. This 
suggests that some combination of the compounds that are present are causing an 
effect greater than the individual contributions or possibly a compound not present 
in the individual herb extracts is being created when the herbs are decocted together. 
4.1.3.2 Morphology of the clots 
 
The clots that were formed in the PT and aPTT assays were visually different are the 
concentration of GSDW increased. They appeared dark, which is consistent with the 
appearance of the herb extract, but also shrunken. It was possible that a mechanical 
interference could be causing the changes and so the extracts were ultra-filtered, but 
the changes remained. Change in clot structure could be due to alteration in the 
production of fibrin. To microscopically examine fibrin morphology, the clots were 
fixed in formaldehyde 37% (v/v) overnight before being placed in cytoblock cassettes 
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for dehydration. They were run through a tissue processor (Citadel 2000); placed in 
70% ethanol, 90% ethanol, 100% ethanol and then xylene. Once completed the 
samples were embedded in paraffin wax and cut into sections 5µm thick using a 
microtome. These were floated in a water bath and mounted on slides which were 
initially dried on a hot plate, then air dried overnight. The slides were dewaxed by 
placing in xylene for five min, then rehydrated in 100% alcohol for one minute, then 
95% alcohol for 30s, 70% alcohol for 30s, 50% alcohol for 30s and then distilled water 
for 30s. Sections were then stained using Martius, Scarlet and Blue (MSB) stain which 
is considered to be a reliable stain for fibrin which should appear red, fresh fibrin can 
be yellow and old fibrin blue. Sections were then dehydrated and placed under a 
coverslip mounted with DPX. 
 
Sections were then examined and photographed under the microscope (Figure 4.7). 
Predominantly the tissue in the sections were stained blue with small areas of red on 
some, but not on all of the slides. It was expected that the tissue being composed of 
recent fibrin clots would be red.  Nothing was elucidated of the structure of the fibrin 
partly because the stains showed no consistent changes and because the sections of 
the clot were very friable and damaged in the microtome. 
 
 
Figure 4.7 Image of clot stained with Martius scarlet blue from an aPTT clot with 20µL Radix Rehmanniae 
added to the plasma in the assay. Image taken using a 20X objective. 
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Fibrin creates a mesh of cross linked fibres that form the structure of the clot. It is 
converted from fibrinogen as a result of thrombin mediated release of 
fibrinopeptides. These two substances have overlapping roles in the formation of a 
clot. The mechanical properties of fibrin are affected by its structure at the level of 
the molecule, fibre, and fibre network. These can be affected by genetics as well as 
environment. Anticoagulants such as heparin affect fibrin characteristics through 
reduced thrombin generation (226). 
 
Fibrin clot structure can be altered by procoagulant stimuli, fibrinogen (227) and 
prothrombin concentration (228). Factor XIIa modulates the structure of the clot 
independent of any changes in thrombin by binding to the N-terminus of fibrinogen 
(229). If Factor XIIa were affected by the herb extracts greater changes in clot 
morphology would be seen in the aPTT assay. The changes in fibrin can alter its 
stability and resistance to lysis (230).  
 
The photos in Figure 4.8 show a possible difference in the structure of the fibrin in 
the clot, and a difference in the photos of the fluids retrieved from around the clot. 
When the clot forms abnormally the fluids are not bound into the fibrin mesh and 
are apparent as shown in Figure 4.9. The photographs of the clots were highly 
inconsistent and the stains did not highlight fibrin so this laborious process was only 
completed on two clots for each condition, and for each assay. There are observable 
changes and this may indicate a direction for future work. 
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Figure 4.8 Photographs of slices of the clots with 0.005mg/mL and 0.040mg/mL GSDW in the aPTT assay. 
Image taken using a 20X objective.  
 
 
Figure 4.9 photographs of the fluid which remains around the formed clot in aPTT assay. Image taken using 
a 20X objective. 
 
An undergraduate student at the University of Portsmouth, Queenie Szeto, 
attempted to investigate this further testing the tensile strength of the clots formed. 
Thrombi were tied at either end with fine suture thread and tied to a force transducer 
in a tissue bath and subjected to pull at either end. This was achieved with clots 
produced with no dilution of plasma, but when herb extract was substituted in the 
assay, the resultant clot was too unstable to connect to the force transducer and 
disintegrated in the process. There are methods for the visco-elastic analysis of fibrin 
at the molecular, fibre and clot level using laser or magnetic tweezers, torsion 
pendulum, thromboelastography which would provide more information about the 
changes seen in the clot morphology (231). 
 
GSDW 0.005mg/mL in aPTT assay; 
no change seen in clot morphology 
during assay 
GSDW 0.040mg/mL in aPTT assay; 
changes seen in clot morphology 
during assay 
GSDW 0.005mg/mL added fluid from 
around clot in aPTT assay; no change 
seen in clot morphology 
GSDW 0.040mg/mL fluid from 
around clot in aPTT assay; changes 
seen in clot morphology 
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The structure of clots formed in vitro are not representative of clots formed in vivo as 
they tend to lack the alignment of fibrin seen in the architecture of the in vivo clots. 
This is better assessed with an electron microscope than a light microscope (232).   
 
Platelets are produced in in bone marrow from megakaryocytes which are the 
fragmented and enter the blood stream. They are activated by a number of pathways 
including contact with collagen which bind to the platelet and they are stabilised in 
the forming fibrin mesh. Bound platelets activate further platelets as by releasing 
TXA2, adenosine triphosphate and thrombin, and by local tissue factor release (233). 
Platelets also have a function in regulation of inflammation binding to neutrophils 
and interacting with leukocytes (233).  
 
Many plant compounds decrease platelet activation and aggregation through a 
variety of mechanisms (225). The general mechanism by which flavonoids have been 
shown to inhibit platelet aggregation is through their effects on the arachidonic 
pathway, which facilitates its conversion to TXA, which amplifies platelet activation 
and aggregation (234). This is true of Radix Paeoniae Alba and Cortex Moutan which 
contain paeonol, thought to inhibit conversion of TXA (235).  Herbs in GSDW have 
been shown to affect platelet aggregation but that does not provide any information 
as to the mechanisms by which PT and aPTT are being elongated in these assays. 
 
Coumarins which are present in Radix Angelicae Sinensis have been shown to inhibit 
vitamin K dependent carboxylation. The amino acid γ-carboxyglutamate residues are 
required for the functioning of procoagulant prothrombin, and factors VII, IX, and X 
and for the anticoagulants such as Protein C (236). Ferulic acid which is present in 
Radix Angelicae Sinensis is inhibitory to tissue factor which activates blood clotting 
via factor VII (224). 
 
Oxypaeoniflorin in Radix Paeonia Alba and Cortex Moutan have been shown to 
increase PT time, catechin and benzoylpaeoniflorin in Paeonia have been shown to 
increase aPTT time (101). Paeonol, gallic acid, catechin and benzoyloxypaeoniﬂorin 
also present in both has been shown to increase TT. 
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Pharmaceutical research remains focussed on factor Xa inhibitors as the inhibition of 
other factors is less direct than influencing factor X and so more difficult to manage. 
Factor X also has no known other functions. Direct inhibition of a number of 
synthetic and natural compounds are being investigated as are indirect inhibitors 
such as the heparan polysaccharides that promote antithrombin (237). aPTT can be 
elongated by inhibition of factors VIII, XII, XI, IX, thrombin inhibitors, promotion of 
Protein C or S which inactivate Factors Va and VIIIa.  Elongation of aPTT occurs with 
administered heparin which acts as physiological heperans do. They inhibit 
coagulation by activating antithrombin (AT) which inhibits the serine proteases 
thrombin (IIa), factor Xa and to a lesser extent factor XIa, and factor IXa (238). 
Elongation of PT may be due to inhibition of tissue factor or factor VII. Any effect on 
prothrombin (II), fibrinogen (I), factors X, V or XIII will affect both PT and aPTT.  
 
4.1.4 Conclusion 
 
Although it has been shown that both in this study and other research that elongation 
of time to clot formation is extended (Figure 4.10, p108) the mechanisms by which it 
exerts its influence are not clear. Radix Paeonia Alba and Cortex Moutan, contain 
compounds shown to inhibit thrombin and fibrin which would affect both pathways 
but the effects are not seen in either assay for either of these herb extracts alone. The 
most significant effects were seen for Fructus Corni for which only mild anti platelet 
activity was found in the literature. Radix Angelicae Sinensis was shown to extend 
both assays and literature was found supporting inhibition of tissue factor by ferulic 
acid which would influence PT and to be anti-thrombin which would affect both 
pathways. It does not seem likely that the elongation effects of GSDW are due to this 
alone as the whole formula shows greater effects than this herb. The herbs do have 
effects on platelet aggregation and on inflammation which will contribute to their 
promotion of blood flow in vivo but a further influence is evidenced by these assays. 
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Figure 4.10 Summary of effects of the herb extracts on the clotting cascade seen in the aPTT and PT assays 
and any expected actions as seen in the literature reviewed. 
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4.2 Angiogenesis: Proliferation  
 
Gui Shao Di Huang Wan may promote endometrial 
receptivity increasing endometrial thickness by 
increasing proliferation of endothelial cells 
 
4.2.1 Introduction 
 
Regeneration of the endometrium occurs following menstruation, the surface of the 
endometrium is re-epithelialised beginning on the second day of bleeding and 
completing at day 5. This occurs through the migration and proliferation of epithelial 
cells accompanied by changes in the supporting endothelial cells (239). Proliferation 
in the endometrium leads to the thickening of the mucosa into distinct zones with 
different vascularity, which may be due to the differing functions of the basilis and 
functionalis. During this proliferative phase oestrogen receptors numbers increase 
(239). 
 
The MTT assay is commonly accepted to be a measure of proliferation, but specifically 
measures cell viability (240). It is possible that there is no increase in the number of 
cells but an upregulation of their mitochondrial activity. It is generally considered in 
most cell populations that total mitochondrial activity is related to the number of 
viable cells (241) and so is indicative of a proliferative effect. A second assay, a 
MultiTox assay was also performed which measures live cell protease activity. 
 
96 well plates were seeded with HUVECs, a serial dilution of the whole formula 
GSDW was added to half of the wells, leaving half as control. Cell viability was 
calculated using either an increase in the colourimetric density using the MTT assays, 
or using MultiTox Glo regents that measure live cell luminescence and dead cell 
fluorescence. The full methodology for these assays can be found in Section 2.4, p60.  
4.2.2 Results 
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4.2.2.1 MTT relative viability data 24, 48, and 72 hours 
 
HUVECs at 24, 48, and 72 hours were exposed to serial dilutions of the neat GSDW 
starting at a concentration of 86.70 µg/mL. There was a clear cytotoxic effect at higher 
concentrations of the extract (86.70 – 10.84 µg/mL) and the effect on endothelial cell 
proliferation was dose dependent. Between 10.84 µg/mL and 5.42 µg/mL GSDW, circa 
100% viability was reached. Test and control values were approximately equal at all 
three time points; % viability is expressed as mean±SD and at 5.42 µg/mL was 24 h 
(109.17±9.70), 48 h, (114.83±16.31), 72 h (109.50±13.44). The analysis presented in Figure 
4.11 shows the level of cytotoxicity of the herb.  
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Figure 4.11 Viability data for HUVECs at 24, 48 and 72 h. 
Used to assess the level at which the herb extracts were no longer cytotoxic. Data is displayed as mean±SD 
at 5.42 µg/mL viability reached parity between test and control, 24 h 112.17±20.70, 48 h 107.17±4.83, and 
72 h is 95.50±5.05. At higher concentrations viability was reduced. 
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4.2.2.2 MTT IC50 data 24, 48, and 72 hours 
 
Figure 4.12 displays the IC50 which is a standard measure of the half inhibitory 
concentration of a drug. In this case it displays the half measure between 100% 
survival and cell death. In these experiments it was considered of greater value to 
establish the levels at which the herbs were not cytotoxic for further cell assays, as 
well as investigating the proliferative effects seen. 
 
 
Figure 4.12 shows the IC50 values for the three time scales used.  
The IC50 doses are at 24h 25.1 µg/mL CI 11.89-52.79 µg/mL, 48h 30.2µg/mL CI 12.34-73.87 µg/mL, and 72h 
12.7 µg/mL 5.45-29.43 µg/mL. 
 
At concentrations below 5.42 µg/mL % cell viability appeared to increase above 
100% suggesting a proliferative effect. This slight increase was still seen at the 9th 
dilution 
1
512
  which is 0.017 µg/mL on a single plate. In order to investigate to what 
dilution this effect was present, the experiment was performed extending the serial 
dilution across two plates to a final dilution of  
1
524288
 or 0.00017 µg/mL. The slight 
increase in % viability was not observed in any well on the second plate (data not 
presented). To examine the increase in % viability a subset of the data was 
considered.  
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4.2.2.3 MTT 24, 48, and 72 hours excluding cytotoxic doses 
 
A one-way ANOVA (either ANOVA with Tukey post hoc tests, or Welch’s ANOVA 
with Games Howell post hoc tests) was performed on the subset of data where herb 
concentrations were below 5.42 µg/mL is shown in Figure 4.13. As discussed above 
this is because an increase in % viability was observed. An ANOVA wad used to 
determine whether this increase was statistically significant.  
 
 
Figure 4.13 Subset of viability data for HUVEC MTT assay cells at 24, 48 and 72 h.  
Data is described here as mean±SD. 24 h; 0.17 µg/mL (109.17±9.70), 0.34 µg/mL (118.33±8.73), 0.68 µg/mL 
(119.33±7.66), 1.35 µg/mL (127.67±15.40), 2.71 µg/mL (131.67±16.06), 5.42 µg/mL (112.17±20.70). 48 h; 
0.17µg/mL (114.83±16.31), 0.34µg/mL (123.83±7.86), 0.68 µg/mL (130±10.75), 1.35 µg/mL (129±8.90), 2.71 
µg/mL (124.33±9.77), 5.42 µg/mL GSDW (107.17±4.83). 72 h; 0.17 µg/mL (109.50±13.44), 0.34 µg/mL 
(123.33±14.26), 0.68 µg/mL (127±9.27), 1.35 µg/mL (140.50±13.41), 2.71 µg/mL (1130.67±15.97), 5.42 
µg/mL (95.50±5.50). 
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Results of the ANOVA: 
 
At 24 h, the differences were not statistically significantly different according to the 
concentration of herb added Welch's F (5, 13.77) = 2.066, p=0.132 
 
At 48 h, differences between herb concentrations were statistically significant F (5, 30) 
= 4.398, p = 0.004, effect size is η2= 0.4 
  
At 72 h, differences between herb concentrations were statistically significant F (5, 30) 
= 10.039, p <.0005, effect size is η2= 0.63 
 
Tukey’s post hoc analysis showed that at 48 h viability increased as compared to 
5.42µg/mL taken as 100% viability when GSDW was added at concentrations of 0.68 
µg/mL (95%CI 4.67 to 40.10) and 1.35 µg/mL (95%CI -.99 to 35.33). 
 
At 72 h, the difference in viability was significant between 5.42µg/mL and 
concentrations between 0.34µg/mL and 2.71 µg/mL. 0.34 µg/mL (95%CI -49.70 to -
5.96.), 0.68 µg/mL (95%CI -53.37 to -9.63), 1.34 µg/mL (95%CI -66.97 to -23.13), 
2.71µg/mL (95%CI -57.04 to -13.30). 
 
The group means showed a statistically significantly difference (p < 0.05) at 48 and 72 
h, indicating that viability of HUVECs at 48 and 72 h is increased by the presence of 
GSDW added to the cell media at concentrations of between 0.34 to 2.71 µg/mL. H1 
Gui Shao Di Huang Wan will increase parameters of uterine perfusion and 
angiogenesis in endothelial cell proliferation, migration, and differentiation can be 
accepted in relation to this assay, GSDW does increase viability. 
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4.2.2.4 MultiTox-Glo Multiplex cytotoxicity assay 
 
The MultiTox-Glo assay was only performed on a single plate, with each dilution 
tested in triplicate, (n=3 each experimental condition, and n=3 for control). The 
purpose was to indicate whether the results observed in the MTT assay described 
above were due to proliferation, rather than due to an increase in mitochondrial 
activity. The MultiTox Glo assay measures live and dead cell protease activity (Figure 
4.14). The GF-AFC reagent enters intact cells and is only cleaved to become 
fluorescent within a live cell by its protease and so fluorescence is proportional to 
viable cell number. The dead cell reagent AAF only becomes luminescent in contact 
with dead cell protease released when cells membranes have lost integrity, and so is 
proportional to dead cell number. 
 
 
Figure 4.14 Results of the MultiTox-Glo cytotoxicity assay indicating the number of live cells  
at 60 and 90 min (test sensitivity potentially changes) versus dead cells as concentration of GSDW increases. 
There is a distinct peak at 5.42µg/mL in live cell protease detected and a corresponding dead cell protease 
increase corroborating the proliferative effect of GSDW. 
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The observed patterns of increase in live cell numbers combined with a decrease in 
protease activity resulting from cell death suggests this herb extract is having a 
proliferative effect at between 2.71 and 5.47 µg/mL. This range overlaps with the MTT 
assays but the peak is at the same concentration as was seen to show parity with 
survival in the MTT assays. 
 
4.2.3 Discussion 
 
Addition of GSDW to endothelial cells resulted in the promotion of cell proliferation 
as seen in the MTT assay between 48 h from 0.68 to 1.35 µg/mL and at 72 h from 0.34 
to 2.71 µg/mL.  The MTT assays are a relatively simple and affordable assay to use for 
large numbers of wells. They are reliable but can indicate increases in mitochondrial 
activity within the cell as well as increase in cell numbers. The MTT was not 
performed using the commercial serum free media as the duration of the cell viability 
did not reach the first investigated time point. Repeating the assay using cell count 
and an early time point with serum reduced media could yield further valuable 
information and this could be performed with each individual herb extract.  
 
By combining the results of the MTT with the MultiTox Glo assay, a more expensive 
assay requiring more sophisticated laboratory equipment, it was possible to indicate 
the effects of GSDW are proliferative rather than due to mitochondrial activity. The 
MultiTox showed a proliferative peak between 2.71 and 5.42 µg/mL. It is not clear why 
the MultiTox Glo assay peak is at a higher concentration, it may be that because this 
assay was run later in the year and so the herbs were less potent than when the first 
assays were run with the MTT. 
 
There is debate over when in the cycle and in which parts of the endometrium 
proliferation of endothelial cells occurs. It is generally considered to be highest after 
menstruation when epithelial cells proliferate to repopulate the functionalis after 
menstruation (79). This is true of the epithelial cells (242, 243) and this proliferation, 
measured as thickness of the functionalis on ultrasound, has been correlated with 
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increased embryo implantation (244). It has been suggested that the number of 
vessels in the endometrium doesn’t change (131) does change (132) and that there is 
little change in the endothelial cells in the basilis but changes in the functionalis (134). 
This last study seems logical, proliferation is required in order to provide vascularity 
to the regenerating epithelial functionalis post menstruation. However, the suggested 
mechanism of intussusception, for the rapid creation of new vessels in the 
endometrium, does not require the extensive proliferation of endothelial cells that 
sprouting angiogenesis does (245). 
 
Radix Angelicae Sinensis whole extract (mechanism for extraction not specified) (145) 
and ferulic acid (147) which it contains have been shown to increase proliferation in 
HUVECs. Rhizoma Dioscoreae has been shown to have a proliferative on endometrial 
epithelial cells (154) but endothelial cells were not studied. No other evidence of 
proliferative activity has been shown for any of the herbs. The MTT requires very high 
numbers of cells and so it was not repeated for each herb individually but this would 
provide valuable additional information.  
 
4.2.4 Conclusions 
 
GSDW does promote proliferation of endothelial cells at concentration of between 
0.68 and 5.47 µg/mL at 48 and 72 hours and this is likely to be due proliferative effects 
on cells and not due to upregulation of mitochondrial activity. Increases in vascularity 
and thickness of the endometrium, and therefore receptivity could be due to the 
influence of GSDW.  
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4.3 Angiogenesis: Migration 
 
Effects of Gui Shao Di Huang Wan and its individual 
herb extracts on HUVEC and HUtMEC migration 
 
4.3.1 Introduction 
 
Migration of endothelial cells is one of the three main processes explored in relation 
to angiogenesis although little research on the migration in the endometrium has 
been published and very little on the herbs in GSDW. Migration can be in response 
to specific ligands pro or anti-angiogenic or relating to mechanotaxic stimulus from 
the sheer stress encountered at the periphery of developing blood vessels (138).  
 
For this version of the wound healing assay HUVECs or HUtMECs are seeded in the 
two well ibidi migration insert in a 6 well plate and left to adhere overnight. Inserts 
are removed and the GSDW or individual herb extract is added in dilute media with 
no manufacturer supplied supplement only 1% (v/v) BSA with the appropriate 
HUVEC or HUtMEC media (Table 2-4, p57). These were incubated and images were 
taken every 15 min for 24 h, the full methodology can be found in Section 2.7, p68.  
 
4.3.2 Results  
4.3.2.1 HUVEC migration experiment GSDW 
These are single wells for each experimental condition and therefore not subject to 
statistical analyses and have not been repeated, they are single instances and as such 
are not conclusive but do indicate that here would be value in repeating the assays 
although insufficient cells were available to do this. 
 
The HUVECs with media containing the commercial supplements (for details see 
Table 2-4) did migrate (Figure 4.15). The HUVECs with media and only 1% (v/v) BSA 
added showed minimal migration.  With GSDW 0.017 µg/mL there was no evidence 
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of migration but an increase in the central gap may suggest cytotoxicity, inhibition of 
proliferation or non adhesion. At the most dilute GSDW 0.0087 µg/mL there was 
evidence of migration, but not to the extent of that observed with media containing 
commercial supplements but still greater than that of media containing 1% (v/v) BSA.  
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a. Media with commercial supplements 
 
b. Media 1% (v/v) BSA 
 
c. GSDW 0.017 µg/mL 
 
d. GSDW 0.0087 µg/mL  
 
Figure 4.15 HUVEC migration in presence of different concentrations of GSDW (c, d),  
and media with 1% BSA (v/v) (b) and commercial supplements (a). 1st image is at 1 h and the 2nd is at 12 h, 
media with commercial supplements (a) showed migration, with only 1% (v/v) BSA in media (b) slight 
migration is observed. At GSDW 0.0087 µg/mL in media with 1 % BSA (d) some migration is observed, at 
higher concentrations of GSDW (c) none is seen. Image taken using a 5X objective. 
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Table 4-4 lists the results of the analysis using ImageJ wound healing tool an hour 
after the assay was set up and again at 12 h. The third row is a calculation of the 
difference between them. In Figure 4.16 the graph shows how GSDW at 0.017 µg/mL 
leads to an increase in the area between the cells either side of the “wound” which 
may be due to cytotoxicity of the herbs at this concentration. The other three 
conditions all show migration, for the media with commercial supplements this was 
the gap almost entirely closing but for media with only BSA this was a very small 
change. GSDW 0.0087 µg/mL in media 1% (v/v) BSA showed a greater closure of the 
wound that without GSDW in the same media, but not as much as the media with 
full supplements. 
 
Table 4-4 Analysis using ImageJ MRI Wound Healing Tool to calculate area in pixels of the gap between cells 
on either side of the insert 
 Media with 
commercial 
supplements 
Media 1% 
(v/v) BSA 
GSDW 0.017 
µg/mL in media 
1% (v/v) BSA 
GSDW 0.0087 
µg/mL in media 
1% (v/v) BSA 
Area of gap at 1 h (pixels) 710022 600221 561026 669050 
Area of gap 12 h (pixels) 174656 543586 779748 571932 
Difference between 1 and 12 h 535366 56635 -218722 97118 
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Figure 4.16 Graph showing the results of the wound healing tool analysis for the HUVEC migration 
with two different concentrations of GSDW in media with BSA 1% (v/v), the media with BSA 1% (v/v), and 
commercial supplements. The 1st bar represents the gap at 1 h after the assay had been set up, the 2nd is 
the gap after 12 h and the third bar is the difference between them showing whether the gap had increased 
(negative value for difference) as in GSDW 0.017 µg/mL in media 1% (v/v) BSA or a decrease in the gap suggesting 
migration as in media with commercial supplements, media 1% (v/v) BSA, and GSDW 0.0087 µg/mL in media 1% (v/v) 
BSA. 
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4.3.2.2 Individual herb extracts HUVEC migration experiment 
The individual herb extracts were tested to see if any differences could be observed 
between them in their effects on endothelial cell migration. This was set up with 
media, whole formula and each of the individual herbs extracts at 1 in 200 dilutions 
(see Table 2-2, p51 for mg/mL). The photographs in Figure 4.17 show the gap 1 h after 
the assay was set up and again at 12 h. The wound gap has been reduced in the 
presence of Sclerotium Poria Cocos, Radix Rehmanniae, Fructus Corni, and Rhizoma 
Alismatis suggesting that migration across the wound has occurred. 
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a. Media with 1% (v/v) BSA 
b. GSDW 0.04335 µg/mL in media with 1% (v/v) BSA 
c. Radix Paeoniae Alba 0.01825 µg/mL in media with 1% (v/v) BSA 
d. Radix Angelicae Sinensis 0.0202 µg/mL in media with 1% (v/v) BSA 
e. Sclerotium Poria Cocos 0.00105 µg/mL in media with 1% (v/v) BSA 
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f. Cortex Moutan 0.0063 µg/mL in media with 1% (v/v) BSA 
g. Radix Rehmanniae preparata 0.0602 µg/mL in media with 1% (v/v) BSA 
h. Rhizoma Dioscoreae 0.0088 µg/mL in media with 1% (v/v) BSA 
i. Fructus Corni 0.0179 µg/mL in media with 1% (v/v) BSA 
j. Rhizoma Alismatis 0.0046 µg/mL in media with 1% (v/v) BSA 
Figure 4.17 HUVECs tested with individual herb extracts added to the media; first image is at 1 h, the 
second is at 12 h 
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Table 4-5 lists the results of the analysis using ImageJ wound healing tool an hour 
after the assay was set up and again at 12 h. The third row is a calculation of the 
difference between them. In Figure 4.17 the graph shows more clearly than the images 
how in the presence of some of the herb extracts in media with BSA 1% (v/v) the cell 
free gap increased rather than decreased. This was for media with BSA (a), GSDW 
0.04335 µg/mL (b), Radix Paeoniae Alba (c), Radix Angelicae Sinensis (d), Cortex 
Moutan (f), and Rhizoma Dioscoreae (h). The gap between areas of cells had reduced 
for Sclerotium Poria Cocos (e), Radix Rehmanniae (g), Fructus Corni (i), and Rhizoma 
Alismatis (j) suggesting migration has occurred. This most pronounced for Rhizoma 
Alismatis (j). 
 
Table 4-5 Analysis using ImageJ MRI Wound Healing Tool to calculate area in pixels of the gap between cells 
from either side of the insert for individual herb extracts 
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Figure 4.18 Graph showing the wound healing tool analysis for the individual herb extracts 
The 1st bar is the gap at 1 h after the assay had been set up, the 2nd is the gap after 12 h and the third bar is 
the difference between them showing whether the gap had increased (negative value for difference) 
suggesting cell death as in media only, GSDW. Radix Paeoniae Alba, Radix Angelicae Sinensis, Cortex 
Moutan, and Rhizoma Dioscoreae. A positive difference suggests cells have migrated across the wound as in 
Sclerotium Poria Cocos, Radix Rehmanniae, Fructus Corni, and Rhizoma Alismatis. 
 
 
4.3.3 Discussion 
 
Although preliminary results suggest that there is an effect on migration, future 
studies including optimisation experiments in this area are warranted.   This effect is 
seen in media with minimal supplementation of 1% BSA (v/v) containing GSDW 
0.0087 µg/mL (Figure 4.15) and with Sclerotium Poria Cocos, Radix Rehmanniae, 
Fructus Corni, and Rhizoma Alismatis (Figure 4.17). Only single wells of the 
experimental conditions were used in these experiments and due to poor boundaries, 
the analysis is not very reliable. It depends upon detecting a clear area without cells 
at an early time point and then repeating this measure with the cells assumed to have 
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migrated across the gap. In many cases here those boundaries were poor to start with 
and cell death occurred so they became even less distinct. 
 
The assay was initially performed with 9th passage HUVECs to obtain the high 
numbers required to produce sufficient replicates but these failed to migrate (data 
not shown), which has been shown with high passage cells (246). It was not presumed 
that the GSDW was inhibiting proliferation as cells in media with only 1% BSA 
without GSDW failed to migrate either. In the subsequent experiments low (4th-6th) 
passage HUVECs were used, but this meant cell numbers were also low and so 
replicates were limited.  
 
The assay was inconclusive due to methodological issues, insufficient low passage 
cells of the HUVECs were obtained, the cells did not adhere well and were not 
confluent. With higher numbers, it might have been possible to experiment with 
higher seeding densities, which may have then formed a more confluent layer from 
which migration could be measured. Lysine coated TC plates were used and it is 
possible that different well coatings such as collagen, laminin or even a matrigel layer 
could support adhesion. The cells did not adhere well but due to the serum reduced 
media were not expected to thrive and proliferate if left for a further 12-24 h. It may 
be that the cells need to remain in media with serum whilst they form a confluent 
layer which can be removed and replaced with the serum free rather than serum 
starved from seeding as is recommended (247). 
 
Despite the poor results obtained with the HUVECs the assay was also performed 
using the HUtMECs. The cells were low passage, 4th. Cells were on the whole better 
adhered than the HUVECs and showed reasonably defined boundaries. However, 
with the exception of the media with commercial supplements all demonstrated the 
presence of a contaminating agent which was not identified (Figure 4.19).  
Investigations into the possible contaminant were undertaken including culturing 
the media, culturing the remaining cells, seeking advice from specialists from images 
on the contaminant. The herb extracts were all used in both the HUVEC and HUtMEC 
experiments as they so the source of the infection was either in the cells themselves, 
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but suppressed in the media with supplements, which does contain antibiotics, or 
was present in the HUtMEC media without supplements. Only one vial of the 
HUtMECs were purchased which stopped proliferating and became quiescent at 
passage 5, which may have been due to the contaminant although this was not seen 
to appear in the cells or in the reduced supplement media when tested. Due to cost 
issues and technical problems encountered with the HUtMEC cells, experiments 
using these cells were not continued further. 
 
Media with commercial supplements 
 
GSDW 0.017 µg/mL in media with 1% (v/v) BSA 
 
Figure 4.19 HUtMECs showing contaminant first image of each pair is at 1 h, second is at 12 h. The media 
with commercial supplements shows that the cells were able to thrive and migrate. 
 
There is limited published work in this area however one study has demonstrated that 
an aqueous extract of Radix Rehmanniae can promote the migration of human 
mammary endothelial cells (152), which is in keeping with the preliminary 
observation made here. In contrast, Radix Angelicae Sinensis has been shown to 
stimulate migration in HUVECs (145), an observation that was not supported in this 
work. Rhizoma Alismatis and Sclerotium Poria Cocos were surprising herb extracts 
to show an effect on endothelial cell migration, no research could be found in the 
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literature than might indicate this type of activity. It also does not correspond with 
an expected TCM activity. 
 
4.3.4 Conclusions 
 
With this level of information, the H0 is retained in relation to this assay awaiting 
further research. There is very limited suggestive evidence that the whole formula at 
0.087 µg/mL and Sclerotium Poria Cocos, Radix Rehmanniae, Fructus Corni, and 
Rhizoma Alismatis might promote endothelial cell migration but insufficient repeats 
meant that no conclusive evidence is provided. Optimisation of the protocol is 
required, as are high numbers of low passage cells. 
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4.4 Angiogenesis: Differentiation 
 
Measurements of HUVEC differentiation into pseudo 
tubules are modified by Gui Shao Di Huang Wan; 
HUVECs show greater effects with composite than 
individual herb extracts 
 
4.4.1 Introduction 
 
Differentiation of endothelial cells occurs in the endometrium during initial repair in 
the early proliferative phase, in the mid proliferative phase, and during the formation 
of the spiral arteries during the early secretory phase (79). Rising oestrogen levels in 
the secretory phase predominantly enhances endometrial cell proliferation but some 
differentiation does occur. Progesterone in the secretory phase promotes 
differentiation (84). Subendometrial vascularity is reduced in women with infertility 
(248) as is uterine perfusion (249). Increased uterine perfusion and vascular 
permeability enhances nutrient transport to the embryo (250) and facilitates the 
embryo maternal signalling which is necessary for successful implantation (251). 
Haemostasis is in part controlled by the endothelium (252). Changes to the uterus 
leading to greater vascularity and uterine perfusion could improve endometrial 
receptivity. 
 
HUVECs and HUtMECs had the media with commercial supplements removed (2.4.3, 
p58) and were suspended in media containing 0.1% (v/v) FBS. They were seeded onto 
an ibidi µ-slide which has a 10 µL well containing growth factor deficient matrigel. 
This provides a meniscus free surface for visualising tubule growth. GSDW or the 
individual herb extracts are added and the cells incubated for 12-18 hours before being 
photographed. Details of the method are found in Section 2.6.2, p66. The method of 
analysis required as much protocol development as the assay itself (p200). 
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4.4.2 Method to assess differentiation 
 
Assessment of angiogenesis according to Staton, Lewis et al. (253) is by four key 
variables; total tubule length, number of tubules, average tubule length and tubule 
area (which may increase or decrease with increased angiogenesis). Khoo, Micklem 
et al. (254) suggest branching points, tubule area and average tubule length. Studies 
differ as to which are considered the optimum metrics for analysis and some authors 
even suggest multiple measures need to be taken into account in each analysis. Wang, 
Pearson at al. (255) in an experiment looking at thrombin showed that it stimulates 
vascular smooth muscle proliferation and VEGF expression, but reduces numbers of 
vascular tubules and branching of new vascular structures; they counted number of 
junctions, number of tubules and tubule length. Rossiter et al. (256) in their study 
showing that honey promotes angiogenesis, looked at tubule length, branching and 
density. It is not clear which are the best metrics to select or what these represent in 
vivo and this is discussed further in Section 5.8. The software used for analysis was 
ImageJ’s angiogenesis analyser. It has a vast array of metrics which are output by the 
analyser (Appendix V). Four metrics including number of tubules, number of 
junctions, tubule length, and area were chosen for this analysis incorporating the 
range of metrics discussed in the literature (253-256). These parameters are explained 
in detail in Figure 4.20. 
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Number of master segments Number of junctions 
Segments defined as master segments which are 
tubules which have junctions at either end. 
 
Junctions are defined by the software as a pixel 
with three neighbours. 
Total mesh area Total length 
 
Mesh area is defined as the area enclosed by 
segments. 
 
Total length is the length of every tubule, 
segments, branch, and isolated branch whether 
delimited by a junction or not. 
 
Figure 4.20 Photographs of HUVEC differentiation with overlay and description of the parameters used for 
assessing the tubule formation. 
 
As endothelial cells adhere to the matrigel basement membrane they begin to 
differentiate and to form pseudo tubules. This protein matrix emulates the 
extracellular environment endothelial cells encounter in vivo. They grow and branch 
forming junctions which are considered to mimic the process of forming new blood 
vessels in vivo through sprouting angiogenesis. The following photographs are taken 
of the network of tubules formed by the cells on the basement membrane at 12 h for 
the HUVECs, 18 h for the HUVEC (Figure 4.21). These were observed to be the optimal 
times showing formation of tubules and prior to their disintegration.  
 
Junctions 
 
Mesh area 
 
Master segments 
 
Total length 
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Figure 4.21 HUVEC cell differentiation at 6 h and 24 h 
At 6 h the cells are beginning to differentiate and at 24 h they have differentiated but cell death is occurring 
and the tubules are now beginning to disintegrate. Image taken using a 5X objective. 
 
4.4.3 HUVEC Results 
 
The first image in each set of two is the photo taken through the microscope, a Zeiss 
Axioscope A1 coupled to a camera, Zeiss Axiocam 503 at 5X magnification. The second 
image is the tubule map created by the ImageJ, from which the tubule metrics are 
calculated. The experiment was performed in triplicate for each experimental 
condition in two independent experiments i.e. n=6 for the analysis. 
  
6 h 24 h 
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4.4.3.1 Representative photographs of tubule development 
 
A single representative photograph and ImageJ overlay of the tubule analysis from 
the of the images of six repeats of each condition analysed is shown Figure 4.22.  
 
Media with 0.1% (v/v) FBS 
 
GSDW 0.0434 µg/mL in media with 0.1% (v/v) FBS 
 
Radix Paeoniae Alba 0.0183 µg/mL in media with 0.1% (v/v) FBS 
 
Radix Angelicae Sinensis 0.0202 µg/mL in media with 0.1% (v/v) FBS 
Effects of Gui Shao Di Huang Wan and its individual herb extracts on uterine perfusion and endothelial function. 
 
136 
 
Sclerotium Poria Cocos 0.0011 µg/mL in media with 0.1% (v/v) FBS 
 
Cortex Moutan 0.0063 µg/mL in media with 0.1% (v/v) FBS 
 
 
Radix Rehmanniae Preparata 0.0602 µg/mL in media with 0.1% (v/v) FBS 
 
 
Rhizoma Dioscoreae 0.0088 µg/mL in media with 0.1% (v/v) FBS 
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Fructus Corni 0.0179 µg/mL in media with 0.1% (v/v) FBS 
 
Rhizoma Alismatis 0.0046 µg/mL in media with 0.1% (v/v) FBS 
 
 
Figure 4.22 Representative photographs of 1 of 6 of the analysed images of HUVEC differentiation after 12 h 
in the 10 experimental conditions, with and without the ImageJ angiogenesis analyser overlay. Image taken 
using a 5X objective. 
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4.4.3.2 HUVEC Parameters 
 
Parameters examined in differentiating HUVECs on GF- matrigel in 0.1% (v/v) FBS 
media displayed as scatter dot plots are shown in Figure 4.23. 
 
 
Figure 4.23 HUVEC parameters measured displayed as scatter dot plot with mean and SD.  
Details of herb extract mg/mL added can be found in Table 2-8, p67. T-tests showed statistically significant 
differences between media and GSDW number of segments 46.34±13.00 (t (10) =3.57, p=0.005), d=2.05, 
number of junctions 58.17±18.83 (t (10) =3.09, p=0.011) d=1.78, mesh area 78.17± 19.32(t (10) =4.05, 
p=0.002), d=2.33 and total length 653±910.79 (t (10) =3.62, p=0.005), d=2.09. ANOVA performed on the 
individual herb extracts showed number of segments was significantly different Welch’s F (8, 18.63) = 4.82, 
p=0.002, number of junctions Welch’s F (8,18.68) =3.91, p=0.007, mesh area Welch’s F (8,18.56) =3.31, 
p=0.016 and total length Welch’s F (8,18.58) =5.151, p<0.002.  
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The group means were statistically significantly different (p < 0.05), differences do exist 
in parameters of HUVEC differentiation with the GSDW over media. H1 Gui Shao Di 
Huang Wan will increase parameters of uterine perfusion and angiogenesis in 
endothelial cell proliferation, migration, and differentiation is accepted, there are 
differences between media and GSDW, and H3 the influence of the extract whole 
formula Gui Shao Di Huang Wan is greater than the individual herb extracts is rejected 
for this assay as no significant differences were seen between media and any of the 
individual herb extracts.  
 
 
 
4.4.4 HUtMEC Results 
4.4.4.1 Representative photographs of tubule development 
 
The first of each of the following sets of two images are taken through a microscope, 
Nikon eclipse 80i coupled to a camera, Nikon digital sight DS-Fi2 at 4X. The second 
image is the tubule map created by the ImageJ, from which the tubule metrics are 
calculated. This experiment was performed in triplicate for each experimental 
condition in two experiments i.e. n=6 for the analysis. Images were taken 18 h after 
the herb extracts had been added as at 12 h the tubules were still forming. 
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Media with commercial supplements 
 
 
 Media with 0.1% (v/v) FBS 
 
GSDW 0.0173 µg/mL in media with 0.1% (v/v) FBS 
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Radix Paeoniae Alba 0.0073 µg/mL in media with 0.1% (v/v) FBS 
 
Radix Angelicae Sinensis 0.0081 µg/mL in media with 0.1% (v/v) FBS 
 
Sclerotium Poria Cocos 0.0004 µg/mL in media with 0.1% (v/v) FBS  
 
Cortex Moutan 0.0025 µg/mL in media with 0.1% (v/v) FBS 
 
Radix Rehmanniae Preparata 0.0241 µg/mL in media with 0.1% (v/v) FBS 
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Rhizoma Dioscoreae 0.0035 µg/mL in media with 0.1% (v/v) FBS 
 
Fructus Corni 0.0072 µg/mL in media with 0.1% (v/v) FBS 
 
Rhizoma Alismatis 0.0018 µg/mL in media with 0.1% (v/v) FBS 
 
Figure 4.24 Representative photographs of 1 of 6 analysed images of HUtMEC differentiation after 18 h in 
the 10 experimental conditions with and without the ImageJ angiogenesis analyser overlay. Image taken 
using a 4X objective. 
 
The HUtMEC cell line produced sufficient cells to run this assay twice and the 
migration once before becoming quiescent at passage 5. No optimisation of the 
protocol specific to this cell type was undertaken. The experiment was performed 
with the herb extracts at a 1:500 dilution in media with 0.1% (v/v) FBS. A more 
conservative concentration was used as cytotoxicity levels had not been established 
with this cell type. The experiment was performed with controls of media, with and 
without supplements. 
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Parameters examined in differentiating HUtMECs on GF- matrigel in media with 0.1% 
(v/v) FBS and herb extracts are displayed as scatter dot plots are shown in Figure 4.25. 
 
 
  
 
 
Figure 4.25 HUtMEC parameters measured displayed as scatter dot plot with mean and SD.  
Details of herb extract mg/mL added can be found in Table 2-8, p67. T-Tests showed a statistically 
significant difference between media and GSDW for all parameters. Data presented here as mean±SD and 
the effects size is Cohen’s D; number of segments 4± 1.63 (t (10) =2.46, p=0.034), d=1.42, number of 
junctions 5.67±2.36 (t (10) = 2.41, p=0.037 d=1.39, mesh area 549304± 208247 (t (10) =3.67, p=0.004), 
d=1.52 and total length 2562±697 (t (10) =2.67, p=0.004), d=2.12.  
An ANOVA was performed to test differences between individual herb extracts, number of segments F (8, 
45) = 6.54, p<0.0005, effect size is η2=0.54; number of junction’s F (8,45) =3.41, p=0.004, effect size is 
η2=3.77; mesh area F (8,45) =5.24, p<0.0005, effect size is η2=0.48 and total length F (8,45) =6.48, 
p<0.0005, effect size is η2=0.54. 
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Tukey post hoc tests showed where these differences between media and the eight 
herb extracts were and are displayed in Table 4-6. 
 
Table 4-6 Tukey post hoc tests for HUtMEC differentiation 
 
The group means were statistically significantly different (p <0.05) so it is shown that 
differences do exist in all measured parameters of HUtMEC differentiation with the 
formula GSDW over media only and for some of the individual herb extracts. 
 
4.4.5 Discussion 
 
Four different measures of differentiation were taken but they are not completely 
independent of one another; higher numbers of junctions and segments will also tend 
towards higher mesh area for example.  All measured parameters of HUVEC 
differentiation were significantly upregulated by GSDW but none of the individual 
herb extracts had a significant effect. It may be that calculations were underpowered 
for an ANOVA with n=6 for each condition and that greater repetition would show 
more differences. In HUtMECs differences between GSDW and media 0.1% FBS were 
HUtMEC differentiation 
parameter 
Herb extract Mean 
difference 
Sig. 95% CI lower 95% CI upper 
Number of junctions Fructus Corni -14.00 0.049 -27.96 -0.04 
Number of segments Radix Paeoniae Alba -5.83 0.041 -11.52 -0.14 
 
Sclerotium Poria Cocos -6.17 0.025 -11.86 -0.48 
 
Rhizoma Dioscoreae -6.50 0.015 -12.19 -0.81 
 
Rhizoma Alismatis -6.50 0.015 -12.19 -0.81 
Total length Radix Paeoniae Alba -4440.33 0.000 -7354.31 -1526.36 
 
Sclerotium Poria Cocos -3887.67 0.002 -6801.64 -973.69 
 
Radix Rehmanniae 
Preparata 
-3991.83 0.002 -6905.81 -1077.86 
 
Rhizoma Dioscoreae -4452.17 0.000 -7366.14 -1538.19 
 
Fructus Corni -4725.00 0.000 -7638.98 -1811.02 
 
Rhizoma Alismatis -4022.33 0.001 -6936.31 -1108.36 
Total mesh area Radix Paeoniae Alba -779772.17 0.001 -1343355.8 -216188.53 
 
Radix Angelicae Sinensis -587414.83 0.035 -1150998.47 -23831.2 
 
Sclerotium Poria Cocos -653197.33 0.013 -1216780.97 -89613.7 
 
Cortex Moutan -837147.67 0.000 -1400731.3 -273564.03 
 
Radix Rehmanniae 
Preparata 
-924884.33 0.000 -1488467.97 -361300.7 
 
Rhizoma Dioscoreae -736179.00 0.003 -1299762.63 -172595.37 
 
Fructus Corni -866539.83 0.000 -1430123.47 -302956.2 
 
Rhizoma Alismatis -836029.67 0.001 -1399613.3 -272446.03 
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significant but here there were also differences in mesh area for all herb extracts, total 
length for all herb extracts except Radix Angelicae Sinensis, Sclerotium Poria Cocos 
and Rhizoma Dioscoreae. There was an increase in number of junctions and segments 
for Fructus Corni. Segment number and length was increased Radix Paeoniae Alba, 
Sclerotium Poria Cocos and Rhizoma Dioscoreae and Rhizoma Alismatis. H1 Gui Shao 
Di Huang Wan will increase parameters of uterine perfusion and angiogenesis in 
endothelial cell proliferation, migration, and differentiation and H3 the influence of 
the extract whole formula Gui Shao Di Huang Wan is greater than the individual herb 
extracts can be accepted for this assay. 
 
The HUVECs showed a different pattern of response to the herb extracts to the 
HUtMECs. A lower concentration of the herb extract was used for the HUtMECs than 
the HUVECs. This was a precaution because no cytotoxicity data had been established 
for this cell type. The whole formula GSDW is at a much higher mg/mL as it contains 
all eight herbs. It seems unlikely that the failure to show differences in the individual 
herbs for the HUVECs was because concentrations were too high compared with the 
HUtMECs, where difference were seen. If inhibition of differentiation was occurring 
it should be more pronounced in the whole formula than for any individual 
component. 
 
The statistically significant results may not represent the full possible effects of the 
herb extracts. The variability in measured parameters between wells of the same 
experimental condition could mask changes that are occurring due to the low number 
of samples. It is recommended that n≥3, so the use of 6 repetitions is above the 
minimum recommended (253). In the first year of performing the differentiation 
assays using media with supplements it was observed that the differences within the 
experimental conditions were as great as between them. Two wells may have been set 
up moments apart, with the same cell suspension, media, and matrigel and yet show 
very different metrics of differentiation (Figure 4.26, p146). Extensive method 
development was undertaken to reducing this variability but it is still present. 
Bioassays are known to be prone to high levels of variability, an entire paper 
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describing research dedicated to reducing this variability were able to reduce it by 
85% (257). 
 
Figure 4.26 Two photographs of HUVEC differentiation after exposure to GSDW in neighbouring wells set up 
moments apart showing how two wells set up almost identically can produce very dissimilar differentiation 
metrics. Image taken using a 4X objective. 
 
Measures of tubule differentiation are complex and drawing parallels to their 
meaning in utero is not straightforward. The endometrium contains endothelial cells 
in a wide range of tissue types which are morphologically dynamic in response to 
hormonal changes (258). The phenotype of a vessel at the section proximal to the 
myometrium will be different from that in the functionalis and in the functionalis it 
will be different in the proliferative and secretory phases. The assay was under 
normoxic conditions but the endometrium is a hypoxic environment and hypoxia 
regulates VEGF (259). It is possibly to mimic a hypoxic environment in vitro and 
eliminate one further in vitro variable. Oestrogen’s influence on angiogenesis does 
appear to be present under normoxic conditions (260).  
 
Mean tubule length in HUVECs has been previously shown to increase with aqueous 
Radix Angelicae Sinensis (145) but sprouting was inhibited in mouse aortic ring with 
the volatile oils of Radix Angelicae Sinensis (146).  This herb extract was not seen to 
increase significantly any parameters of differentiation in either cell type except for 
mesh area in the HUtMECs which was seen for every herb extract. Quercetin in 
Cortex Moutan has been shown to be inhibitory to tube formation (150) but no 
inhibition was observed in the assays conducted in this study. Radix Rehmanniae has 
been shown to increase tubule length, sprout formation and cell migration (152).  In 
the current study, this herb was seen to increase total length of segments and mesh 
area in the HUtMECs but not in the HUVECs. The literature would suggest that an 
aqueous extract of Radix Angelicae might show increase in differentiation but this 
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was not observed, Radix Rehmanniae would be expected to increase length and 
junctions however only length increases were observed here. Increased number of 
segments and length were seen for Radix Paeoniae Alba or Sclerotium Poria Cocos for 
which no references were found in the literature relating to angiogenesis. Fructus 
Corni also showed increases in number of junctions in the HUtMECs and it has been 
shown that the cornel iroid glycosides upregulate VEGF (155), this herb and Radix 
Paeonia Alba are both peonies and share many of the same compounds including 
glycosides. Sclerotium Poria Cocos is an interesting herb to upregulate differentiation 
as most research performed has been in relation to the immune stimulating 
properties of the polysaccharides (261-263). 
 
There are a wide range of factors that influence differentiation, multiple regulators 
and growth factors including VEGF, vascular endothelial cadherin, plasminogen 
activators,  angiopoietin’s, fibroblast growth factor, and matrix metalloproteinase 
(130). It is possible that for the HUVECs, individual parts of the whole formula each 
have a small influence on different aspects of the regulation of the whole process 
which in combination make a significant difference, this has been shown in the Liu 
Wei Di Huang Wan (53) and in combinations of some of the herbs in GSDW (54, 56). 
In the HUtMECs the influence of some of the individual herb extracts appeared to be 
greater than the whole. Radix Paeonia Alba would appear to have a greater effect on 
number of segments than GSDW although this was not significant due to the high 
variance in the number of segments with four of the six images showing far greater 
numbers and 2 of them very similar numbers; this was also true of junction number. 
It is possible that there are both pro and anti angiogenic influences within the herbs 
which would mean that the sum of herbs in GSDW was less than the parts. It is also 
important to note that no overall downregulation was seen for any individual herb, 
all increased measures of differentiation. 
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4.4.6 Conclusion 
 
All parameters of HUVEC and HUtMEC differentiation were significantly increased 
by GSDW. The HUVEC differentiation parameters were not increased by any of the 
individual herb extracts. The HUtMEC mesh was increased by all herb extracts, total 
length, and segment number by Radix Paeoniae Alba, Sclerotium Poria Cocos, Radix 
Rehmanniae Preparata, Rhizoma Dioscoreae, Fructus Corni, and Rhizoma Alismatis, 
total length and junction number for Fructus Corni.  
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4.5 Immunoblotting for oestrogen and progesterone receptor expression 
 
Downregulation of ERα and upregulation PRβ in 
Ishikawa cells observed following administration of  
Gui Shao Di Huang Wan 
4.5.1 Introduction 
 
The endometrium becomes receptive to implantation due to controlling influences 
of oestrogen and progesterone receptors (264). Oestrogen acts through uterine and 
stromal ERα with some involvement of ERβ. Oestrogen increases epithelial cell 
proliferation and differentiation through stromal ERα and both stromal and epithelial 
ERβ (265). Progesterone receptors work with oestrogen to promote stromal cell 
proliferation and inhibit oestrogen induced epithelial cells proliferation (266). 
Progesterone promotes differentiation post ovulation and decidualisation post 
implantation (168). It is also responsible for increased vascular permeability pre 
implantation  (167) and modulating uterine perfusion during pregnancy (169). 
 
The Ishikawa epithelial cell line was chosen to examine the effects of the herb extracts 
on expression of receptor proteins using immunoblotting. Ishikawa cells are clones 
of an human endometrial adenocarcinoma. This is a cancer originating in the 
epithelial glandular structures. They have been shown to express both oestrogen and 
progesterone receptors (199) making them a valuable  cell line for the study of 
hormonally regulated processes in the endometrial epithelium (267).  
 
These cells were exposed to GSDW and the herb extracts for 24 and 48 hours and the 
lysates of the cells in each of these experimental conditions were then probed using 
immunoblotting for changes to the ovarian steroid receptors ERα, ERβ, mPRα (which 
was not detected, no data is presented), and PRβ. The full methodology is presented 
in Section 2.8, p70. 
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4.5.2 Method of analysis 
 
For each image auto exposure was used to obtain optimal saturation for the images. 
Lanes were manually configured and bands typically were autodetected successfully. 
Images of the ladders were also taken and merged images were used to verify 
molecular weights for all blots (Figure 4.27). A custom standard was set up in 
ImageLab for the Ultraprism ladder. ImageLab subtracts background automatically 
using a rolling disc background subtraction which can be checked and amended as 
required, automated settings were always found to be acceptable. 
 
 
Figure 4.27 shows a ERα 48 hour blot with ladder merged with Beta Actin (βA) and the Ultraprism ladder. 
This was completed for each image to verify that the bands detected are close to the expected molecular 
weight. 
 
Accurate quantitation of proteins requires that the signal intensity is proportional to 
the volume loaded. This can be verified using a serial dilution of the lysate. The 
ChemiDoc camera has a larger linear range than traditional film based detection and 
the auto expose in the ImageLab software detects the optimal exposure without 
saturated pixels. 
 
  
βA 
ERα 
Ultraprism 
ladder 
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Intensities of the bands are a measure of the abundance of the protein and are 
obtained by the software from captured images and exported to an Excel spreadsheet.  
Data was analysed quantitatively in three ways: 
1. Relative abundance compared to media only control. Relative intensities are 
also calculated by the software following user selection of a reference band in 
this case the media only condition for the Ishikawa cell lysates.  
2. Ratio/normalisation to β actin loading control. The normalisation to the β actin 
loading control was performed as described in Equation 2 and Equation 3. 
 
 
Equation 2 calculate normalisation ratio 
 
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑏𝑎𝑛𝑑 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 𝑓𝑜𝑟 𝑚𝑒𝑑𝑖𝑎
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑏𝑎𝑛𝑑 𝑜𝑓 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑓𝑜𝑟 𝑚𝑒𝑑𝑖𝑎
 =  𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 
 
And applying the normalisation ratio to all subsequent lanes as in Equation 3 
 
Equation 3 normalise all lanes 
 
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑏𝑎𝑛𝑑 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑏𝑎𝑛𝑑 𝑜𝑓 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 ∗  𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 = 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦  
 
3. Mean absolute values/volumes of intensity. Presentation of the mean absolute 
volumes of intensity enables concurrent changes in receptor and loading 
control band intensities to be evaluated and compared for each test condition.  
 
Due to the use of relative not absolute values as the key variable for comparison, i.e. 
that of the relative abundance to media only control, and normalisation to the βA 
loading control, standard statistical analyses could not be performed. No variance 
exists in the data to which the other samples have been normalised therefore an 
ANOVA is not appropriate. Absolute volumes were analysed but again the statistics 
were not appropriate given the high variability between blots. 
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Displayed in the following results are three blots for each of the three receptors at 24 
and 48 hours of exposure to the herb extracts. N=3 for each condition, each blot was 
performed on lysates originating from different wells, they are not three repeats on 
the same lysate. The individual blots in each Figure are numbered, for example, in 
Figure 4.26 they are ERα 24-1, ERα 24-2, ERα 24-3 respectively. 
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4.5.3 Results 
4.5.3.1 Oestrogen Receptor alpha (ERα) expression in Ishikawa cells after 
24 hours incubated with the herb extracts 
 
The blots in Figure 4.28 show ERα and βA in three separate lysates prepared from 
Ishikawa cells after 24 h exposure to the herb extracts where the proteins have been 
transferred to a PVDF membrane. The first probe was for ERα, then the membrane 
was stripped using a guanidine hydrochloride (GnHCL) buffer (Appendix VII) and a 
second probe was performed for βA. ERα purified protein as the positive control was 
detected in the blots and at the same kDa as the proteins in the samples. 
 
In the blot ERα 24-1 (Figure 4.28) increases in the intensity of the ERα bands are 
observed following treatment with Radix Paeonia Alba and Rhizoma Alismatis. The 
βA band is more intense in the media only, Radix Angelicae Sinensis, Sclerotium Poria 
Cocos and Rhizoma Alismatis treated samples. This would suggest the increases in 
ERα levels are not due to variability in loading as, a higher ERα with correspondingly 
higher βA would be expected if protein levels were higher in a particular lane. For the 
blot ERα 24-2, ERα levels are increased in GSDW, Sclerotium Poria Cocos and 
Rhizoma Alismatis treated samples. ERα expression is increased in Rhizoma Alismatis 
treated samples in blots ERα 24-1 and 2, but not in blot ERα 24-3. βA bands are more 
intense in Radix Paeonia Alba and Sclerotium Poria Cocos treated samples in blot ERα 
24-2. In blot ERα 24-3, Sclerotium Poria Cocos and Fructus Corni treated samples 
produce more intense ERα bands but for βA, intensity is greatest in GSDW and Radix 
Angelicae Sinensis treated samples. Thus, from a visual inspection of the blot, it 
appears that no consistent patterns in protein expression emerge. Figure 4.29 shows 
the results of the quantitative analysis of the blots. 
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Oestrogen receptor alpha 24 hours 
 
Full blots can be seen in the appendices in Figure 8.1, Figure 8.2, Figure 8.3, Figure 
8.4, and  Figure 8.5. ERα was detected at ~68kDa which is close to the expected 66kDa 
in the manufacturers data sheet. 
 
Figure 4.28 Oestrogen receptor alpha expression from lysates of three different wells of Ishikawa cells  
that have been exposed to herb extracts for 24 h showing few consistent changes in receptor expression 
between the blots.  
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Figure 4.29 Oestrogen receptor alpha expression at 24 h  
Displayed as relative abundance compared to a media control lane, ERα normalised to βA loading control 
and absolute volumes for ERα and βA. The first two graphs show that at 24 h ERα appears upregulated and 
the in absolute volume ERα is more consistently higher and BA lower than in other bands. 
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In the both the graphs showing relative abundance to media only control and 
normalisation to βA loading control (Figure 4.29) it would appear there is 
upregulation of ERα at 24 h following treatment with GSDW. In the analysis of 
relative abundance to media only control, it appears that Sclerotium Poria Cocos and 
Rhizoma Alismatis both upregulate ERα but this is less consistent when normalised 
to the βA loading control. When analysing the data according to the mean absolute 
volumes, again there is no evidence of consistent upregulation of ERα. The mean 
absolute volumes for βA are reasonably consistent but the variance between the 
individual data points is much higher than for the ERα suggesting that βA is not 
functioning as an effective loading control here. 
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4.5.3.2 Oestrogen Receptor alpha (ERα) expression in Ishikawa cells after 
48 hours incubated with the herb extracts 
 
 
The blots presented in Figure 4.30 show ERα and βA protein in three separate 
Ishikawa cell lysates prepared after 48 h exposure to the herb extracts where the 
proteins have been transferred to a PVDF membrane. The first probe was for ERα 
then the membrane was re-probed without stripping for βA. Quantitative analysis of 
the blots are presented in Figure 4.31 
 
The blots in Figure 4.30, ERα 48-1, 2 and 3 look similar to a blot where stripping is 
poor (Figure 4.42, p179) but these blots were not stripped before re-probing. In all 
blots, the intensity of bands in the media only samples are higher for both ERα and 
βA than for the lysates obtained following treatment with GSDW, Radix Paeonia Alba, 
and Radix Angelicae Sinensis. For samples treated with Rhizoma Dioscoreae and 
Fructus Corni, the ERα bands are more intense on all three blots. Blot ERα 48-3 does 
not show the same high intensity ERα band for Sclerotium Poria Cocos treated 
samples that is seen in the other two blots. There does appear to be some 
downregulation of the ERα in particular in response to the Blood nourishing herbs 
Radix Paeonia Alba, Radix Angelicae Sinensis, Cortex Moutan and Radix Rehmanniae. 
The variance in ERα 48 and βA for several of the herbs would, in a single blot appear 
to be due to errors of loading but seen in three separate blots is more likely to indicate 
a variation in the levels of the detected proteins. 
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 Oestrogen receptor alpha 48 hours 
 
Full blots can be found in the appendices in Figure 8.6, Figure 8.7,Figure 8.8, and 
Figure 8.9. ERα was detected at ~68kDa which is close to the expected 66kDa in the 
manufacturers data sheet. 
 
 
 
Figure 4.30 Oestrogen receptor alpha expression from lysates of three different wells of Ishikawa cells  
that have been exposed to herb extracts for 48 h. There is marked downregulation in all three blots of ERα 
at 48 h for GSDW, Radix Paeoniae Alba, Radix Angelicae Sinensis, Cortex Moutan, and Radix Rehmanniae 
and predominantly correspondingly lower βA. 
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Figure 4.31 Oestrogen receptor alpha expression at 48 h  
Displayed as relative abundance compared to a media control lane, ERα normalised to βA loading control 
and absolute volumes for ERα and βA. Downregulation of ERα is consistent in all three graphs for Radix 
Angelicae Sinensis, Radix Paeoniae Alba, Sclerotium Poria Cocos, Cortex Moutan, and Radix Rehmanniae. 
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At 48 h, the pattern appears to be of downregulation of ERα as shown in both the 
analyses of relative abundance to media only control and normalisation ratio to βA 
loading control (Figure 4.31). Fructus Corni treatment appears not to have 
downregulated ERα in the relative abundance to media only control analysis, unlike 
all of the other herb extracts. However, variation of ERα expression is high when 
normalised to the βA loading control, and the absolute volumes would also suggest 
that Fructus Corni is not affecting the expression of ERα since βA remains 
consistently lower in absolute volume. The results of ERα expression when 
normalised to βA loading control also become highly variable for Radix Rehmanniae, 
Rhizoma Dioscoreae and Fructus Corni treated samples.   The absolute volumes show 
the same pattern of overall downregulation of ERα at 48 h and particularly following 
treatment with Radix Paeoniae Alba, Radix Angelicae Sinensis, Cortex Moutan and 
Radix Rehmanniae. 
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4.5.3.3 Oestrogen Receptor beta (ERβ) expression in Ishikawa cells after 
24 hours incubated with the herb extracts 
 
The blots (ERβ 24-1, -2 and -3) in Figure 4.32 show protein expression in three separate 
Ishikawa cell lysates prepared after 24 h exposure to the herb extracts where the 
proteins have been transferred to a PVDF membrane. The first probe was for ERβ 
then the membrane was stripped using a GnHCL buffer (Appendix VII) then a second 
probe for βA was used. Quantitative analyses of the blots are presented in Figure 4.33. 
 
Visual examination of the blots shows that, on blot ERβ 24-1, a very faint ERβ band in 
the media only sample is seen which is dissimilar to the other two blots where the 
band intensity of ERβ in this sample is more intense. This may be due to an error in 
loading, however the intensity of the βA band in ERβ 24-1 is not dissimilar to that 
seen in blot ERβ 24-2 for the media only sample. This will lead to an error in the 
quantitative analysis of the blots by relative abundance to the media only control and 
normalisation ratio to βA loading control. Blots ERβ 24-1 and 2 both show intense 
ERβ bands for Radix Angelicae Sinensis treated samples but in Blot ERβ 24-3 the 
opposite is true, there is an intense band for βA and a faint band for ERβ for the Radix 
Angelicae Sinensis treated band and for Radix Rehmanniae treated samples the ERβ 
signal is more intense, but βA intensity is very variable between the three blots. No 
consistent pattern of expression is seen across the blots for both media only or GSDW 
treated lysates.  
 
The ERβ purified receptor protein (positive control) was not detected on any blot 
despite using two different ERβ antibodies (ab3577 and ab133467). The band at 
55~59kDa was detected in all samples and with both antibodies so it is considered to 
be the ERβ receptor that is being detected. 
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Oestrogen receptor beta 24 hours 
 
Full blots can be seen in the appendices in Figure 8.11, Figure 8.12, Figure 8.13, Figure 
8.14,  and Figure 8.15. ERβ was detected at ~62 kDa which is close to the expected 
55~59 kDa in the manufacturers data sheet. 
 
Figure 4.32 Oestrogen receptor beta (ab3577) expression from lysates of three different wells of Ishikawa 
cells that have been exposed to herb extracts for 24 h. 
No consistent changes are seen between experimental conditions across the three blots. 
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Figure 4.33 Oestrogen receptor beta expression at 24 h 
Displayed as relative abundance compared to a media control lane, ERβ normalised to βA loading control 
and absolute volumes for ERβ and βA. Changes between experimental conditions are not consistent. 
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Changes in ERβ expression in Ishikawa cells following treatment with herb extracts 
are small and inconsistent at 24 h. This is the cases for all three analyses, relative 
abundance to media only control, the normalised ration to βA loading control, and 
the absolute volumes (Figure 4.33). Observations of the less intense ERβ band on the 
blots for Cortex Moutan treated lysates are also seen in the ERβ reduced absolute 
volume, but this is not observed in the relative abundance to media only control or 
normalised ratio to βA loading control plots. The intense ERβ bands for Radix 
Rehmanniae treated samples do show as one of the higher points in the plot of mean 
absolute volumes but again this is not seen in the other two plots. As previously 
discussed the variance in band intensity in the media only lane for all three blots 
means that neither of these methods of normalising can be considered to be accurate. 
Absolute volumes of βA increase across the blot for ERβ 24-1 and -2 but not for -3 and 
so the variability of the absolute volume measurements becomes very high. Thus, 
little can be deduced with any certainty from the analyses of these blots. 
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4.5.3.4 Oestrogen Receptor beta (ERβ) expression in Ishikawa cells after 
48 hours incubated with the herb extracts 
 
The blots ERβ 48-1, -2, and – 3 (Figure 4.34) show ERβ and βA expression in three 
separate lysates prepared after 48 h exposure of Ishikawa cells to the herb extracts, 
where the proteins have been transferred to a PVDF membrane. The first probe used 
was for ERβ, then the membrane was stripped using a GnHCL buffer (Appendix VII) 
and a second probe for βA applied. Quantitative analyses of the blots by three 
methods are presented in Figure 4.35. 
 
Visual examination of the blots in Figure 4.34  show few consistent changes in protein 
expression following treatment. ERβ 48-1 and 2 are more alike with fainter bands for 
ERβ observed in samples following treatment with Radix Rehmanniae, Rhizoma 
Dioscoreae, Fructus Corni, and Rhizoma Alismatis. Blot ERβ 48-3 has a faint ERβ band 
for samples treated with Fructus Corni but not for the other three herbs. The βA band 
in blots ERβ 48-1 and 2 is relatively consistent in intensity across the blots. Blot 
ERβ48-1 shows a faint βA band for Cortex Moutan treated samples and blot ERβ 48-3 
shows quite variable intensity in βA bands. 
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Oestrogen receptor beta 48 hours 
 
Full blots can be seen in the appendices in Figure 8.10, Figure 8.11, Figure 8.12, Figure 
8.13, Figure 8.14, and Figure 8.15. ERβ was detected at ~62 kDa which is close to the 
expected 55~59 kDa in the manufacturers data sheet. 
 
Figure 4.34 Oestrogen receptor beta expression from lysates of three different wells of Ishikawa cells that 
have been exposed to herb extracts for 48 h. Changes observed are not consistent between experimental 
conditions across the three blots. 
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Figure 4.35 Oestrogen receptor beta expression at 48 h  
Displayed as relative abundance compared to a media control lane, ERβ normalised to βA loading control 
and absolute volumes for ERβ and βA. Absolute volumes would suggest a downregulation of ERβ at 48 h but 
the high variability seen in the βA loading control that does not parallel the changes of ERβ makes it difficult 
to draw any conclusions. 
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There are inconsistencies in the quantitative analyses of the three blots (Figure 4.35) 
but there is a possible slight downregulation of ERβ following Radix Paeoniae Alba 
and Radix Angelicae Sinensis treatment. In both the analysis of relative abundance to 
media only control and the normalised ratio to βA loading control, the same patterns 
of expression are seen, but there are differences in the blot ERβ 48-3 compared to 
blots ERβ 48-1 and -2 and this is represented by the highest data points in the 
normalised ratio to βA loading control graph. On this blot, the bands for ERβ are 
more intense and bands for βA fainter than on the other two blots. As a result, little 
can be concluded with certainty about the effects of the herbs extracts at 24 or 48 
hours on expression of ERβ in Ishikawa cells. 
  
Effects of Gui Shao Di Huang Wan and its individual herb extracts on uterine perfusion and endothelial function. 
 
169 
4.5.3.5 Progesterone Receptor beta (PRβ) expression in Ishikawa cells 
after 24 hours incubated with the herb extracts 
 
The blots in Figure 4.36 show protein expression in three separate Ishikawa cell 
lysates prepared after 24 h exposure to the herb extracts where the proteins have been 
transferred to a PVDF membrane. The first probe was for PRβ then the membrane 
was re-probed without stripping for βA. Quantitative analyses of the blots by three 
methods are presented in Figure 4.37. The PRβ recombinant protein was detected and 
can be seen in PRβ 24-3. 
 
Visual examination of the blots indicates that the PRβ band in the media only lysate 
on blot PRβ 24-1 is very faint, on blot PRβ 24-2 it is visible and on blot PRβ 24-3 it is 
relatively intense. The βA band is of similar intensity on all three blots for the media 
only lysate samples. This variation will again disrupt any calculation based on the 
relative abundance to the media only control, or normalisation ratio to the βA loading 
control. The PRβ band for GSDW treated samples is generally more intense than PRβ 
bands for other samples, and more so on blots PRβ 24-2 and 3. The band for βA is also 
more intense in Radix Paeoniae Alba and Sclerotium Poria Cocos treated samples on 
blot PRβ 24-3 and for Radix Angelicae Sinensis and Sclerotium Poria Cocos treated 
samples on blot PRβ 24-2. On blot PRβ 24-1 the βA band is marginally more intense 
for Sclerotium Poria Cocos treated samples, however it is of fairly even intensity 
across all samples on this blot. 
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Progesterone receptor beta 24 hours 
 
Full blots can be seen in the appendices in Figure 8.22, Figure 8.23, Figure 8.24, and 
Figure 8.25. PRβ was detected at ~52 kDa which is higher than the expect ~40 kDa 
in the manufacturers data sheet. 
 
Figure 4.36 Progesterone receptor beta expression from lysates of three different wells of Ishikawa cells 
that have been exposed to herb extracts for 24 h.  
Upregulation of PRβ at 24 h for GSDW can be seen in these blots but other changes are not consistent 
between blots. 
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Figure 4.37 Progesterone receptor beta expression at 24 h 
Displayed as relative abundance compared to a media control lane, PRβ normalised to βA loading control 
and absolute volumes for PRβ and βA.  These graphs also show that whichever analysis is used normalised 
to media lane, loading control or absolute volume there does appear to be upregulation of PRβ.   
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Quantitative analysis of the blots indicates that PRβ at 24 h shows a clear upregulation 
in GSDW treated samples in both the relative abundance to media only control and 
normalisation ratio to βA loading control graphs. Changes in expression are less clear 
for Radix Rehmanniae, Rhizoma Dioscoreae, Fructus Corni and Rhizoma Alismatis 
treated samples where there is some upregulation when analysed by the 
normalisation ration to βA loading control but when analysed by the relative 
abundance to the media only control there is a lot of variability. As observed from 
visual examination of the blots, the variation in the intensity of the PRβ band in media 
only samples make both of these measures unreliable. The pattern of variation in 
expression of protein is quite different in the absolute volumes of PRβ and βA 
suggesting there is an effect of the herb extract on one or both of the proteins. The 
most clear and consistent change seen from all three methods of analysis is the 
upregulation of PRβ expression following treatment of Ishikawa cells with GSDW.  
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4.5.3.6 Progesterone Receptor beta (PRβ) expression in Ishikawa cells 
after 48 h incubated with the herb extracts 
 
 
The blots PRβ 48-1, -2, and -3 (Figure 4.38) show three separate Ishikawa cell lysates 
prepared after 48 h exposure to the herb extracts where the proteins have been 
transferred to a PVDF membrane. The first probe was for PRβ then the membrane 
was re-probed without stripping for βA. Quantitative analyses of the blots by three 
methods are presented in Figure 4.39. The background staining on these blots is quite 
high as a relatively long exposure time was required for detection of the bands 
although this was more pronounced on the blots for the 48 h incubation than those 
for the 24 h incubation. 
 
Visual examination of the blots Figure 4.38 do indicate that there are relatively 
consistent changes in the intensity of the bands for PRβ in all samples. The intensity 
of the bands for βA and PRβ in the media only samples were consistent meaning that 
the analyses of relative abundance to media only control and normalisation ratio to 
βA loading control are likely to be reliable. In all three blots, PRβ bands were visibly 
more intense for Radix Paeoniae Alba, Radix Angelicae Sinensis, Sclerotium Poria 
Cocos, and Radix Rehmanniae treated samples. The intensities of the βA bands were 
also relatively consistent across all blots with the exception of a slight increased 
intensity for Radix Rehmanniae treated samples in blot PRβ 48-2.  
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Progesterone receptor beta 48 hours 
 
Full blots can be seen in the appendices in Figure 8.26, Figure 8.27, Figure 8.28, 
Figure 8.29, Figure 8.30, and Figure 8.31.  PRβ was detected at ~52 kDa which is 
higher than the expect ~40 kDa in the manufacturers data sheet. 
 
 
Figure 4.38 Progesterone receptor beta expression from lysates of three different wells of Ishikawa cells 
that have been exposed to herb extracts for 48 h. Upregulation of PRβ can be seen in Radix Angelicae 
Sinensis, Radix Paeoniae Alba, Cortex Moutan, and Radix Rehmanniae treated lysates. 
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Figure 4.39 Progesterone receptor beta expression at 48 h  
Displayed as relative abundance compared to a media control lane, PRβ normalised to βA loading control 
and absolute volumes for PRβ and βA.  
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From the quantitative analysis of blots, in both the relative abundance to media only 
control and normalisation ratio to βA loading control graphs the patterns of change 
were similar, in that PRβ is upregulated following Radix Paeonia Alba, Radix 
Angelicae Sinensis, Sclerotium Poria Cocos, and Radix Rehmanniae treatment. This 
was also shown in the analysis of absolute volumes. The absolute volumes for βA in 
this assay also remained fairly constant and mirrored the change in PRβ intensities 
but to a lesser extent. These results give a clear pattern of expression which is 
consistent across the three blots and using each of the three methods of quantitative 
analysis of the data and so it is with relative confidence it can be suggested that Radix 
Paeoniae Alba, Radix Angelicae Sinensis, Sclerotium Poria Cocos, and Radix 
Rehmanniae upregulate the expression of PRβ in Ishikawa cells after 48h incubation. 
It is interesting that the observed possible increase in PRβ following GSDW treatment 
for 24 h is not seen here in the quantitative analysis. This is similar to the results of 
ERα expression where there is possible upregulation after GSDW treatment for 24 h 
and likely downregulation after GSDW treatment for 48 h. 
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4.5.4 Discussion 
 
Ideally all immunoblotting is analysed in reference to what is known as a loading 
control which is expected to be expressed at constant levels in the cell type. This is 
in order to correct for any inconsistencies in loading volume not accounted for by 
the calculations performed using the Pierce colorimetric assessment of protein 
levels.  
 
βA was used as a loading control as seen in the blots in the results but not with 
complete confidence that it is an appropriate loading control (268). This was 
observed in the results of the blots as well as through research. It was seen to vary in 
level across experimental condition but at times increasing with a corresponding 
decrease in target proteins or decreasing with increases in target proteins Figure 
4.40. 
 
Figure 4.40 Inconsistent abundance of βA compared to ERα does not support loading errors as the main 
cause of variation and that any changes in βA are not due to experimental conditions 
 
This is not conclusive but it is possible changes in βA levels may be due to the 
treatment not loading volumes. βA is involved in proliferation, differentiation, and 
migration, which all occur in the epithelium and under the influence of the sex 
steroids and so are likely affected by the herb extracts.  Actin is a major subunit of 
tubules, re-epithelialization in the early proliferative phase requires significant 
alterations in the organization of the actin cytoskeleton (138). 
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It is also considered inappropriate when high levels of protein are required to probe 
for low abundance proteins (187). Beta actin bands were seen to be over saturated if 
probed simultaneously at an exposure that allowed the protein of interest to be 
visualised. Overexposure of the image leads to underestimates of protein levels ( 
Figure 4.41). 
  
 
Figure 4.41 Early blot with ERα and βA probed simultaneously show that the band is highly over exposed 
and therefore protein levels would be underestimated. 
 
Beta actin at 42 kDa was also considered to be a poor choice as it was theoretically 
too close for simultaneous detection for progesterone receptors (Figure 2.8, p77). In 
practice PRβ was detected at a higher kDa (molecular weight) than stated and the 
identity of the bands were confirmed with a sample of the purified receptor. 
 
Stripping and re-probing was performed but mild stripping such as the Abcam mild 
stripping buffer (Appendix VII for all stripping buffer recipes) was ineffective at 
removing the primary antibody. A harsh stripping agent containing GnHCL 557.046 
mg/mL was seen to remove proteins inconsistently throwing doubt on the accuracy 
of second and third probes. It has been shown that a substantial proportion of the 
proteins can be lost in stripping (269). Stripping is not always even, as seen in Figure 
4.42, a blot of ERβ and βA. The second probe with βA would in isolation suggest very 
poor loading but in combination with the first of ERβ suggests poor stripping. In 
Figure 4.42, it is very clear that there has been uneven stripping. It is not clear to what 
extent this affects other blots. Later blots were probed for the protein of interest with 
the antibody for the loading control without stripping to eliminate this uncertainty. 
  
ERα 
βA 
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Figure 4.42 Blot showing ERβ first probe followed by harsh stripping and a second probe with ΒA.  
The lower row of βA bands shows loss of proteins from Radix Angelicae Sinensis to Radix Rehmanniae which 
does not correspond with the first blot of ERβ. 
 
Cyclophilin is another commonly used loading control used and was also tested and 
appears to be affected by the treatment (Figure 4.43). Cyclophilin A is an important 
protein expressed at the maternofoetal interface, it regulates Th1 and Th2 balance and 
increases during pro-inflammatory diseases (270). All of these are functions that may 
be altered by a treatment shown to improve the receptivity of the endometrium. 
 
The graph in Figure 4.43 shows the variation by blot rather than mean and SD to 
illustrate that there are some changes which appear to be consistent between blots 
performed with different lysates and at different times. There is low abundance 
cyclophilin in lysates from of Radix Rehmanniae Preparata and Rhizoma Alismatis 
treated cells which are consistent between all four blots and unlikely to be due to 
errors of loading. 
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Figure 4.43 Cyclophilin absolute volume in four blots shows a consistent pattern of variation  
across the blots indicating that the protein may well be influenced by the experimental conditions and is 
therefore not an effective loading control. 
 
Another loading control protein GAPDH is frequently used but research suggests it is 
upregulated in response to oestrogen receptors which are also likely to be affected by 
the applied treatments (271) and so is an unsuitable candidate. It was tested, and like 
cyclophilin appeared to vary consistently with the herb extracts. 
 
Research on other suitable loading control proteins suggested the 5-aminolevulinate 
synthase (ALAS). In one study looking at gene expression profiles in response to 
oestradiol, the researchers used a loading control gene selection kit by Roche and 
determined this to be appropriate for Ishikawa cells in response to hormonal test 
conditions (272). This was using RT-PCR, looking at gene expression, not protein 
expression. ALAS was expected to be expressed in endometrial adenocarcinoma cells 
as shown in the human tissue atlas (273). The ALAS proteins are expected to be 
detected at 56-71 kDa which overlaps with both of the oestrogen receptors at 55-
59kDa for ERβ and 67kDa for ERα. Stripping and re probing would be required for 
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this protein. The ALAS was probed for but not detected in any of the samples. 
Troubleshooting included probing only for this protein with no prior stripping, 
varying transfer time, two different variants of the antibody, longer incubation time, 
varying quantities of both antibodies but it was never detected.  
 
The lysates could have been loaded onto a gel and an antibody used to detect a protein 
in the samples in a series of dilutions thereby manipulating the concentration of the 
protein loaded. This could have been used to verify that loading techniques were 
robust. 
 
A measure of total protein is generally considered to be a more reliable method for 
normalisation and so Ponceau red was applied (274). This was unsuccessful possibly 
due to low overall concentrations of protein 20µg/mL in the samples obtained from 
the Ishikawa cells. It is a relatively low sensitivity, Ponceau red staining of total 
proteins (40 to 80μg) in heart homogenates show that stains were linear between 40 
to 60 μg of total protein (275). In order to have all experimental variables on the same 
blot the 12 well combs were used which meant in total 20µL could be loaded in each 
well. Initially an 8 well comb was used with larger wells and more protein was loaded. 
It was found that further inconsistencies for analysis were introduced when 
comparing across two blots as seen in Figure 4.3. Ideally all of the blots would be 
repeated using the stain free total protein normalisation (Bio-Rad) gels. 
 
 
 
Figure 4.44 Initially an 8 well comb was used and the samples spread across two gels. 
Comparison of the blots with an effective loading control would be possible but in the absence of this 
densitometry cannot be used across multiple blots and exposures. 
 
Despite the concerns about normalisation of the blots to βA the overall pattern of 
regulation of the ERα and PRβ is consistent. This was true whether normalised to the 
media only control and therefore not taking into account errors of loading, or 
whether using βA as a loading control which may be subject to variations due to 
influence of the treatment on actin expression. It may be that with total protein 
Gel 1 GSDW-Poria Cocos Gel 2 Cortex Moutan-Rhizoma Alismatis 
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normalisation influence at 24 h with ERα would be informative and for ERβ, but the 
results obtained here are inconclusive. H2 Gui Shao Di Huang Wan will modify 
oestrogen and progesterone receptor expression is rejected in the absence of 
statistical data. 
 
The literature would suggest that Radix Angelicae Sinensis can upregulate ERα and 
β (174) and downregulate PRβ (177). In fact, the observation made in this study was 
the opposite, there was downregulation of ERα and upregulation of PRβ expression 
following treatment with Radix Angelicae Sinensis.  
 
The effects for Radix Angelicae Sinensis are interesting and perhaps indicate that 
there are compounds within the herb capable of both up and downregulating the 
receptors. It is often considered to be an adaptogen, although there is debate over 
whether that is a useful term (42). It, like ginseng with its pro and anti angiogenic 
properties (15), may have the ability to influence the steroid receptors differently 
according to disease or time in the cycle. It is prescribed for a very wide variety of 
menstrual problems. 
 
Rhizoma Dioscoreae was the only other herb for which any published research was 
found and this was for both no effect (179) and downregulation (178) of ERα and 
upregulation of PR (178) and anti progesterone effects (177). No consistent changes 
were seen in either direction for any of the receptors following treatment with this 
herb. 
 
 
4.5.5 Conclusion 
 
Due to a lack of confidence in either using a loading control or using a media only 
control lane to normalise the protein of interest, only when both of these methods 
showed the same changes has it been reported here. It is of interest that βA appears 
to be variable in some blots but not others. Since βA is important in some functions 
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regulated by the steroid receptors it may be that there is an interaction occurring that 
modifies the expression of βA, possibly through VEGF (96, 97).  
 
ERα at 24 h did show an upregulation in receptor expression compared to a media 
only lane and in some blots when compared to βA but this was not as consistent. ERα 
at 48 h showed a trend towards downregulation for Radix Paeoniae Alba, Radix 
Angelicae Sinensis, Sclerotium Poria Cocos, and Cortex Moutan treatments. The 
pattern for the other herb extracts is less clear due to high variability between the 
blots. Fructus Corni is noticeable for its lack of effects, levels of ERα and βA were 
consistent with those of the media only control for ERα and βA. 
 
ERβ expression after 24 h of herb treatment showed no particular changes and this is 
confounded by the band for ERβ in the media only samples being very different for 
each of the three blots whilst the band for βA in the media only samples remained 
relatively consistent. At 48 h, there were again few consistent changes. One blot ERβ 
48-3 showed very different patterns of band intensity than the other two. The 
variability seen in values for the normalisation ratio to βA loading control for ERβ 
expression undermines confidence in the normalised values, the variability in βA 
intensity was greater than for ERβ at 48 h and these changes did not appear to 
correspond to loading. 
 
PRβ expression at 24 h showed an increase for GSDW treated cells but with 
inconsistent changes for the individual herb extracts. Here, as for ERβ 24 h, the PRβ 
band in the media only sample was very different between the three blots whilst the 
βA band intensities remained more consistent undermining confidence in the 
normalised values. After 48 h incubation, the expression of PRβ in GSDW treated cells 
showed little change. There was however consistent upregulation in Radix Paeoniae 
Alba, Radix Angelicae Sinensis, Sclerotium Poria Cocos and Radix Rehmanniae 
Preparata treated cells. 
 
Effects of Gui Shao Di Huang Wan and its individual herb extracts on uterine perfusion and endothelial function. 
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It appears that GSDW does modify the expression of endometrial steroid receptors 
and the individual herbs of the formula GSDW will vary in the contributions to any 
changes seen in receptor protein expression. 
 
Discussion 
 
185 
5 Discussion 
 
5.1 Background 
 
Infertility affects a huge number of women and their partners. It leads to 
psychological distress and creates a financial burden on state and individual. In 24% 
of cases infertility is idiopathic (2) and in this situation a typical progression will be 
rapidly to the most expensive and invasive solution which is IVF. Success rates are 
only around 30% (2) even once eggs have been collected, fertilised and embryos 
returned to the uterus. The quality of the embryo is a key factor, but so is the 
receptivity of the endometrium to implantation. The pharmacological treatments 
used in IVF to improve the implantation environment in relation to the quality of the 
endometrium are limited to aspirin, clexane and sildenafil citrate (276). Treatments 
targeting the intra uterine immune environment include prednisolone, 
dexamethasone, intralipids and intravenous immunoglobulin (277-281). These 
treatments can be expensive and experimental, with limited and controversial 
research. There is a need for more options to improve the outcome for those 
diagnosed with idiopathic infertility. This applies whether couples want to try to 
conceive naturally, or choose the route of assisted reproduction. Herbal medicines 
are generally more affordable than the pharmaceutical options, but despite some 
positive clinical trials (40) (3) (4) herbal medicines have gained no widespread respect 
within the medical community. 
 
This research aims to investigate some of the mechanisms by which the positive 
effects seen in some clinical trials of herbal medicine (3, 4, 16) are mediated. The 
contribution of Chinese herbs to fertility has been demonstrated to improve sperm 
quality (282), oocyte quality (283), and to regulate the immune system (284) but this 
investigation looks only at the haematology of the endometrium. Because this 
investigation bridges two contradictory paradigms an area of common understanding 
was chosen, that of the blood of the uterus being vital to conception. 
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The trials by Dr Wing (3) demonstrated changes in the vascularity and blood flow of 
the uterus in women treated with Chinese herbal treatment using GSDW as measured 
by 3D doppler. These changes occur within the complex environment of the constant 
remodelling of the endometrium influenced by the immune and hormonal systems. 
In order to look for particular mechanisms by which these changes are mediated the 
complexities were reduced. In vitro techniques were used to examine specific effects 
of the herb extracts on aspects of the haematology of the endometrium. 
 
The receptivity of the endometrium is determined by both uterus and blastocyst, 
autocrine, paracrine and juxtracrine factors at hormonal, cellular and molecular levels 
(192). There is a complex cascade of molecules involved in endometrial receptivity 
including integrins, growth factors, selectins, cytokines, mucins and transcription 
factors but it is the steroid hormones that direct this system (266). 
 
Figure 5.1 Summary of GSDW actions on haematology of the endometrium.  
Haemostasis, proliferation, and expression of ovarian steroid receptors have all been observed in the 
assays. 
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The assays performed indicate that the herb extracts are influencing the haematology 
of the endometrium in that they increased time to clot formation in tests of the 
extrinsic and intrinsic pathways, increasing proliferation of endothelial cells, and 
increasing parameters of endothelial cell differentiation. These functions are in part 
regulated by the ovarian steroid hormones and the expression of these receptors are 
also seen to be modified. 
 
The modifications in these parameters will be more or less appropriate dependent on 
time in the menstrual cycle. Differentiation of vessels would not be appropriate in the 
menstrual phase and nor would upregulation of progesterone receptors; proliferation 
would be inappropriate in the secretory phase as would upregulation of oestrogen 
receptors.  
 
In a clinical setting, the herb extracts given will be varied through the cycle. A formula 
like GSDW would be modified with herbs added and removed dependent on the time 
of the cycle and proportions of herbs would also be altered. The herbs taken by a 
woman, the compounds absorbed and the metabolites formed which reach the uterus 
in what relative doses may vary significantly from what is added to cells in vitro. 
 
5.2 The herbs 
 
All grown natural products, including herbs, are subject to significant variation due 
to growing location, year, season of harvest, genotype, chemotype and phenotype of 
the source materials (285). Chinese herbs are subject to additional issues of quality, 
contamination, and substitution. The herbs obtained were from an RCHM approved 
supplier in the UK and were visually tested for authenticity at the Jodrell Laboratory 
in Kew by their botanist for TCM materials (192).  
 
Standardisation and identification of herbal products is currently based on 
quantification of one or two “active” substances. The -omic techniques may allow the 
standardisation using a fingerprint in the same way plant materials are now being 
accurately identified regardless of processing. There remain the challenges of working 
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with plant materials whose ingredients and concentration of compounds vary 
according to climatic growing conditions and time of harvest and it is likely an 
expressions profile will require concentration ranges required for mechanism of 
action (32). 
 
Extraction of the herbal materials although a repeatable process cannot be done with 
the same source materials and variation is expected. All extracted herbs were reduced 
to their dry matter in order to calculate a mg/mL value which can be seen in Table 
2-2, p51. In order to minimise variation that might result from natural variation in the 
herbs themselves, replicates of an experiment were completed with a single extraction 
of the herbs and all the cellular assays used one extraction. TLC was a separate set of 
extractions, as were the haemostasis assays. In the method development, other 
extracts were used as herbs were not considered to be stable and active, over the five 
year course of the research. Experiments were conducted during method 
development of the differentiation assay where extracts were made up monthly, 
stored and tested together to see if herb age was influencing differentiation. No 
differences were seen over the course of 3 months (data not presented) but at this 
stage of experimentation consistent differences were not detected in the assay. It 
would be valuable to assess the stability of compound profile and levels in the herb 
extracts looking at 7 °C, -18 °C and -80°C storage  
 
Variability is an inherent problem in the use of natural products which might be 
overcome in a number of ways, but each have their own limitations. It is possible to 
modify the volumes used so that mg/mL remains constant in the assay but the key 
hypothesis concerns the use of the whole formula which cannot be decocted together 
and then mg/mL varied for all of the 8 herbs contained within it. The eight individual 
herbs could be varied, but then they would not represent the parts of the whole under 
investigation. Extraction of the active compounds is a common approach (110) but 
identifying the compounds that are active is a flawed approach. Compounds have 
been shown not to act in isolation, and an apparently insignificant compound can 
make a difference to the function of the whole (34). 
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This variation is also the reality of treating in a clinical setting. The TLC experiments 
was performed because of the frequency with which alcohol (99), acetone (13) or other 
extraction methods are used in published research. These extraction methods are 
used dependent on the molecules to be recovered. The purpose of this investigation 
was not to maximise recovery of compounds but to emulate the process by which 
herbs are extracted for consumption by a patient, and therefore to evaluate the 
possible biological mechanisms of action of the herbal extract. 
 
5.3 Drug administration 
 
When a person consumes a herbal medicine, there will be food in their digestive tract, 
they will each have a unique microbiome that modifies absorption, their own 
metabolome, liver enzymes, and body volume. Pharmacokinetic studies show that 
ingestion of a substance is not the same as absorption and a compound may be 
modified during absorption. Compounds may be absorbed best in the acid 
environment of the stomach; there is absorption into the blood through the small 
intestine, and although there are few apparent absorption sites in the rectum, it too 
can be a very effective route of administration. There can be 60 types of bacteria in 
the colon which catalyse drug reactions. Initial metabolism can occur in the intestines 
such as oxidation, reduction, hydrolysis as well as glucorination, sulphation, N-
acetylation, methylation, gluthianone and glycine conjugation. Once through the gut 
wall it must then pass through the liver where substances are subject to first pass 
hepatic metabolism which modifies many compounds. Food changes the absorption 
of drugs and distribution will depend on absorption, permeability, diffusion, 
perfusion and tissue binding (286). 
 
One of the limitations of using a cellular assay is that the cells in the experiments are 
presented with the whole extract, not a selection of compounds which may have been 
altered when absorbed through the gut or in hepatic metabolism as would occur in a 
patient. Only a series of tissue assays at different time points after the consumption 
of the herbs would indicate the actual compounds present in the target tissues. This 
is not feasible in patients, but metabolomics may be able to provide an approximation 
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of this information. This could be through blood samples or urinary markers to see 
what had been absorbed and metabolised and at what levels. This will not indicate 
what is present in the blood in the uterus, but it would show what has been absorbed 
and metabolised and how this compares to the administered decoction. In rats Radix 
Angelicae Sinensis new compounds have been identified as metabolites not present 
in the original herb  (116). 
 
Systems biology assesses the interactions of environment and behaviour through 
gene control much as Traditional Chinese Medicine theory allows for the effects of 
environment and emotion (287). A paradigm shift from the “one drug fits all” mindset 
may occur with the use of pharmacogenomics leading to the creation of personalised 
medicines (288). This mirrors the TCM view of a medicine needing to be specific to a 
patient based on their individual characteristics and expression of symptoms. 
 
5.4 Complexity, synergy, and polyvalence 
 
The interaction between compounds in herbs and herbs in formula are at the heart 
of Chinese medicine and theory. The interconnectedness of the organism and each of 
its biological processes is now widely accepted in western medicine as is evidenced 
by whole fields of research in systems biology and specialist fields such as 
psychoneuroimmunology. Treating a complex organism with a complex medicine 
makes the interpretation of outcomes within the scientific method challenging. But 
not sufficiently so that those therapeutics should be overlooked or reduced to a single 
pharmaceutical compound. Those substances are simpler to manufacture and to test. 
They often have more easily measurable influence, and have their place but their own 
problems. Deaths from adverse reactions to prescribed drugs is estimated in Europe 
at 200,000/year (289), it is the 4th leading cause of death. It is considered by herbalists 
that it is the complexity of a herb and the way it acts on multiple systems that make 
them so useful. This is seen in Radix Ginseng which contains adaptogenic 
ginsenosides (290). The planned polypharmacy within a formula tries to predict any 
possible negative impact of any herb and ameliorate them at the point of 
administering the medication. Radix Glycyrrhizae is added to many formulae to 
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ameliorate potential toxicity The molecular mechanism for this, in relation to one 
very toxic herb Radix Aconiti, has been shown to be due to the creation of a complex 
between liquritin and aconitine, binding the free aconitine (291). The definition of 
synergy depends on context. It has been considered to be as a literal as the definition 
of working together, to needing to be proven by a mathematical model such as the 
isobolograms (292). This requires dose response curves rather than the evidence of 
herbs working in combination to produce an effect greater than the sum of the 
individual parts.  
 
The assays performed here did not include dose response except for the proliferation 
assay and this was performed for the whole formula only. This could be repeated with 
each of the individual herb extracts and a dose response curve generated to see is 
there is an increased response in proliferation. However, a very large number of cells 
is required to perform these assays. Insufficient HUtMECs were ever obtained to 
performed the MTT for the whole formula. The angiogenesis assays were performed 
with each individual herb but due to the variation between wells it is likely that a high 
number of repetitions for each condition would be required to create a dose response 
curve. With sufficient cells, it could be repeated with 20 repeats of 10 experimental 
conditions for 10 concentrations; a total of 2000 wells but this was not within the 
scope of this study. 
  
A more general term, less subject to controversy is polyvalence. This is used to 
describe different compounds that influence the same disease process by altering 
metabolism, excretion, absorption and distribution (293). It is likely that GSDW has 
an effect on the steroid receptors in promoting angiogenesis, but the increased 
perfusion of less coagulable blood assists in the sheer stresses than promote 
endothelial cell proliferation and differentiation (294). The increase in blood 
perfusion will likely lead to increased delivery of systemic circulating sex steroids to 
the receptors that are upregulated by the herb extracts. 
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In the aPTT assay was there evidence that points to an effect greater than the 
individual parts and in the differentiation assays with the HUVECs where the whole 
formula showed effects not present in any one individual herb extract. 
 
5.5 Haemostasis 
 
The assays examining haemostasis through PT and aPTT are useful tests of 
coagulation but are not accurate representations of thrombus formation in vivo. Nor 
do they show how the herbal products are interacting in the cascade to extend the 
duration of coagulation. There are 21 key proteins in the coagulation cascade (Figure 
4.10, p108) and 289 compounds in the herbs (Appendix III), which could be affecting 
any of these in any combination. They could be competing for their binding site, 
blocking receptors, affecting calcium availability or blocking co-factor availability.  
 
The prothrombin time will indicate whether the compounds inhibit factors II, V, VII, 
X, fibrinogen or thrombin and the activated partial thromboplastin time will indicate 
whether the compounds inhibit factors II, V, VIII, IX, X, XII and high molecular 
weight kininogen (90). These two tests do not account for effects that might be seen 
in vivo interacting with endothelial cells, collagen and surrounding tissues or the 
sheer stresses of blood flow. It does not factor in the blood flow changes due to 
interaction with platelets or with mediators of inflammation as discussed in Section 
4.1.3.  
 
Fructus Corni increased the PT and the aPTT and although it does contain anti 
thrombotic compounds these would not extend clotting time. Radix Paeoniae Alba 
has anti thrombin effects which would extend PT time although this no extending of 
clotting time was observed in the assays for Radix Paeoniae Alba. These two herbs are 
closely related peonies and have many of their compounds in common.  
 
In the aPTT Radix Angelicae Sinensis extended clotting time. Compounds in Radix 
Angelicae Sinensis  (z)-ligustilide (110) and N-butylphthalide (111) inhibit clot 
formation and platelet aggregation so these are not the mechanisms acting here. α-
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pinene is found and Radix Angelicae Sinensis and has been shown to be weakly 
antithrombin (115). Ferulic acid in Radix Angelicae Sinensis and inhibits tissue factor 
(224).  
 
The assays did show that there was an increase in time to clot formation in both 
pathways and that this was dose dependent. The effect seen was comparable in PT to 
an estimation of the therapeutic dose of heparin. In the aPTT assay heparin at the 
same dose did not form a clot in the assay but it did at a 1/10th dilution. 
 
The changes observed in clot morphology warrant further investigation because of 
the visual differences noted when performing the PT and aPTT. Clot structure was 
examined and did show microscopic differences but staining did not demonstrate this 
to be clearly due to fibrin. Fibrin is key in providing the tensile strength of the clot, 
but tests of tensile strength could not be completed as the clot was friable. Altering 
fibrin structure may be the entire effect of the herb extracts on the clotting cascade, 
or it may just be one of several effects. The conversion of fibrinogen to fibrin under 
the influence of thrombin is common to both pathways but the changes in clot 
morphology were more pronounced in the aPTT assays than the PT. It may be that 
the time to clot formation being longer in the aPTT assay meant the changes in fibrin 
structure were compounded (230). 
 
Fibrin morphology does change in pregnancy becoming 1.3x stiffer than non pregnant 
and more resistant to lysis (295). Friable fibrin, such as that seen in the clots under 
the influence of the herb extracts, tends to be stiffer (296). The outer cells of the 
blastocyst are the trophoblast, which will form the placenta. During invasion of the 
endometrium, at around day 9, these cells create a fibrin plug enclosing the blastocyst 
within the endometrial layer (297). The trophoblast is then embedded in a matrix of 
fibrin (298) as the spiral arteries decidualise. This is the process where the spiral 
arteries become fibrinoid as elastic tissue and smooth muscle is destroyed. This 
facilitates the invading trophoblast, plugs form in the arteries shielding it from 
maternal circulation and allowing it to develop in an environment where the blood 
flow is high and blood pressure low (299). It is thought that abnormal uterine 
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perfusion can lead to problems in pregnancy such as intrauterine growth retardation 
and pre-eclampsia (80) but these failures are set up during the conception cycle as 
failures of decidualisation (300). Changes in fibrin could affect the receptivity of the 
endometrium by facilitating implantation through the remodelling of the spiral 
arteries. 
 
Balanced haemostasis is essential for the commencement and cessation of menstrual 
bleeding (301). Much of the research on haemostasis in the endometrium relates to 
the pathologies of abnormal uterine bleeding and suggests an imbalance of clotting 
factors. In this situation herb extracts that are anti-coagulant would be detrimental. 
Clinically it is more common for infertility patients to have short duration of bleeding, 
increased incidence of clots in the menstrual blood, and painful periods in which case 
the balance may be shifted towards a pro coagulable state that would benefit from 
the anti-coagulant function.  
 
Coagulation is influenced by oestrogen and progesterone. Oestrogen is a vasodilator 
and increases uterine perfusion  in the vascular bed of the myometrium and 
endometrium (302). It induces vascular relaxation by stimulating release of 
endothelium-derived vasodilatory substances and by acting directly on the vascular 
muscle (303). The greater the ratio of oestrogen to progesterone, the greater the 
quantity of blood flowing through the endometrium as the progesterone counteracts 
the vasodilatory response to oestrogen (298). Women with subfertility have 
significantly poorer measures of endometrial uterine perfusion and vascularity (304). 
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5.6 Cell types 
 
Human Umbilical Vein Endothelial Cells (HUVEC) were chosen as a relatively robust, 
stable, affordable primary cell line which is well suited and extensively used for the 
chosen in vitro techniques of investigating angiogenesis. The HUVECs are 
macrovascular endothelial cells and so they are not directly comparable to the uterine 
endothelial cells which are microvascular. Endothelial cells are not heterogenous 
(140), at different parts of the vasculature they are responsible for pro and anti-
coagulant functions, inflammation, angiogenesis, permeability, and vessel tone. It is 
their heterogeneity that permits this range of responses (305). HUVECs can be used 
from cryopreservation for between 5 and 10 passages before they begin to lose their 
organ specific phenotype and this results in decreased migration and differentiation 
(246). 
 
Human Uterine Microvascular Endothelial Cells (HUtMEC) were also used for the 
assays as these are cells of specific interest.  Obtained from the myometrium these 
cells are known to modulate adhesion molecule expression, show increased 
proliferation, cell survival and angiogenic activity in response to the ovarian steroids 
(306). This is also a primary cell line but is expensive, and more difficult to work with. 
The intention was to optimise the assays with the HUVECs and repeat with the 
HUtMECs. This proved to be difficult and the cell line produced enough cells to 
perform the differentiation twice and the migration assays only once. The cells then 
became quiescent at their fifth passage, proliferation slowed so it was not possible to 
obtain the required numbers of cells to perform further assays. Performing the 
proliferation assays with this cell type would be beneficial. The heterogeneity of the 
endothelial cells was seen in the results obtained in the differentiation assays where 
the HUVECs showed different responses to the herb extracts than the HUtMECs.  
 
The Ishikawa epithelial cell line was used to examine the effects of the herb extracts 
on expression of receptor proteins using immunoblotting. Ishikawa cells are clones 
of an human endometrial adenocarcinoma and they have been shown to express both 
oestrogen and progesterone receptors (199).. There are other cell lines such as the 
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HEC-1A which is appropriate to investigate the post-menopausal endometrium. 
Ishikawa cells were chosen as the most appropriate cell line to examine the effects of 
the herb extracts on steroid receptors in the premenopausal endometrium (307) and 
this was used for the analysis of effects of the herb extracts on the expression of the 
steroids receptor proteins using immunoblotting. 
 
The primary cells lines do alter each passage and have a very short usable time for the 
assays. The HUtMECs should, according to the supplier (2bScientific), have been able 
to reach their 10th passage but this was not achieved. Ishikawa cells are stable, 
proliferate rapidly, and as they transformed they theoretically have no passage limit. 
It has however been shown that they will transform into undifferentiation cells after 
long term culture, but long term was not defined (199). 
 
An MTT assay was performed with the Ishikawa cells to establish a cytotoxic level of 
the herb extracts. GSDW was inhibitory to proliferation in concentrations over 
0.035µg/mL in the Ishikawa cells and never showed any proliferative effects (data not 
shown). The HUVECs were not inhibited below 5.42µg/mL and showed a proliferative 
effect at lower doses. It is interesting that the primary cell line proliferated in response 
to the herbs and a cancerous cell line did not, and that the Ishikawa were inhibited 
from growing at a much lower dose than the HUVECs. Radix Angelicae Sinensis has 
been shown to be more toxic to breast and cervical cancer cell lines than primary cell 
lines and this is attributed to its anti-mutagenic actions (308). 
 
All in vitro cellular assays, even with the primary cell lines are in an artificial 
environment, without the normal stimulation of their environment and neighbouring 
cells, different epigenetic changes will occur. Endothelial cells forming structures will 
behave differently in contact with pericytes and smooth muscles cells and subject to 
the sheer stress of vascular flow (141).  
 
A non cancer cell line would be more representative and normal endometrial cells 
can be cultured from patient derived samples or bought as endometrial tissue blocks 
commercially. Research can be performed on biopsied cells but these are 
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phenotypically unstable and do not grow well. Few cell lines were available to 
purchase other than cancer cell lines, such as the Ishikawa’s which are epithelial-like 
but there are transformed human endometrial, epithelial, and stromal cells. 
Repeating the assays with a wider range of cells types might yield further interesting 
results that would show effects in a wider representation of the uterine tissues 
involved in receptivity. 
 
In vitro cell assays have significant limitations and cannot be taken as direct evidence 
that the same behaviour would exist in the specific cell type in vivo. When looking at 
therapeutic effects it may be necessary to be able to model the actual pathology of the 
disease to see true effects. Would the effects of the herb extracts on haemostasis be 
greater in patients with antiphospholipid syndrome? If the cells of the sub fertile 
endometrium were cultured would they be more responsive to treatment? In the 
research using normal women changes were not significant after administration of 
herbs in a normally fertile control group (3). These assays do allow investigation of 
specific functions outside the uncontrolled variables of the organism and so have 
their place in a diverse portfolio of evidence. In this case it enabled the investigation 
of the observed clinical effects of administering a herb extract, to examine the 
pharmacological mechanisms by which it may be exerting its effect. 
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5.7 Proliferation 
 
It is generally considered that after menstruation, the cells of the endometrium 
proliferate and migrate in order to repopulate the shed functionalis. Proliferative 
activity with GSDW was observed within a narrow range (Section 4.2.4, p117). The 
herb extract was able to promote cell proliferation at 48 h from 0.68 to 1.35 µg/mL 
and at 72 h from 0.34 to 2.71 µg/mL.  The individual herbs extracts were not assessed 
as very high numbers of herbs were required for each assay to be repeated at three 
time points. Measuring proliferation using cell count would reduce the requirement 
for such high numbers of cells.  
 
A second assay looking at the protease activity of live cells would also suggest that 
this effect is due to the proliferative effects on the endothelial cells rather than an 
upregulation of their mitochondrial activity.  Proliferation of epithelial cells leads to 
a thickening of the endometrium, as measured using ultrasound or 3D doppler which 
is correlated with endometrial receptivity (242, 243) although this measure is debated. 
Some researchers show that 3D doppler and uterine perfusion are considered more 
useful measures (309).  
 
 
There are different opinions as to whether there are peaks in endothelial cell 
proliferation. There is variance between the different regions of the endometrium and 
there is proliferation of epithelial cells (310). If epithelial cells were to proliferate 
without concurrent proliferation of endothelial cells a thickening of the endometrium 
with poor uterine perfusion could occur, which would have poor prognosis for 
implantation. 
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5.8 Differentiation 
 
The blood flows through the uterine arteries into the arcuate arteries, the radial 
arteries and into the basal arteries. In the myometrium, the basal arteries supply the 
endometrium from where regeneration occurs post menstruation, and from which 
the spiral arteries emerge which characterise the luteal phase endometrium (209). 
 
Endothelial cell morphology will be determined by the specific tissue in which is 
forms (208).  Endothelial cells in the umbilical vein (HUVEC) may be continuous and 
they are polygonal because fluid exchange occurs at the placenta not in the veins 
themselves. The uterine HUtMECs are likely to be fenestrated as the myometrium 
where the cells originate is a tissue where fluid exchange is occurring (252). Although 
HUVECs are a useful model they are not the same as the cells that are involved in 
implantation. The HUtMECs are microvascular cells from the myometrium, which 
are one of the multiple tissue types with which an implanting blastocyst will interact. 
It will first come into contact the luminal epithelium, displacing this to invade the 
basal lamina and into the stroma (311). The myometrium where HUtMECs originate 
is below the stroma. The myometrium is not the functionalis, the part which is 
remodelled through the cycle. It is not the tissue most dynamically responsive to the 
sex steroids, nor is it part of the regenerative basal layer. It is however, a closer tissue 
type to those intimately involved in implantation than HUVECs, and the vascularity 
of the myometrium will affect the downstream uterine perfusion and may be 
sufficiently similar to be a useful model.  
 
In the differentiation experiments performed with the HUVECs all four measured 
parameters of differentiation, number of segments, number of junctions, length of 
tubules and mesh area were increased significantly by the whole formula GSDW but 
no significant change was seen in any individual herb extract (Section 4.4.6, p148). 
When tested the HUtMECs again showed this significant difference between media 
and GSDW but also for some of the individual herb extracts for total length and mesh 
area. This difference in effect was not surprising given the evidence of heterogeneity 
of the endothelial cells investigated.  
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The upregulation of the tubules in vitro suggests that there are compounds within the 
herb extracts that are promoting differentiation but the comparison to a growth 
factor deficient media for growth is artificial since there would be growth factors 
present in vivo. It is not possible to establish whether the herb extracts are having a 
beneficial effect when the cells are in an environment optimised for their survival. 
When put under stress it is possible to evaluate possible beneficial properties of the 
herbs. In vivo the herbs are not used in healthy women only when a disease process 
is present and the cells are no longer in their optimal environment. It is unclear 
exactly how these metrics of endothelial cell differentiation translate into changes in 
the endometrium. Is an increase in length advantageous? Does it lead to greater 
penetration of the myometrium? Increase tubule available for intussusception? 
Translating the metrics of tubule development to function of the vessels in vivo is not 
direct. The formation of a network it is argued is not the same process as a functional 
lumen and therefore blood containing vessel (136). It is debated whether a functional 
lumen is present in the tubules formed by endothelial cells on a basement matrix. A 
functional lumen is in part stimulated to form by blood flow (312). 
 
The matrigel assay is a simplistic assay and it is possible to extend this investigation 
through the use of endometrial endothelial cells from biopsy, the use of multiple 
basement matrix, endothelial mural co culture, organ culture and in vivo angiogenesis 
assays (141). The current research using this assay is in itself subject to inconsistency. 
It is rare to find the specifics of the measurement techniques used, from where does 
the length of a tubule being measured begin? At the centre point of the cells? Where 
the projection reaches a consistent pixel width? Automated techniques have a 
consistent algorithm but typically papers describe that image manipulation is 
required for the images to be of sufficient quality for automated analysis. The details 
of how precisely measures are taken are part of the intellectual property of the 
developers and are not readily available. An extensive comparison of the outcomes of 
analysis of the same image processed through Wimasis, ImageJ and Angiosys at the 
start of the investigation showed that each gave different results. The use of 
automated software analysis eliminates human error and introduces computer ones. 
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A human is able to distinguish between a clump of cells and a mesh but a computer 
may not. Or it may be optimised so that the clump of cells is ignored but then also 
overlooks a small but clear mesh. Human analysis is prone to bias, which the 
computer is not.  
 
The most consistent and accurate analysis was found to be from a microscope and 
camera, obtained by the laboratory towards the end of the research period, which 
captures extremely high resolution, clear photographs. These were not subjected to 
analysis through the three different software and manual analysis, as some early 
images were. They were seen to produce accurate tubule maps, when compared 
visually to the original photographs, and these can both be seen in Section 4.4.2, p135. 
 
The best understood mechanisms for development of new vessels is by sprouting. A 
new vessel is formed as an outgrowth from an existing vessel. The mechanism seen in 
the endometrium and the developing embryo is known as intussusception. This is 
where new vessels are formed when an existing vessel divides its lumen in two. 
Proliferation of endothelial cells as measured by integrin αVβ3. This adhesion 
molecule is required for the survival and maturation of blood vessels (310). It was seen 
to occur within the existing endometrial vessels, supporting the theory that 
intussusception is the most important mechanisms for new vessel growth in the 
endometrium (310). This mechanism is not mimicked in the differentiation assay on 
matrigel but may be induced in the chick chorio-allantoic membrane assay (313). 
Vessel length may be a useful comparison to the elongation seen as a result of the 
influence of oestrogen. Junctions have several different types which are not all related 
to sprouting and do occur in intussusceptive differentiation. Different junction types 
are another difference between micro and macrovascular endothelial cells (314).  
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5.9 Migration 
 
Preliminary migration assays were performed. These assays were not optimised and 
not replicated, due to resourcing and issues with the cell lines, so it was not possible 
to reach any firm conclusions. The assays performed with the HUVECs show that 
there may be differences in the whole formula at 0.087 µg/mL and in the individual 
herb extracts of Sclerotium Poria Cocos, Radix Rehmanniae, Fructus Corni, and 
Rhizoma Alismatis but these were a single well, single experiments. In addition, the 
poor adhesion of the HUVECs meant the analysis using this method or coverage of 
the denuded area of cells is not very accurate.  
 
The assay was not repeated due to the difficulties of obtaining sufficient cells to 
complete the desired replicates. Timing of an appropriate number and passage of the 
cells to correspond with availability of the time lapse facilities proved another 
significant hurdle. The results seen warrant further investigation. Migration is an 
important factor in the regenerating endometrium and this repair ensures the 
continuity of the entire endometrial surface to support the development of the 
functionalis reducing non-receptive areas for implantation. 
 
Migration assays, in particular this wound healing type have a number of limitations 
the use of the ibidi insert overcomes many of the commonly cited ones. Using the 
scratch assay can lead to inconsistent wounding and inhibition of migration from 
molecules released from damaged cells (141). Migration occurs in response to multiple 
ligands and sheer stress across a basement membrane, these variables are not 
simulated in these assays. The effects of proliferation also need to be considered since 
these processes occur together (141).  
 
Other in vitro assays would not account for these variables either. To model these 
would require in vitro /in vivo assays such as the aortic ring assay, or the in vivo zebra 
fish assays (253). 
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5.10 Steroid receptors 
 
The expression of four receptors were analysed, three were intracellular ERα, ERβ and 
PRβ. The fourth was a membrane bound receptor mPRα which was never detected. 
On consultation with the supplier of the antibody (Abcam) it was suggested that a 
beta-mercaptoethanol free (i.e. non denaturing) Laemmli loading buffer should be 
used (Appendix VII). When this was used the lysates remained viscous. Only 6 of the 
10 samples were successfully loaded into the wells in the gel, and the protein was still 
not detected. It may also be due to the protein extraction protocol that mPRα was not 
detected. Although RIPA is a suitable lysis buffer for membrane bound receptors 
there are other protocols which may have been more suitable. Most membrane 
receptors are integral and extraction requires disruption of the lipid bilayer using a 
non-ionic detergent such as Triton X-100 or CHAPS can be used to retain the proteins 
shape during extraction (315). SDS which is found in RIPA buffer in known to 
denature membrane bound proteins (316).  Low expression of the mPRα protein in 
mammalian cells has been a significant challenge to the investigation of its actions 
(171). In order to obtain greater volume the protein was transfected into yeast and 
isolated with mechanical lysis (317) so it may be that concentrations are too low and 
it is not a problem with antibody or methodology. 
 
Reference proteins were purchased and MPRα protein could be identified so the 
blotting protocol and antibody were appropriate. Reference proteins for ERα and PRβ 
were used to verify the antibody. For ERβ the reference protein was never identified 
despite using two antibodies, increased incubation times and increasing volumes of 
the reference protein well above the recommended loading volume. 
 
Ishikawa cells were incubated for 24 and 48 h with the herb extracts and it was at 48 
h that most of the consistent changes were seen. It is likely that there was a 
downregulation in ERα by Radix Paeoniae Alba, Radix Angelicae Sinensis, Sclerotium 
Poria Cocos, and Cortex Moutan and upregulation of PRβ for GSDW at 24 h and Radix 
Paeoniae Alba, Radix Angelicae Sinensis, Sclerotium Poria Cocos, and Radix 
Rehmanniae Preparata at 48 h. The only literature found relating to expression of the 
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steroid receptors was for Rhizoma Dioscoreae which was not observed to modify 
expression and Radix Angelicae Sinensis. The opposite effects to that seen in the 
literature were observed here with downregulation of ERα and upregulation of PRβ 
(182). 
 
It would appear that the steroid receptors ERα and PRβ are affected by the treatment 
but whether this is advantageous to receptivity or not would depend on the stage of 
the cycle. Downregulation of ERα would be beneficially early in the cycle and again 
from the time of ovulation and through implantation but needs to be upregulated for 
migration and proliferation during the secretory phase (149). Upregulation of PRβ 
would support the changes required for differentiation of the vessels (84), 
implantation (167) and maintenance (169)  of the pregnancy but would be inhibitory 
to the migration and differentiation during the middle part of the secretory phase. 
 
In specific disease processes these actions may be of benefit. Downregulation of ERα 
may be appropriate when treating luteal phase defects and polycystic ovarian 
syndrome (135). Upregulation of PRβ could be appropriate in endometriosis (140). 
 
The observations here are without the influence of circulating sex steroids, in a very 
discrete cell type, in one part of a complex of tissues, and in a transformed 
endometrial cancer cell line. Circulating sex steroids may significantly modify 
observed influences. Oestrogenic effects might be expected since Rhizoma 
Dioscoreae contains a steroidal glycosides diosgenin known to have oestrogenic 
effects (318) and this could lead to changes in oestrogen receptor expression although 
diosgenin has been shown not to affect ER expression in rat uterus (319). Oestrogen 
receptors can be upregulated or downregulated by oestrogen dependent on their co 
factors (320). The receptors themselves are interdependent and any pre-existing 
disease state, as well as time of cycle, will change the appropriateness of and 
upregulation or downregulation of receptors in a cycling endometrium.  
 
It can be said that there is an influence on the steroid receptors which could 
contribute to the changes seen in receptivity of the endometrium in clinical studies 
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of this formula. The influences observed here would be most beneficial in the 
ovulatory and post ovulatory phase when ERα is downregulated and PRβ is 
upregulated. Radix Paeoniae, Radix Angelicae Sinensis, Sclerotium Poria Cocos all 
showed these effects on ERα and PRβ. Cortex Moutan additionally downregulated 
ERα and Rhizoma Rehmanniae upregulated PRβ. GSDW showed upregulation of PRβ 
at 24 h. The whole formula did not show any other consistent changes. 
 
5.11 The whole and the parts 
 
A summary (Table 5-1) is presented of the assays, the outcomes, and a recap of the 
evidence from the introduction, Figure 5.2, p208 shows a pictorial summary. There is 
some congruence between the evidence in the literature and that presented here but 
also discordance. Radix Paeoniae Alba, Fructus Corni, Rhizoma Alismatis stand out 
as herbs seen to have effect in the assays but are poorly represented in the literature 
as is GSDW. Radix Angelicae Sinensis is well researched and the evidence here is 
much the same as has been seen in previous studies (107, 145, 176, 321-323). Rhizoma 
Dioscoreae was the opposite, much was expected (123, 154, 177, 179) but little shown 
in these assays. 
 
GSDW was chosen as one formula amongst many that could have been selected. As 
seen in the Section 1.12 each research study uses a different formula. This is typical of 
the method of treating in Chinese medicine; a formula is selected for the patient not 
the disease and then modified for them specifically. It is frequently observed in 
teaching, that when multiple students are presented with a case they will choose 
different base formulae. They then modify them for the patient to end up with very 
similar final herbs. GSDW has been used in clinical research, recommended in core 
texts on the subject and in the authors clinic and personal practice. The conclusions 
reached for this specific formula are not intended to be definitive answer for treating 
infertility but signposts to a deeper understanding of the potential effects of this 
medicine. 
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Table 5-1 Summary of herb functions and literature review 
 
In the haemostasis assays, there was a dose dependent increase in time to clot 
formation in both PT and aPTT. When compared to heparin a 1U and 1/10th U were 
used. The pharmacokinetics of heparin with a short half-life of 90 min and non 
selective binding (195) mean that the plasma concentration is unlikely to be at 1U for 
long. PT had a similar effect as a 1U and for the aPTT to a 1/10th, the 1U did not form a 
clot within 15 min. 
 
In the PT assay the whole formula GSDW had a significant increase over control and 
this increase was similar to that of Fructus Corni so this herb may convey the full 
effects seen in the formula. The aPTT was increased by the whole formula and this 
effect appears to be greater than the individual herbs which might be attributable to 
polyvalent activity. Some interaction is occurring between the herbs that create an 
prolonging of time to clot formation that is not seen in any of the individual herb 
extracts. Two herbs, Radix Angelicae Sinensis and Fructus Corni showed an increase 
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Gui Shao Di 
Huang Wan 
Increase PT and 
aPTT 
Differentiation HUVECs all 
parameters and HUtMECs all 
parameters 
Proliferation 
Migration 
Upregulate PRβ 24 h    
Radix Paeoniae 
Alba 
 Differentiation HUtMECs segments, 
mesh area, total length 
Upregulate PRβ 48 h Yes   
Radix 
Angelicae 
Sinensis 
Increase aPTT Differentiation 
HUtMECs mesh 
Downregulate ERα 48 
h 
Upregulate PRβ 48 h 
Yes Yes Yes 
Sclerotium 
Poria Cocos 
 Differentiation HUtMECs segment, 
mesh, total length 
Migration 
Downregulate ERα 48 
h 
Upregulate PRβ 48 h 
 Yes  
Cortex Moutan  Differentiation HUtMECs mesh Downregulate ERα 48 
h 
Yes Yes  
Radix 
Rehmanniae 
Preparata 
 Differentiation HUtMECs mesh, 
total length 
Migration 
Upregulate PRβ 48 h Yes Yes  
Fructus Corni Increase aPTT 
Increase PT 
Differentiation HUtMECs junctions 
Migration 
  Yes  
Rhizoma 
Dioscoreae 
 Differentiation HUtMECs mesh  Yes  Yes 
Rhizoma 
Alismatis 
 Differentiation HUtMECs segment, 
mesh, total length 
Migration 
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in time to clot formation, but a simple addition of the effect of those two over control 
was not equal to that of the whole formula. Research would suggest that Radix 
Angelicae Sinensis would be anti-thrombotic and time to clot formation in both 
assays was increased. In TCM terms it is a mild blood mover and so this action concurs 
with tradition. 
 
A greater effect was observed with Fructus Corni for which no research suggesting 
such action was found. It is an astringent in TCM theory, it contains the fluid and is 
used for excessive bleeding which does not concur with antithrombotic action. 
 
When looking at angiogenesis the proliferative effects were only explored in whole 
formula. In differentiation assays the HUVECs showed greater effects for all 
parameters for GSDW than the control but the individual herb extracts had a mean 
effect both higher and lower than control although no others showed significant 
differences. In the HUtMECs the situation was different as might be expected in 
heterogenous cells. The effects of GSDW was significantly greater than for control but 
not as great as for some of the individual herb extracts. 
 
In the migration assays, there were preliminary results that suggest further work 
might yield results but resourcing of cells and of time lapse prevented this being 
undertaken. The GSDW did show an effect at a low dose 0.00087 mg/mL 
and with the individual herb extracts Radix Rehmanniae Preparata, Fructus Corni and 
Rhizoma Alismatis.  
 
Oestrogen and progesterone expression were affected by the whole formula and by 
the individual herb extracts. Fewer changes were observed in the whole formula than 
in the other assays and this would be consistent with the upregulation by some herb 
extracts and downregulation by others. In such a complex and interrelated system as 
the hormonal regulation of angiogenesis conclusions are difficult to draw from these 
studies except that receptor expression is modified by the herb extracts.  
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GSDW does have demonstrable effects on measures of haematology that would 
provide rationale for the positive effect seen in clinical trials as is summarised in 
Figure 5.2. There was increased time to clot formation, increased vascular density in 
angiogenesis, and modification of steroid receptors. Increases in uterine perfusion 
presented here are linked to the uterus but ovarian function also requires good blood 
flow and so results might be generalisable to oocyte and corpus luteum development.  
It should be used with caution with other anti-thrombotic medications as it may have 
an additive effect but it has potential to be used as an antithrombotic in IVF to treat 
the pro-coagulable state induced by supra physiological oestradiol levels, where 
uterine perfusion is poor, or with recurrent implantation failures.  
 
 
 
Figure 5.2 Summary of research presented on the effects of GSDW on the haematology of the endometrium 
in the PT, aPTT, MTT, differentiation, and immunoblotting assays. 
 
A compound is complex, a herb complete with all its compounds is both variable and 
complex, the cells and organism, the patient and their disease are all variable and 
complex. A reductionist approach to research disregards the complexity at every level 
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of the natural environment in which we exist. Even if an effect is seen in vitro it may 
not be in vivo and vice versa but this does not make the approach worthless. It too 
has a place, but as a one piece of evidence not a definitive answer. 
 
The Chinese philosophical thinkers look at the complexity of the universe and us as 
a microcosm of that. They look for patterns and commonalities at a higher level and 
try to observe similarities and trends. Plant medicines exist because of 
experimentation and systematic observation of effects. Conventional science looks at 
the nuance of a cell’s behaviour to understand the organism and its disease, but 
should this be considered “higher evidence”?  Approaching the question of the 
usefulness of the herbs from the opposite poles of a clinical trial as well as in vitro 
cellular assay can lead to greater confidence in the outcomes of both where they 
concur. By combining the use of herbal formulae, the science behind them and the 
science of the reproductive technologies, it might be possible to harness the best of 
both systems in order to meet their shared goal of offering women with fertility 
problems a hope of becoming mothers. 
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5.12 Future work 
 
5.12.1 Systems biology and the -omics 
 
Systems biology is an emerging method of investigation which utilises novel 
techniques such as metabolomics and metabonomics that allow for the analysis of an 
entire system. This is possible using techniques such as nuclear magnetic resonance 
spectroscopy, liquid, and gas chromatography mass spectrometry to identify variance 
in a wide range of biomarkers. TCM faces severe challenges due to a lack of scientific 
and technical research restricting development across the world (324). However, 
TCM is getting more popular and has advantages in early intervention, combination 
therapy and personalised medicine and as these are backed up by evidence from the 
new -omics technologies they may gain wider acceptance. Systems biology and 
specifically metabolomics is the ultimate phenotyping and provides a methodology 
for the examination of complex interventions on complex systems. This creates a 
bridge between TCM and molecular pharmacology leading to the possibility of a 
science based practice of herbal medicine (325). Genomics, proteomics, 
metabolomics are technologies which over the long term may economise the 
evidence of efficacy without the active compound principle; the outputs of these 
technologies raises questions over the appropriateness of the reductionist style of 
investigation (20). 
 
Zhang et al. (326) describes how metabolomics represents the metabolite 
complement of an integrated living system and can be used to analyse the responses 
to both endogenous and exogenous factors. This top down strategy of metabolomics 
coincides with the holistic thinking of Chinese medicine. According to metabonomics 
(the analysis of drug responses through metabolomic profiling) there are identifiable 
metabolic patterns of disease and these can be correlated with TCM diagnoses (327) 
of syndromes such as that of Liver Qi stagnation (328)  and Kidney Yang deficiency 
(329).  
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Herbalomics has been described as a system for studying the pharmacological effects, 
mechanisms, safety, and compatibility of Chinese medicines using a systems biology 
approach. The strategy of herbalomics is to analyse the plant for as many compounds 
as possible using chromatographic techniques. These plants can then be tested for 
bioactivity in cell lines, animal models, or humans using body fluids such as saliva, 
urine, and blood. Then a technique known as multivariate data analysis enables the 
visualisation and interpretation of patterns between compounds and bioactivity 
(325). 
 
A study using metabolomics has cross referenced specific metabolic patterns that 
relate to the syndromes of TCM theory. The study looked at the formula Liu Wei Di 
Huang Wan which is the base formula from which GSDW is created. A rat model of 
Kidney Yin deficiency was induced using thyroxine and reserpine. This study used 
liquid chromatography to analyse the urine of rats that had induced Kidney Yin 
deficiency that were untreated, treated using the herbal formula as well as normal 
controls. They were able to characterise the metabolite changes from healthy rats to 
the induced Kidney Yin deficiency state and then to the treated rats. Subsequently 
they identified twenty differentiating metabolites using an orthogonal projection to 
latent structures discriminate analysis (330).  
 
TCM modulates functional units within the body and in thinking about disease and 
especially developing drugs from TCM herbs this complexity needs to be respected. 
A model called instance based mutual information was proposed by Li et al. (331) to 
map relationships between herbs, genes and disease. Exploring relationships between 
herbs within formulae, in particular looking at angiogenesis, they found that Radix 
Angelicae Sinensis, Radix Paeoniae Alba and Radix Rehmanniae Preparata are pro 
angiogenic. Also, that the biological activities of the six herbs of Liu Wei Di Huang 
Wan are connected closely with genes in cancer pathways and neuro-endocrine-
immune pathway, which are the diseases frequently treated with this formula. 
Identification of molecular mechanisms is going to be a key step in validating the use 
of herbal products. Another advantage of the -omics analyses are that they can be 
performed in human studies looking at metabolites in urine (25), post administration 
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of the formula in a fashion consistent with its clinical use. This study does not use the 
-omics technologies but they have great potential for future work. The richness of the 
data produced by these techniques means mining for meaning is often advanced by 
understanding where to seek within the data, and these bioassays can provide that 
data. This study does address complexity at the formula level by analysing the whole 
and each individual herb in each of the assays to identify any polyvalent interactions. 
 
There is scope within this area of research to answer many more questions. These are 
just a few of the areas that are most directly connected to continuing to answer the 
questions posed here as to how the receptivity of the endometrium is improved by 
Chinese herbal medicines. 
 
Herbs and administration: 
Metabolomic studies of urine or blood samples in women after administration of 
herbs could be used to examine bioavailability and metabolites of the herbs. This 
would give far greater insight into the likely compounds eliciting the effects seen and 
possibly narrow a search for the mechanisms. Modifying the formula to be more 
tailored to Blood stasis and see the effects on the haemostasis or to be more Yang 
nourishing and to look for effects on PR expression for example. 
 
Haemostasis: 
The origins of the changes in the clot morphology have not been found and nor have 
the mechanisms for the extension of the clotting times. Fractions of the extracts could 
be used to investigate which compounds are causing the elongation. Methods for 
examining the fibrin structure such as laser or magnetic tweezers, torsion pendulum, 
or thromboelastography could be used. Platelet aggregometry could also be 
performed. Although the research is substantial that the individual herbs will alter 
platelet aggregation it would be interesting to test the whole formula. 
 
Proliferation: 
Exploring proliferation of HUVECs using the individual herbs using the MTT assay, 
cell counts or the MultiTox Glo assay. Repeating these with GSDW and each herb 
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extract with the HUtMECs and with other uterine cell types including epithelial cells, 
culture endometrial cells from biopsy both healthy and diseased. 
 
Migration: 
Only preliminary data was obtained for the migration assays and this assay requires 
optimising, and then repeating with HUtMEC using GSDW and each herb extract. In 
vivo assays of cell migration could then be explored if the results were promising. 
Migration of epithelial cells could also be explored. 
 
Immunoblotting: 
Using total protein normalisation to verify all the results found here. Exploring 
extraction methods for receptor bound mPRα and the for the G protein-coupled 
oestrogen receptor. Looking at expression in cultured endometrial cells from biopsy 
form healthy and infertile women. Looking at receptor expression in epithelial cells. 
Probing for a wider range of molecules involved in implantation such as VEGF, 
integrin αVβ3 and MMP’s 
 
 
 
Conclusions 
 
214 
6 Conclusions 
 
Studies exist demonstrating positive outcomes of studies both as RCT’s, retrospective 
analyses and meta-analyses of the impact of Chinese herbs on fertility both natural 
and alongside IVF. The methodologies of these studies and the numbers of 
participants have been criticised but they contribute to a growing body of evidence 
about the use of Chinese herbs. Studies such as these have not been undertaken in 
the west. This study is also unusual in its approach of analysing both the whole 
formula and components parts on the processes that underlie changes that have been 
observed on the endometrium. 
 
In vitro cell assays have their limitations, but in light of a clinically observed 
improvement in endometrial uterine perfusion and the small number of studies 
indicating evidence of increased pregnancy rates this research indicates mechanisms 
by which the effects of Gui Shao Di Huang Wan may be mediated.  The herbs are 
suggested to have an anticoagulant action leading to improved uterine perfusion. 
There is increased proliferation of endothelial cells and increased differentiation 
shown in tubule numbers, junction number, length and mesh area suggesting 
improvements in the vascularity of the endometrial tissues. Modification of the 
oestrogen and progesterone receptors may also contribute to the increased 
receptivity. These actions have the potential to lead to the observed increases 
endometrial receptivity, conception, and pregnancy. All of the effects are interlinked 
in vivo with uterine perfusion stimulating tubule development, flow of blood 
delivering sex steroids to the receptors, the receptors stimulating proliferation and 
differentiation. In two of the assays the combination of herbs within the formula was 
seen to have a greater effect than the herbs individually. This suggests a polyvalent 
activity that might be lost if, instead of the formula, a herb or compound was defined 
as the “active”. This study offers a pharmacological perspective on key mechanisms 
from which further research into possible effects of Chinese herbal medicines and 
their use in infertility can be examined, contributing a different perspective to the 
limited clinical trials currently available.  
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8 Appendices 
 
I. KEW IDENTIFICATION OF SAMPLES 
 
 
  
Name of sample 
provided by Rebecca 
O'Cleirigh 
Macroscopic authentication provided by Christine Leon, RBG Kew 15/7/2016 
Bai Shao  
good match with Kew's authentic samples of Bai Shao (i.e. sliced root of Paeonia lactiflora 
Pall.). 
Dang Gui  
good match with Kew's authentic samples of Dang Gui (i.e. longitudinally sliced root of 
Angelicae Sinensis (Oliv.) Diels ('head, body and tail'). 
Fu Ling 
 good match with Kew's authentic samples of Fu Ling (i.e. Wolfiporia extensa (Peck) Ginns 
[synonym: Sclerotium Poria Cocos (Schw.) Wolf]).  
Mu Dan Pi  
good match with Kew's authentic samples of Mu Dan Pi (i.e. transversely sliced root-bark 
of Paeonia suffruticosa Andrews or Paeonia ostii T. Hong & J.X. Zhang) - both are official.   
Shu Di  
 good match with Kew's authentic samples of Shu Di Huang (i.e. root of Rehmanniae 
glutinosa (Gaertn.) Libosch. ex Fisch. & C.A. Meyer processed with yellow-rice wine). 
Shan Yao  
 good match with Kew's authentic samples with Kew's authentic samples of Shan Yao (i.e. 
sliced rhizome of Dioscoreae polystachya Turcz. [synonym: D. batatas Decne.]  structure, 
taste, and fracture seem consistent.     
Shan Zhu Yu  
good match with Kew's authentic samples of Jiu Shan Zhu Yu (i.e. fruit of Cornus officinalis 
Siebold & Zuccarini wine). 
Ze Xie  
good match with Kew's authentic samples of Ze Xie (i.e. sliced rhizome of Alisma orientale 
(Sam.) Juz.) 
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II. HERBS REFERRED TO IN THIS STUDY WITH PINYIN, SCIENTIFIC NAME, AND AUTHORITY 
 
  
Latin Pin Yin Scientific name and authority 
Carapax et Plastrum testudines Gui Ban Tortoise shell 
Colla Corii asini E Jiao Donkey hide gelatine 
Cornu cervi Lu Jiao Deer antler 
Cortex Cinnamomi Rou Gui Cinnamomum cassia (L.) J. Presl 
Cortex Eucommiae Du Zhong  Eucommia ulmoides Oliv.  
Cortex Moutan Mu Dan Pi Paeonia ostii T. Hong & J. X. Zhang 
Flos Carthami Hong Hua Carthamus tinctorius L. 
Fluoritum Zi Shi Ying Fluorite 
Folium Artemisiae argyi Ai Ye Artemisia argyi H. Lév. & Vaniot 
Fructus Amomi Sha Ren Aframomum angustifolium (Sonn.) K. Schum. 
Fructus Corni Shan Zhu Yu Cornus officinalis Siebold & Zuccarini1  
Fructus Ligustri Lucidi Nu Zhen Zi Ligustrum lucidum W.T. Aiton 
Fructus Lycii Gou Qi Zi Lycium barbarum L. 
Fructus Rubi Fu Pen Zi Rubus Chingii Hu 
Herba Eclipta Alba Han Lian Cao Eclipta prostrata (L.) L. 
Herba Epimedii Yin Yang Huo Epimedium brevicornu Maxim 
Herba Taxilli Sang Ji Sheng Taxillus chinensis (DC.) Danser 
Placenta hominis Zi He Che Human placenta 
Sclerotium Poria Cocos Fu Ling Wolfiporia extensa (Peck) Ginns 
Radix Aconiti Preparata Zhi Fu Zi Aconitum carmichaelii Debeaux  
Radix Angelicae Sinensis Dang Gui Angelicae Sinensis (Oliv.) Diels 
Radix Astragali seu Hedysari Huang Qi Astragalus propinquus Schischkin 
Radix Bupleuri Chai Hu Bupleurum chinense DC 
Radix Codonopsis Dang Shen Codonopsis affinis Hook.f. & Thomson 
Radix Dipsaci Xu Duan Dipsacus inermis Wall. 
Radix Ginseng Ren Shen Panax ginseng C.A. Mey 
Radix Glycyrrhizae Preparata Zhi Gan Cao Glycyrrhiza glabra L. 
Radix Ligusticum wallichii Chuan Xiong Ligusticum striatum DC 
Radix Morindae Officinalis Bai Ji Tian Morinda officinalis F.C. How 
Radix Paeoniae Alba Bai Shao Paeonia lactiflora Pall. 
Radix Paeoniae Rubra Chi Shao Paeonia lactiflora or veitchii Pall 
Radix Polygoni Multiflori He Shou Wu Reynoutria multiflora (Thunb.) Moldenke 
Radix Rehmanniae Preparata Shu Di Huang  
Rehmannia glutinosa (Gaertner) Liboschitz ex 
Fischer & C. A. Meyer 
Radix Salviae miltiorrhizae Dan Shen Salvia miltiorrhiza Bunge 
Ramulus Cinnamomi  Gui Zhu Cinnamomum cassia (L.) J. Presl 
Ramulus Loranthi Sang Ji Sheng Ramulus Loranthi Seu Visci  
Rhizoma Alismatis Ze Xie Alisma orientale (Samuelsson) Juzepczuk 
Rhizoma Atractylodis 
Macrocephalae 
Bai Zhu Atractylodes macrocephala Koidz. 
Rhizoma Corydalis Yan Hu Suo 
Corydalis yanhusuo Y.H. Chou & Chun C. Hsu) W.T. 
Wang ex Z.Y. Su & C.Y. Wu 
Rhizoma cyperi Xiang Fu Cyperus rotundus L. 
Rhizoma Dioscoreae Shan Yao Dioscoreae polystachya Turczaninow 
Semen Cassiae Jue Ming Zi Senna obtusifolia (L.) H.S. Irwin & Barneby 
Semen Cuscutae Tu Si Zi Cuscuta chinensis Lam 
Semen Pruni Persicae Tao Ren Prunus persica (L.) Batsch 
Appendices 
 
231 
 
III. LIST OF COMPOUNDS PRESENT IN THE 8 HERBS OF GUI SHAO DI HUANG WAN 
Compound Herb 
(24R)-α-methyl cholest-8(14)-enol Rhizoma Dioscoreae 
(24R)-α-methyl cholestanol Rhizoma Dioscoreae 
(24S)-β-methyl cholest-8(14)-enol Rhizoma Dioscoreae 
(E)-4-(5-(hydroxymethyl) furan-2-yl) but-3-en-2-one Radix Rehmanniae Preparata 
(E)-4-(5-(methoxymethyl) furan-2-yl) but-3-en-2-one Radix Rehmanniae Preparata 
1-O-Galloyl pedunculagin Radix Paeoniae Alba 
1,2,3-tri-O-galloyl-β-D-glucose Fructus Corni 
1,2,3,4,6-penta-o-galloyl glucose Cortex Moutan 
1,2,3,4,6-penta-o-galloyl-beta-D-glucose Radix Paeoniae Alba 
1,2,3,6-tetra-o-galloyl-β-D-glucose Fructus Corni 
1,2,6-tri-O-galloyl-β-D-glucose Fructus Corni 
1,5-bis(5-methoxymethyl) furan-2-yl-penta-1,4-dien-3-en-2-
one 
Radix Rehmanniae Preparata 
11-alpha, 12-alpha-epoxy-3β,23 dihydroxy-30-norolean-
20(29)-en-13 β -olode 
Radix Paeoniae Alba 
11 alpha, 12alpha-epoxy-3 β,23dihudroxolean-28,13 β olide Radix Paeoniae Alba 
13-methyl tetradecanoic acid Radix Paeoniae Alba 
2-methyl-dodecane-5-one Radix Angelicae Sinensis 
2-Phenylethyl glycosides Radix Rehmanniae Preparata 
2,3-di-O-galloyl-β-D-glucose Fructus Corni 
2,3-dicresol Radix Angelicae Sinensis 
2,3-dihydroxy-4-methoxyacetophenone Cortex Moutan 
2,3-dimethylphenol Radix Angelicae Sinensis 
2,4-dihydroxyacetophenone Radix Angelicae Sinensis 
2’-acetylacteoside Radix Rehmanniae Preparata 
24-trien-21-oic acid Sclerotium Poria Cocos 
3-hydroxy-4-methoxyacetophenone Cortex Moutan 
3,4-dihydroxy-β-phenethyl-O-α-L- rhamnopyranosyl-(1 -> 3)-O-
β-D-galactopyranosyl-(1 -> 6)-4-O-caffeoyl-β-D- 
glucopyranoside 
Radix Rehmanniae Preparata 
3,4-seco-lanostanes Sclerotium Poria Cocos 
3,5-dihydroxybenzoic acid Fructus Corni 
30-norhederagenin Radix Paeoniae Alba 
3Β-hydroxy olean-12-en-28-al Radix Paeoniae Alba 
3Β-p-hydroxybenzoyl Sclerotium Poria Cocos 
3β-hydoxylanosta-7,9(11),24-trien-21-oic acid Sclerotium Poria Cocos 
3β-p-hydroxybenzoyldehydrotumulosic acid Sclerotium Poria Cocos 
4-ethylresorcinol Radix Angelicae Sinensis 
4-Methoxy-1,2-benzodioxole Fructus Corni 
4-terpineol Fructus Corni 
5-hydroxy aeginetic acid Radix Rehmanniae Preparata 
5-Hydroxymethylfurfural  Radix Rehmanniae Preparata 
5-methyl furfural Fructus Corni 
6-O-E-feruloylajugol Radix Rehmanniae Preparata 
6-O-p-coumaroylajugol Radix Rehmanniae Preparata 
6-O -sec-hydroxyaeginetoyl ajugol Radix Rehmanniae Preparata 
6-O -sec-hydroxybenzoyl ajugol Radix Rehmanniae Preparata 
6-O-vanilloylajugol Radix Rehmanniae Preparata 
6-O-Z-feruloylajugol Radix Rehmanniae Preparata 
7-O-methyl morronoside Fructus Corni 
8-epiloganic acid Radix Rehmanniae Preparata 
abscisin Rhizoma Dioscoreae 
acetoside Radix Rehmanniae Preparata 
acetylcatalpol Radix Rehmanniae Preparata 
acoradiene Radix Angelicae Sinensis 
adenine Sclerotium Poria Cocos 
adenine Radix Angelicae Sinensis 
adenosine Radix Rehmanniae Preparata 
aeginetic acid Radix Rehmanniae Preparata 
ajugol Radix Rehmanniae Preparata 
ajugoside Radix Rehmanniae Preparata 
albiflorin Radix Paeoniae Alba 
alismaketone C 23 acetate Rhizoma Alismatis 
alisman SI and PII Rhizoma Alismatis 
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alismol Rhizoma Alismatis 
alismoxide Rhizoma Alismatis 
alisol A Rhizoma Alismatis 
alisol A 24 acetate Rhizoma Alismatis 
alisol Β Rhizoma Alismatis 
alisol Β 23 acetate Rhizoma Alismatis 
alisol C Rhizoma Alismatis 
alisol C 23acetate Rhizoma Alismatis 
alisol D Rhizoma Alismatis 
alisol E Rhizoma Alismatis 
allantoin Rhizoma Dioscoreae 
alloocimene Radix Angelicae Sinensis 
α-pinene Fructus Corni 
anethol Fructus Corni 
angelica ketone Radix Angelicae Sinensis 
angelicide Radix Angelicae Sinensis 
angelicin Radix Angelicae Sinensis 
anisic acid (methoxybenzoic acid) Radix Angelicae Sinensis 
anthraquinone Rhizoma Alismatis 
apiopaeonoside Cortex Moutan 
arachidic acid Radix Rehmanniae Preparata 
astragalin Radix Paeoniae Alba 
aucubin Radix Rehmanniae Preparata 
azelaic acid Radix Angelicae Sinensis 
β Sitosterol Cortex Moutan 
β Sitosterol Fructus Corni 
β Sitosterol Radix Angelicae Sinensis 
β Sitosterol Radix Paeoniae Alba 
β Sitosterol Radix Paeoniae Alba 
β Sitosterol Radix Rehmanniae Preparata 
β Sitosterol Rhizoma Alismatis 
β Sitosterol Rhizoma Dioscoreae 
β -amyrin acetate Sclerotium Poria Cocos 
β -bisabolene Radix Angelicae Sinensis 
β -ocimene-X Radix Angelicae Sinensis 
β -pinene Fructus Corni 
β -sitosterol β -D- glucopyranoside Cortex Moutan 
β -sitosterol D -glucoside Radix Angelicae Sinensis 
batatasin I Rhizoma Dioscoreae 
batatasin IV Rhizoma Dioscoreae 
behenic acid (docosanoic acid) Radix Rehmanniae Preparata 
benzoic acid Cortex Moutan 
benzoic acid Radix Paeoniae Alba 
benzoyloxypaeoniflorin Cortex Moutan 
benzoylpaeoniflorin Cortex Moutan 
benzoylpaeoniflorin Radix Paeoniae Alba 
benzyl cinnamate Fructus Corni 
benzyl ethyl alcohol Fructus Corni 
beta glucan Sclerotium Poria Cocos 
betulinic acid Radix Paeoniae Alba 
bicycloelemene Radix Angelicae Sinensis 
biotin (vitamin H, coenzyme R, B7) Rhizoma Alismatis 
brefeldin A Radix Angelicae Sinensis 
caffeic acid stearyl ester Cortex Moutan 
calyosin Radix Angelicae Sinensiss 
campesterol Radix Rehmanniae Preparata 
camphene Fructus Corni 
camphene Radix Angelicae Sinensis 
camphoric acid Radix Angelicae Sinensis 
capric acid (decanoic acid) Radix Rehmanniae Preparata 
caprylic acid Sclerotium Poria Cocos 
caprylic acid (octanoic acid) Radix Rehmanniae Preparata 
carvacrol Radix Angelicae Sinensis 
catalpol Radix Rehmanniae Preparata 
celebroside Radix Rehmanniae Preparata 
chamigrene Radix Angelicae Sinensis 
cholestanol Rhizoma Dioscoreae 
cholesterol Rhizoma Dioscoreae 
choline Sclerotium Poria Cocos 
choline Radix Angelicae Sinensis 
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choline Rhizoma Dioscoreae 
cinnamic acid Radix Rehmanniae Preparata 
cis-2,5- dicarboxylic acid Fructus Corni 
cistanoside A Radix Rehmanniae Preparata 
cistanoside F Radix Rehmanniae Preparata 
clerosterol Rhizoma Dioscoreae 
cnidilide Radix Angelicae Sinensis 
cornin Fructus Corni 
cornuside Fructus Corni 
cornusiins A, B, C, G, Fructus Corni 
cresol Radix Angelicae Sinensis 
cuparene Radix Angelicae Sinensis 
D-arabinose Radix Rehmanniae Preparata 
D -catechin Radix Paeoniae Alba 
D -galactose Radix Angelicae Sinensis 
D -galacturonic acid Radix Angelicae Sinensis 
D -galacturonic acid Radix Rehmanniae Preparata 
D -glucosamine Radix Rehmanniae Preparata 
D -glucose Radix Angelicae Sinensis 
D -mannitol Radix Rehmanniae Preparata 
D -rhamnose Radix Rehmanniae Preparata 
danmelittoside Radix Rehmanniae Preparata 
daturic acid (heptadecanoic acid) Radix Rehmanniae Preparata 
daucosterol Radix Angelicae Sinensis 
daucosterol Radix Paeoniae Alba 
daucosterol Radix Rehmanniae Preparata 
dehydroeburicoic acid Sclerotium Poria Cocos 
dehydrologanin Fructus Corni 
dehydromorroniaglycone Fructus Corni 
dehydrotrametenolic acid Sclerotium Poria Cocos 
deltonin Rhizoma Dioscoreae 
deoxypaeonisuffrone  Cortex Moutan 
dihydrocatalpol Radix Rehmanniae Preparata 
dihydroxy-β-ionone Radix Rehmanniae Preparata 
dihyrophthalic anhydride Radix Angelicae Sinensis 
dihyropinosylvin Rhizoma Dioscoreae 
dimethyl camphorate Radix Angelicae Sinensis 
dimethyl phthalate Radix Angelicae Sinensis 
dimethyl sebacate Radix Angelicae Sinensis 
dioscin Rhizoma Dioscoreae 
diosgenin Rhizoma Dioscoreae 
diosgenin dioglucoside Rhizoma Dioscoreae 
dodecanol Radix Angelicae Sinensis 
dopamine (3,4-dihydroxyphenyl ethyl amine) Rhizoma Dioscoreae 
eburicoic acid Sclerotium Poria Cocos 
echinacoside Radix Rehmanniae Preparata 
elemicin Fructus Corni 
epialisol A Rhizoma Alismatis 
ergosterol Sclerotium Poria Cocos 
ethyl-α-D-galactoside Radix Rehmanniae Preparata 
ethylphenol Radix Angelicae Sinensis 
eugeniin Radix Paeoniae Alba 
eugenol methyl ether Fructus Corni 
ferulic acid Radix Angelicae Sinensis 
folinic acid Radix Angelicae Sinensis 
formyltetrahydrofolate Rhizoma Alismatis 
forsythiaside Radix Rehmanniae Preparata 
furfural Fructus Corni 
furfural Rhizoma Alismatis 
gallic acid Cortex Moutan 
gallic acid Fructus Corni 
gallic acid Radix Paeoniae Alba 
gallotanin Radix Paeoniae Alba 
galloyloxypaeoniflorin Cortex Moutan 
gemin D Fructus Corni 
geniposide Radix Rehmanniae Preparata 
glucosamine Radix Rehmanniae Preparata 
glutinoside Radix Rehmanniae Preparata 
gracillin Rhizoma Dioscoreae 
guaiacol Radix Angelicae Sinensis 
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hederagenin Radix Paeoniae Alba 
heneicosanoic acid Radix Rehmanniae Preparata 
histidine Sclerotium Poria Cocos 
isoacetoside Radix Rehmanniae Preparata 
isoamyl alcohol Fructus Corni 
isobutanol Fructus Corni 
isobutyl alcohol Fructus Corni 
isocnidilide Radix Angelicae Sinensis 
isoeugenol Radix Angelicae Sinensis 
isofucosterol Rhizoma Dioscoreae 
isoterchebin Fructus Corni 
jiocarotenoside A1, A2,  Radix Rehmanniae Preparata 
jiofuran Radix Rehmanniae Preparata 
jioglutins A-E, Radix Rehmanniae Preparata 
jioglutosides A, B. Radix Rehmanniae Preparata 
l-rhamnose Radix Rehmanniae Preparata 
lactiflorin Radix Paeoniae Alba 
lathosterol Rhizoma Dioscoreae 
lauric acid (dodecanoic acid) Sclerotium Poria Cocos 
lauric acid (dodecanoic acid) Radix Rehmanniae Preparata 
leonurine Radix Rehmanniae Preparata 
(z)-ligustilide Radix Angelicae Sinensis 
limonene Fructus Corni 
linoleic acid Fructus Corni 
linoleic acid Radix Angelicae Sinensis 
linoleic acid Radix Rehmanniae Preparata 
loganin Fructus Corni 
malic acid Fructus Corni 
mannan Rhizoma Dioscoreae 
mannotriose Radix Rehmanniae Preparata 
margaric acid (Heptadecanoic acid) Radix Rehmanniae Preparata 
martynoside Radix Rehmanniae Preparata 
melittoside Radix Rehmanniae Preparata 
methyl gallate Radix Paeoniae Alba 
mioporosidegenin Radix Rehmanniae Preparata 
morroniside Fructus Corni 
mudanoside B Cortex Moutan 
mudanpinoic acid A  Cortex Moutan 
mudanpiosides A Cortex Moutan 
mudanpiosides B Cortex Moutan 
mudanpiosides C Cortex Moutan 
mudanpiosides E Cortex Moutan 
mudanpiosides F Cortex Moutan 
myrcene Radix Angelicae Sinensis 
myristic acid Radix Angelicae Sinensis 
myristic acid Radix Rehmanniae Preparata 
n-butylphthalide Radix Angelicae Sinensis 
n-nonadecanoic acid Radix Rehmanniae Preparata 
n-tetracosanoic acid Radix Angelicae Sinensis 
n-valerophenone-O-carboxylic acid Radix Angelicae Sinensis 
nicotinic acid Radix Angelicae Sinensis 
nonanoic acid Radix Rehmanniae Preparata 
oleanic acid Cortex Moutan 
oleanic acid Fructus Corni 
oleanic acid Radix Paeoniae Alba 
oleic acid Radix Angelicae Sinensis 
orientalols A-E (Sulfoorientalols) Rhizoma Alismatis 
oxypaeoniflorin Cortex Moutan 
oxypaeoniflorin Radix Paeoniae Alba 
p-cymene Fructus Corni 
pachyman Sclerotium Poria Cocos 
pachymaran Sclerotium Poria Cocos 
pachymic acid Sclerotium Poria Cocos 
paeoniflorigenone Radix Paeoniae Alba 
paeoniflorin Cortex Moutan 
paeoniflorin Radix Paeoniae Alba 
paeonilactone A Radix Paeoniae Alba 
paeonin Radix Paeoniae Alba 
paeonisothujone Cortex Moutan 
paeonisuffral Cortex Moutan 
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paeonisuffron Cortex Moutan 
paeonol Cortex Moutan 
paeonol Radix Paeoniae Alba 
paeonoside Cortex Moutan 
palmitic acid Sclerotium Poria Cocos 
palmitic acid (hexadecanoic acid) Fructus Corni 
palmitic acid (hexadecanoic acid) Radix Angelicae Sinensis 
palmitic acid (hexadecanoic acid) Radix Rehmanniae Preparata 
palmitoleic acid Radix Rehmanniae Preparata 
pedunculagin Radix Paeoniae Alba 
pentadecanoic acid Radix Rehmanniae Preparata 
peonolide Cortex Moutan 
phenethyl alcohol Fructus Corni 
phenol Radix Angelicae Sinensis 
phenylacetic acid Radix Rehmanniae Preparata 
phenylalanine Radix Paeoniae Alba 
phthalic anhydride Radix Angelicae Sinensis 
phytic acid Rhizoma Dioscoreae 
pinicolic acid Sclerotium Poria Cocos 
plantamajoside Radix Rehmanniae Preparata 
polyporenic acid C Sclerotium Poria Cocos 
poriaic acid A, B, C Sclerotium Poria Cocos 
poricoic acid A, B, D, AM Sclerotium Poria Cocos 
protogracillin Rhizoma Dioscoreae 
pulegone Fructus Corni 
pyrethrin II Radix Paeoniae Alba 
quercetin Cortex Moutan 
raffinose Radix Rehmanniae Preparata 
rehmaglutins A, B, C, D,  Radix Rehmanniae Preparata 
rehmaionosides A Radix Rehmanniae Preparata 
rehmaionosides B Radix Rehmanniae Preparata 
rehmaionosides C Radix Rehmanniae Preparata 
rehmannans A, B, C,  Radix Rehmanniae Preparata 
rehmannans SA Radix Rehmanniae Preparata 
rehmannans SB Radix Rehmanniae Preparata 
rehmanniosides A, B, C, D,  Radix Rehmanniae Preparata 
rehmapicrogenin Radix Rehmanniae Preparata 
resacetophenone Cortex Moutan 
rhamnose Radix Angelicae Sinensis 
salidroside  Radix Rehmanniae Preparata 
scopoletin Radix Angelicae Sinensis 
sebacic acid Radix Angelicae Sinensis 
sec-hydroxyaeginetic acid Radix Rehmanniae Preparata 
stachyose Radix Rehmanniae Preparata 
stearic acid Radix Angelicae Sinensis 
stearic acid Radix Rehmanniae Preparata 
stigmasterol Radix Angelicae Sinensis 
stigmasterol Radix Rehmanniae Preparata 
stigmasterol Rhizoma Alismatis 
Stigmasterol Rhizoma Dioscoreae 
stigmasterol-β-D-glucoside Radix Angelicae Sinensis 
succinic acid Radix Angelicae Sinensis 
succinic acid Radix Rehmanniae Preparata 
suffructicosa A-E Cortex Moutan 
sulfoorientalols A-D Rhizoma Alismatis 
sweroside Fructus Corni 
tartaric acid Fructus Corni 
tellimagrandin I Fructus Corni 
tellimagrandin II Fructus Corni 
tetrahydrofuran Fructus Corni 
trametenolic acid Sclerotium Poria Cocos 
trans-β-farnesene Radix Angelicae Sinensis 
trans-linalool oxide Fructus Corni 
tumulosic acid Sclerotium Poria Cocos 
undecanoic acid Sclerotium Poria Cocos 
uracil Radix Angelicae Sinensis 
uracil Radix Rehmanniae Preparata 
ursolic acid Fructus Corni 
vanillic acid Radix Angelicae Sinensis 
vanillin Radix Angelicae Sinensis 
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verbascose Radix Rehmanniae Preparata 
verbenalin Fructus Corni 
vitamin A Fructus Corni 
vitamin A Radix Angelicae Sinensis 
vitamin B12 Radix Angelicae Sinensis 
vitamin B12 Rhizoma Alismatis 
y-elemene Radix Angelicae Sinensis 
α-cedrene Radix Angelicae Sinensis 
α-pinene Radix Angelicae Sinensis 
β-phellandrene Radix Angelicae Sinensis 
ϒ-aminobutyric acid Radix Rehmanniae Preparata 
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IV. ETHICS APPROVAL 
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V. IMAGE J DOCUMENTATION FOR ANALYSIS ANALYZER ADD IN 
 
« Image Name » : name of the recorded analyzed image (initial name plus the suffix « -tr »). 
 « Analysed area »: area of the image or the user selection concerned by the analysis. 
 « Nb extrem. »: number of extremities in the analyzed area. 
 « Nb nodes »: number of nodes in the analyzed area. 
 « Nb Junctions »: number of junctions in the analyzed area. 
 « Nb master junction »: number of master junctions in the analyzed area. 
 « Nb master segments »: number of master segments in the analyzed area. 
 « Tot. master segments length »: sum of the length of the detected master segments in the analyzed 
area. 
 « Nb meshes »: number of meshes in the analyzed area. 
 « Tot.meshes area »: sum of mesh areas detected in the analyzed area. 
 « Nb pieces »: sum of number of segments, isolated elements and branches detected in the analyzed 
area. 
 « Nb segments »: number of segments in the analyzed area. 
 « Nb branches »: number of branches in the analyzed area. 
 « Nb isol. seg. »: number of isolated elements in the analyzed area. 
 « Tot. length »: sum of length of segments, isolated elements and branches in the analyzed area. 
 « Tot. branching length »: sum of length of the trees composed from segments and branches in the 
analyzed area. 
 « Tot. segments length »: sum of length of the segments in the analyzed area. 
 « Tot. branches length »: sum of length of the branches in the analyzed area. 
 « Tot. isol. branches length »: sum of length of the isolated elements in the analyzed area. 
 « Branching interval »: mean distance separating two branches in the trees in the analyzed area. (Tot. 
segments length / Nb branches). 
 « Mesh index »: mean distance separating two master junctions in the trees in the analyzed area. (Tot. 
master segments length / Nb master segments). 
 « Mean Mesh Size »: mean mesh size in the analyzed area. 
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VI. MATERIALS LIST 
 
Herb preparation 
Millex syringe driven filter units PES 22µm express 
 
Haemostasis 
Bell and Alton platelet substitute BAPS040 
Diagen Calcium rabbit brain thromboplastin CBRT000/001 
Diagen Freeze Dried Rabbit Brain Thromboplastin FRBT010  
 
Cells and media 
Thermo scientific Nucleon delta EasYFlask 25cm2 
Neubauer C-Chip Haemocytometer DHC-N01 
Gibco Phosphate Buffered Saline Sterile 100010-031 
Gibco Type Express 12604-013 
 
Human Umbilical Vein Cells (HUVEC)  
Caltag Cellworks Early Passage Human Umbilical Vein Endothelial Cells ZHC-2301 
Cellworks Human Large Vessel Endothelial Cell Basal Medium KC1015  
Cellworks Human Large Vessel Endothelial Cell Growth Supplement KC1016 
Cellworks Antibiotic Supplement (Gentamycin/Amphotericin B) KC1019 
 
Human Uterine Microvascular Endothelial Cells (HUtMEC) 
Human Uterine Microvascular Endothelial Cells purchased from 2bScientific 
Promo cell Endothelial Cell Basal Medium MV2 (prf) 
 
Ishikawa 
Sigma-Aldrich Ishikawa Cell line human endometrial adenocarcinoma 9904021 purchased from Sigma 
Aldrich 99040201 originating from the European collection of authenticated cell cultures 
Ishikawa Culture Medium MEM + 2mM Glutamine + 1% Non-Essential Amino Acids (NEAA) + 5% 
Foetal Bovine Serum (FBS) 
 
Angiogenesis 
Cellworks angiogenesis assay control kit ZHA-1300 
Ibidi u-slide angiogenesis 18 well 
Ibidi u-slide angiogenesis 96 well 
Corning matrigel matrix basement membrane growth factor reduced 356231 
Gilson Micron positive displacement pipette 
 
Migration 
Ibidi Culture-Insert 2 Well 81176 
 
Protein extraction 
Pierce RIPA buffer 89900 
 
Immunoblotting 
Fisher Bis acrylamide 37 5:1 40% 
Marvel Skimmed milk powder 
Fisher Tween 20 BP337-500 
Fisher Tris base BP 152-1 
Fisher Sodium dodecyl sulphate S/5200/53 
Sigma Ammonium persulfate A3678-100G  
Sigma Aldrich 2-Mercaptoethanol M6250 
Fisher NP40 Alternative 4920 16 
Sigma TEMED T-9281 
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Fisher Methanol M/4000/PC17 
Millipore Luminata Forte Western HRP Substrate 
Sigma Phosphate Buffered Saline P4417 
Fisher Guanidine Hydrochloride BP178-500 
Gibco 1M Tris HCL 15568-025 
Sigma Aldrich Sodium hydroxide S7770 
  
Appendices 
 
241 
 
VII. SOLUTION RECIPES FOR IMMUNOBLOTTING 
 
Laemmli loading buffer 
9.5mL pure H2O 
2.5mL 0.5M Tris HCL pH 6.8 
2.0mL Glycerol 
4.0mL 10% SDS (omitted for non-reducing) 
1.0mL 2-beta Mercaptoethanol 
1.0mL 1.5% Bromophenol blue 
 
10 x Running buffer 
25g SDS 
75.5g Tris 
360g glycine 
make up to 2.5l in dH20 
 
1 x Transfer buffer 
28.8 g glycine 
400 mL methanol 
6.06 g Tris base 
Add dH20 to get 2 liters 
 
Ammonium persulfate (APS) liquid from powder 
2g + 18mL dH20—makes 20mL 
APS: freeze 100 ul aliquots 
 
Sodium dodecyl sulphate (SDS) liquid from powder 
2g + 18mL dH20—makes 20mL  
SDS: store at room temp 
 
Abcam mild stripping buffer 
15 g glycine 
1 g SDS 
10 mL Tween20 
Adjust pH to 2.2 
Bring volume up to 1 L with ultrapure water. 
GnHCL Stripping buffer 
 
Abcam harsh stripping buffer 
20 mL SDS 10% 
12.5 mL Tris HCl pH 6.8 0.5M 
67.5 mL ultra-pure water 
Add 0.8 mL ß-mercaptoethanol 
 
GnHCL Very harsh stripping buffer 
57.32g GnHCL powder 
0.2mL 0.2% NP40 
0.7mL 0.1M B-mercaptoptoethanol 
2mL 1M TrisHCL 
Adjust pH to 7.5 
Make up to 100mL with dH2O 
 
TBS 
6.05g 50Mm Tris 
8.76g NaCl 
800mL dH2O 
Appendices 
 
242 
Adjust pH to 7.6 with 1M HCL 
Make up volume to 1L and store at 4°C 
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VIII. BCA CALCULATIONS 
 
Sample of the spreadsheet used to calculate protein levels in the samples from Pierce BCA assay 
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IX. HAEMOSTASIS RAW DATA 
  
 
Test 
GSDW 
added ul 
Repeat Time 
APTT 0.4 1 598.8 
APTT 0.4 2 145.3 
APTT 0.4 3 266.1 
APTT 0.4 4 639.1 
APTT 0.4 5 548.2 
APTT 0.35 1 530.3 
APTT 0.35 2 248.7 
APTT 0.35 3 324 
APTT 0.35 4 676.1 
APTT 0.35 5 548.2 
APTT 0.3 1 478.7 
APTT 0.3 2 386 
APTT 0.3 3 260.3 
APTT 0.3 4 235.2 
APTT 0.3 5 201.2 
APTT 0.25 1 196 
APTT 0.25 2 225.1 
APTT 0.25 3 171.9 
APTT 0.25 4 264 
APTT 0.25 5 228.8 
APTT 0.2 1 152.7 
APTT 0.2 2 151.1 
APTT 0.2 3 125.5 
APTT 0.2 4 167.1 
APTT 0.2 5 158.1 
APTT 0.15 1 101.7 
APTT 0.15 2 123.4 
APTT 0.15 3 115.6 
APTT 0.15 4 122.7 
APTT 0.15 5 99.2 
APTT 0.1 1 81.8 
APTT 0.1 2 67.1 
APTT 0.1 3 81.7 
APTT 0.1 4 73.3 
APTT 0.1 5 72.5 
APTT 0.05 1 70.5 
APTT 0.05 2 64.6 
APTT 0.05 3 63.2 
APTT 0.05 4 61.1 
APTT 0.05 5 63.4 
APTT 0 1 65.5 
APTT 0 2 63.3 
APTT 0 3 63.4 
APTT 0 4 62.3 
APTT 0 5 64.2 
Test 
GSDW 
added ul 
Repeat Time 
PT 0.4 1 67.9 
PT 0.4 2 129.3 
PT 0.4 3 78 
PT 0.4 4 150.2 
PT 0.4 5 134.6 
PT 0.35 1 44.9 
PT 0.35 2 42.5 
PT 0.35 3 42.3 
PT 0.35 4 38.4 
PT 0.35 5 46.1 
PT 0.3 1 33.6 
PT 0.3 2 36.6 
PT 0.3 3 30.2 
PT 0.3 4 32 
PT 0.3 5 36.1 
PT 0.25 1 27.4 
PT 0.25 2 27.6 
PT 0.25 3 25.6 
PT 0.25 4 27.2 
PT 0.25 5 23.3 
PT 0.2 1 23.5 
PT 0.2 2 21.5 
PT 0.2 3 21.4 
PT 0.2 4 22.8 
PT 0.2 5 20.1 
PT 0.15 1 21.6 
PT 0.15 2 24 
PT 0.15 3 24.1 
PT 0.15 4 22.6 
PT 0.15 5 20.6 
PT 0.1 1 20.2 
PT 0.1 2 19.8 
PT 0.1 3 21 
PT 0.1 4 19.8 
PT 0.1 5 19.8 
PT 0.05 1 19.5 
PT 0.05 2 20.3 
PT 0.05 3 18.8 
PT 0.05 4 19.1 
PT 0.05 5 19.2 
PT 0 1 18.4 
PT 0 2 18.5 
PT 0 3 19.9 
PT 0 4 16.3 
PT 0 5 15.3 
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GSDW Hours 
Test or 
Control 
Absorbance 
0.00002 24 1 0.2236667 
0.00002 24 1 0.28 
0.00002 24 1 0.1856667 
0.00002 24 1 0.2556667 
0.00002 24 2 0.1856667 
0.00002 24 2 0.2896667 
0.00002 24 2 0.167 
0.00002 24 2 0.268 
0.00003 24 1 0.2223333 
0.00003 24 1 0.318 
0.00003 24 1 0.27 
0.00003 24 1 0.286 
0.00003 24 2 0.225 
0.00003 24 2 0.33 
0.00003 24 2 0.207 
0.00003 24 2 0.2386667 
0.00007 24 1 0.2003333 
0.00007 24 1 0.3593333 
0.00007 24 1 0.2746667 
0.00007 24 1 0.2886667 
0.00007 24 2 0.1923333 
0.00007 24 2 0.3253333 
0.00007 24 2 0.21 
0.00007 24 2 0.2543333 
0.00014 24 1 0.2493333 
0.00014 24 1 0.2823333 
0.00014 24 1 0.3283333 
0.00014 24 1 0.2923333 
0.00014 24 2 0.1973333 
0.00014 24 2 0.2523333 
0.00014 24 2 0.212 
0.00014 24 2 0.2513333 
0.00027 24 1 0.3246667 
0.00027 24 1 0.3966667 
0.00027 24 1 0.3363333 
0.00027 24 1 0.3133333 
0.00027 24 2 0.2176667 
0.00027 24 2 0.3876667 
0.00027 24 2 0.2273333 
0.00027 24 2 0.2743333 
0.00055 24 1 0.235 
0.00055 24 1 0.331 
0.00055 24 1 0.2913333 
0.00055 24 1 0.272 
0.00055 24 2 0.2476667 
0.00055 24 2 0.3173333 
0.00055 24 2 0.224 
0.00055 24 2 0.2646667 
0.00109 24 1 0.07333333 
0.00109 24 1 0.2073333 
0.00109 24 1 0.1923333 
0.00109 24 1 0.2086667 
0.00109 24 2 0.2843333 
0.00109 24 2 0.37 
0.00109 24 2 0.225 
0.00109 24 2 0.2616667 
0.00218 24 1 0.062 
0.00218 24 1 0.065 
0.00218 24 1 0.082 
0.00218 24 1 0.09633333 
0.00218 24 2 0.24 
0.00218 24 2 0.3493333 
0.00218 24 2 0.2166667 
0.00218 24 2 0.2726667 
0.00437 24 1 0.036 
0.00437 24 1 0.048 
0.00437 24 1 0.05333333 
0.00437 24 1 0.08366667 
0.00437 24 2 0.2486667 
0.00437 24 2 0.3026667 
0.00437 24 2 0.1896667 
0.00437 24 2 0.2726667 
0.00874 24 1 0.057 
0.00874 24 1 0.02 
0.00874 24 1 0.03333333 
0.00874 24 1 0.068 
0.00874 24 2 0.2783333 
0.00874 24 2 0.239 
0.00874 24 2 0.1603333 
0.00874 24 2 0.2426667 
0.00002 48 1 0.3363333 
0.00002 48 1 0.343 
0.00002 48 1 0.3296667 
0.00002 48 2 0.2533333 
0.00002 48 2 0.2 
0.00002 48 2 0.223 
0.00003 48 1 0.358 
0.00003 48 1 0.3523333 
0.00003 48 1 0.319 
0.00003 48 2 0.2613333 
0.00003 48 2 0.205 
0.00003 48 2 0.2083333 
0.00007 48 1 0.3463333 
0.00007 48 1 0.342 
0.00007 48 1 0.3296667 
0.00007 48 2 0.27 
0.00007 48 2 0.2236667 
0.00007 48 2 0.1923333 
0.00014 48 1 0.3246667 
0.00014 48 1 0.3346667 
0.00014 48 1 0.343 
0.00014 48 2 0.2566667 
0.00014 48 2 0.2053333 
0.00014 48 2 0.186 
0.00027 48 1 0.3213333 
0.00027 48 1 0.3176667 
0.00027 48 1 0.3116667 
0.00027 48 2 0.225 
0.00027 48 2 0.24 
0.00027 48 2 0.1926667 
0.00055 48 1 0.2793333 
0.00055 48 1 0.2926667 
0.00055 48 1 0.284 
0.00055 48 2 0.2236667 
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0.00055 48 2 0.2353333 
0.00055 48 2 0.1916667 
0.00109 48 1 0.21 
0.00109 48 1 0.183 
0.00109 48 1 0.1946667 
0.00109 48 2 0.204 
0.00109 48 2 0.2313333 
0.00109 48 2 0.1916667 
0.00218 48 1 0.091 
0.00218 48 1 0.088 
0.00218 48 1 0.084 
0.00218 48 2 0.244 
0.00218 48 2 0.2373333 
0.00218 48 2 0.1916667 
0.00437 48 1 0.104 
0.00437 48 1 0.07833333 
0.00437 48 1 0.08266667 
0.00437 48 2 0.214 
0.00437 48 2 0.2086667 
0.00437 48 2 0.1633333 
0.00874 48 1 0.07033333 
0.00874 48 1 0.07566667 
0.00874 48 1 0.072 
0.00874 48 2 0.187 
0.00874 48 2 0.16 
0.00874 48 2 0.136 
0.00002 72 1 0.3006667 
0.00002 72 1 0.2676667 
0.00002 72 1 0.2286667 
0.00002 72 2 0.303 
0.00002 72 2 0.2613333 
0.00002 72 2 0.2203333 
0.00003 72 1 0.2123333 
0.00003 72 1 0.2743333 
0.00003 72 1 0.2593333 
0.00003 72 2 0.151 
0.00003 72 2 0.231 
0.00003 72 2 0.2186667 
0.00007 72 1 0.2236667 
0.00007 72 1 0.298 
0.00007 72 1 0.2513333 
0.00007 72 2 0.183 
0.00007 72 2 0.231 
0.00007 72 2 0.2076667 
0.00014 72 1 0.256 
0.00014 72 1 0.216 
0.00014 72 1 0.2743333 
0.00014 72 2 0.166 
0.00014 72 2 0.1413333 
0.00014 72 2 0.215 
0.00027 72 1 0.2803333 
0.00027 72 1 0.2263333 
0.00027 72 1 0.2916667 
0.00027 72 2 0.2106667 
0.00027 72 2 0.144 
0.00027 72 2 0.2146667 
0.00055 72 1 0.215 
0.00055 72 1 0.145 
0.00055 72 1 0.2086667 
0.00055 72 2 0.2176667 
0.00055 72 2 0.1666667 
0.00055 72 2 0.2186667 
0.00109 72 1 0.05433333 
0.00109 72 1 0.05166667 
0.00109 72 1 0.04233333 
0.00109 72 2 0.2153333 
0.00109 72 2 0.162 
0.00109 72 2 0.2106667 
0.00218 72 1 0.052 
0.00218 72 1 0.05266667 
0.00218 72 1 0.048 
0.00218 72 2 0.1923333 
0.00218 72 2 0.1636667 
0.00218 72 2 0.202 
0.00437 72 1 0.03733333 
0.00437 72 1 0.03333333 
0.00437 72 1 0.02933333 
0.00437 72 2 0.1833333 
0.00437 72 2 0.1696667 
0.00437 72 2 0.1816667 
0.00874 72 1 0.025 
0.00874 72 1 0.02066667 
0.00874 72 1 0.022 
0.00874 72 2 0.1336667 
0.00874 72 2 0.1323333 
0.00874 72 2 0.1586667 
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X. ANGIOGENESIS RAW DATA
HUVEC 
Image Name Nb Junctions Nb master segments Tot.meshes area Tot. lenght 
12hr BS 1-tr 151 99 604787 21897 
12hr BS 2-tr 149 101 874629 21909 
12hr BS 3-tr 157 108 611015 22384 
12hr BS 4-tr 139 84 471170 20580 
12hr BS 5-tr 162 132 709484 22094 
12hr BS 6-tr 149 86 757713 20773 
12hr DG 1-tr 146 80 304810 22066 
12hr DG 2-tr 161 99 1176575 22111 
12hr DG 3-tr 160 114 325960 21537 
12hr DG 4-tr 137 91 912826 20743 
12hr DG 5-tr 146 80 304810 22066 
12hr DG 6-tr 126 58 759144 21211 
12hr FL 1-tr 143 94 516391 20536 
12hr FL 2-tr 138 77 750046 21137 
12hr FL 3-tr 138 76 891020 21930 
12hr FL 4-tr 140 84 959405 20847 
12hr FL 5-tr 114 52 241280 19220 
12hr FL 6-tr 130 68 541931 20655 
12hr GSDW 1-tr 207 127 800049 25032 
12hr GSDW 2-tr 198 126 333175 23873 
12hr GSDW 3-tr 222 150 742404 26140 
12hr GSDW 4-tr 186 111 824230 24501 
12hr GSDW 5-tr 170 96 739592 22646 
12hr GSDW 6-tr 164 99 399231 22978 
12hr MDP 1-tr 153 72 440544 21100 
12hr MDP 2-tr 84 39 58271 15239 
12hr MDP 3-tr 115 71 394000 20498 
12hr MDP 4-tr 107 44 132776 18566 
12hr MDP 5-tr 107 54 251386 19241 
12hr MDP 6-tr 101 43 92850 17693 
12hr Media 1-tr 126 68 384164 21299 
12hr Media 2-tr 157 83 928511 22846 
12hr Media 3-tr 127 74 1053787 21088 
12hr Media 4-tr 184 123 930875 23112 
12hr Media 5-tr 129 65 398357 20992 
12hr Media 6-tr 146 79 1031346 21632 
12hr SD 1-tr 173 109 317257 23125 
12hr SD 2-tr 117 68 251142 17464 
12hr SD 3-tr 126 75 292816 20556 
12hr SD 4-tr 84 31 22537 16350 
12hr SD 5-tr 178 120 1298754 24610 
12hr SD 6-tr 146 100 267445 23358 
12hr Sura 1-tr 111 59 67740 17429 
12hr Sura 2-tr 103 50 170995 14765 
12hr Sura 3-tr 98 42 92795 15450 
12hr Sura 4-tr 91 37 35621 12446 
12hr Sura 5-tr 103 32 23825 15068 
12hr Sura 6-tr 90 43 40694 14901 
12hr SY 1-tr 106 61 292395 18926 
12hr SY 2-tr 134 86 1065953 21590 
12hr SY 3-tr 118 72 1021118 19622 
12hr SY 4-tr 120 76 1020311 20155 
12hr SY 5-tr 135 84 823407 21058 
12hr SY 6-tr 117 46 129703 20440 
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12hr SZY 1-tr 135 91 431722 19296 
12hr SZY 2-tr 139 92 1224699 23114 
12hr SZY 3-tr 135 75 342920 22028 
12hr SZY 4-tr 116 62 864936 20127 
12hr SZY 5-tr 148 95 1145438 21863 
12hr SZY 6-tr 148 99 612491 19889 
12hr VEGF 1-tr 129 80 478753 22058 
12hr VEGF 2-tr 149 82 430507 21281 
12hr VEGF 3-tr 143 85 502480 21159 
12hr VEGF 4-tr 112 49 339313 20360 
12hr VEGF 5-tr 121 66 792342 20600 
12hr VEGF 6-tr 176 119 573784 21939 
12hr ZX 1-tr 142 80 1033967 22651 
12hr ZX 2-tr 159 135 1457279 23700 
12hr ZX 3-tr 136 80 876752 22422 
12hr ZX 4-tr 152 94 1047043 22446 
12hr ZX 5-tr 150 103 752324 22056 
12hr ZX 6-tr 160 90 761952 23148 
HUtMEC 
 
 
 
Image Name 
Nb 
Junctions 
Nb 
master 
segments 
Tot.meshes 
area 
Tot. length 
160708 GF- 21hr Media with supplements 1 25 6 337072 8730 
160708 GF- 21hr Media with supplements 2 10 6 32982 7421 
160708 GF- 21hr Media with supplements 3 26 10 1271666 11415 
160708 GF- 21hr Media with supplements 4 20 14 1187320 10121 
160708 GF- 21hr Media with supplements 5 12 3 492258 8617 
160708 GF- 21hr Media with supplements 6 9 5 716358 8319 
160708 GF- 21hr Media with FBS 0.1% 1 12 6 724102 7992 
160708 GF- 21hr Media with FBS 0.1% 2 17 6 399131 8890 
160708 GF- 21hr Media with FBS 0.1% 3 12 6 267043 7973 
160708 GF- 21hr Media with FBS 0.1% 4 17 9 188423 6727 
160708 GF- 21hr Media with FBS 0.1% 5 18 8 745662 8310 
160708 GF- 21hr Media with FBS 0.1% 6 5 2 222584 5604 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 1 33 11 981886 11014 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 2 29 9 525856 9910 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 3 42 6 949327 12935 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 4 21 5 494372 8448 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 5 19 9 867764 9900 
160708 GF- 21hr GSDW 1000 with FBS 0.1% 6 21 8 637442 10623 
160708 GF- 21hr GSDW 500 with FBS 0.1% 1 22 11 939171 10201 
160708 GF- 21hr GSDW 500 with FBS 0.1% 2 14 6 398498 8469 
160708 GF- 21hr GSDW 500 with FBS 0.1% 3 19 10 1234346 11970 
160708 GF- 21hr GSDW 500 with FBS 0.1% 4 20 13 1317068 10118 
160708 GF- 21hr GSDW 500 with FBS 0.1% 5 22 14 1460716 10837 
160708 GF- 21hr GSDW 500 with FBS 0.1% 6 18 7 492973 9274 
160708 GF- 21hr BS 500 with FBS 0.1% 2 30 14 1457064 12559 
160708 GF- 21hr BS 500 with FBS 0.1% 3 17 10 1040071 9462 
160708 GF- 21hr BS 500 with FBS 0.1% 4 18 7 534474 9540 
160708 GF- 21hr BS 500 with FBS 0.1% 5 35 12 962243 10743 
160708 GF- 21hr BS 500 with FBS 0.1% 6 75 14 1666225 18118 
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160708 GF- 21hr BS 500 with FBS 0.1% 1 44 14 1565501 14807 
160708 GF- 21hr DG 500 with FBS 0.1% 1 14 12 969303 9222 
160708 GF- 21hr DG 500 with FBS 0.1% 2 20 10 1176511 8873 
160708 GF- 21hr DG 500 with FBS 0.1% 3 33 8 1212770 11436 
160708 GF- 21hr DG 500 with FBS 0.1% 4 18 12 1170224 10810 
160708 GF- 21hr DG 500 with FBS 0.1% 5 15 11 713184 8441 
160708 GF- 21hr DG 500 with FBS 0.1% 6 29 10 829442 11574 
160708 GF- 21hr FL 500 with FBS 0.1% 1 22 10 951388 10738 
160708 GF- 21hr FL 500 with FBS 0.1% 2 24 12 737579 11153 
160708 GF- 21hr FL 500 with FBS 0.1% 3 21 10 858289 10032 
160708 GF- 21hr FL 500 with FBS 0.1% 4 21 15 1194127 11141 
160708 GF- 21hr FL 500 with FBS 0.1% 5 26 12 1290502 11558 
160708 GF- 21hr FL 500 with FBS 0.1% 6 38 15 1434244 14200 
160708 GF- 21hr MDP 500 with FBS 0.1% 1 33 13 1700544 13693 
160708 GF- 21hr MDP 500 with FBS 0.1% 2 20 12 1052968 10319 
160708 GF- 21hr MDP 500 with FBS 0.1% 3 23 11 1209291 10179 
160708 GF- 21hr MDP 500 with FBS 0.1% 4 21 18 1191863 10822 
160708 GF- 21hr MDP 500 with FBS 0.1% 5 34 14 1382531 13332 
160708 GF- 21hr MDP 500 with FBS 0.1% 6 21 10 1032634 10474 
160708 GF- 21hr SD 500 with FBS 0.1% 1 16 10 999147 9205 
160708 GF- 21hr SD 500 with FBS 0.1% 2 26 17 1469371 12483 
160708 GF- 21hr SD 500 with FBS 0.1% 3 27 16 1270088 12258 
160708 GF- 21hr SD 500 with FBS 0.1% 4 21 14 1223873 11191 
160708 GF- 21hr SD 500 with FBS 0.1% 5 24 18 1824129 12721 
160708 GF- 21hr SD 500 with FBS 0.1% 6 25 16 1309643 11589 
160708 GF- 21hr SY 500 with FBS 0.1% 1 19 10 836902 10340 
160708 GF- 21hr SY 500 with FBS 0.1% 2 29 10 1253253 12289 
160708 GF- 21hr SY 500 with FBS 0.1% 3 29 17 1527741 13254 
160708 GF- 21hr SY 500 with FBS 0.1% 4 31 16 1183334 12933 
160708 GF- 21hr SY 500 with FBS 0.1% 5 27 14 1134200 11980 
160708 GF- 21hr SY 500 with FBS 0.1% 6 24 9 1028589 11413 
160708 GF- 21hr SZY 500 with FBS 0.1% 1 22 17 1562879 12264 
160708 GF- 21hr SZY 500 with FBS 0.1% 2 20 10 597154 10146 
160708 GF- 21hr SZY 500 with FBS 0.1% 3 36 20 1562082 13921 
160708 GF- 21hr SZY 500 with FBS 0.1% 4 29 13 1357063 12842 
160708 GF- 21hr SZY 500 with FBS 0.1% 5 29 14 1159215 11701 
160708 GF- 21hr SZY 500 with FBS 0.1% 6 29 19 1507791 12972 
160708 GF- 21hr ZX 500 with FBS 0.1% 1 25 12 806986 10708 
160708 GF- 21hr ZX 500 with FBS 0.1% 2 27 16 1699361 12464 
160708 GF- 21hr ZX 500 with FBS 0.1% 3 30 13 1267552 11867 
160708 GF- 21hr ZX 500 with FBS 0.1% 4 17 8 957505 9440 
160708 GF- 21hr ZX 500 with FBS 0.1% 5 44 11 1453083 14688 
160708 GF- 21hr ZX 500 with FBS 0.1% 6 19 16 1378636 10463 
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XI. IMMUNOBLOTTING RAW DATA 
 
ERα 24 
 
  
1 ERα 24 βA Ratio Normalised ratio 
Relative to 
media 
Media 2405844 14736540 0.16 1 1.00 
GUI SHAO DI HUANG WAN 4310644 10623698 2.49 15.5625 1.86 
RADIX PAEONIAE ALBA 5243088 11481662 0.18 1.125 2.32 
RADIX ANGELICA SINENSIS 2234438 15125786 0.8 5 0.99 
PORIA COCOS 3801406 16176030 0.29 1.8125 1.62 
CORTEX MOUTAN 2480526 12163002 0.7 4.375 1.10 
RADIX REHMANNIAE 
PREPARATA 
2457422 7889180 0.45 2.8125 1.07 
RHIZOMA DIOSCOREAE 2981594 10854168 0.62 3.875 1.30 
FRUCTUS CORNI 3952494 13713516 0.47 2.9375 1.72 
RHIZOMA ALISMATIS 8155158 16559698 1.05 6.5625 3.37 
2      
Media 1684158 996606 1.69 1 1.00 
GUI SHAO DI HUANG WAN 3511200 1575954 2.23 1.318416701 2.08 
RADIX PAEONIAE ALBA 2069277 3548952 0.58 0.345031837 1.23 
RADIX ANGELICA SINENSIS 1925427 1901664 1.01 0.599147756 1.14 
PORIA COCOS 3429279 2187774 1.57 0.927557899 2.04 
CORTEX MOUTAN 1580649 1534518 1.03 0.609542678 0.94 
RADIX REHMANNIAE 
PREPARATA 
2620884 1218654 2.15 1.272647258 1.56 
RHIZOMA DIOSCOREAE 2424009 1365066 1.78 1.050802853 1.44 
FRUCTUS CORNI 764988 794682 0.96 0.56964188 0.45 
RHIZOMA ALISMATIS 7523292 1147644 6.56 3.879193047 4.47 
3      
Media 1677662 3826116 0.44 1 1 
GUI SHAO DI HUANG WAN 2901395 5068404 0.57 1.31 1.729428 
RADIX PAEONIAE ALBA 2997687 2561944 1.17 2.67 1.786824 
RADIX ANGELICA SINENSIS 4123380 5174370 0.80 1.82 2.457813 
PORIA COCOS 5945727 4784526 1.24 2.83 3.544055 
CORTEX MOUTAN 4289098 4358466 0.98 2.24 2.556592 
RADIX REHMANNIAE 
PREPARATA 
5056641 4225716 1.20 2.73 3.0141 
RHIZOMA DIOSCOREAE 4748252 4095990 1.16 2.64 2.830279 
FRUCTUS CORNI 4842321 4049342 1.20 2.73 2.886351 
RHIZOMA ALISMATIS 3873188 5286880 0.73 1.67 2.308682 
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ERα 48 
 
  1 ERα 48 βA Ratio Normalised ratio 
Relative 
to 
media 
Media 3493217 2778906 1.26 1 1.00 
GUI SHAO DI HUANG WAN 2363049 1842064 1.28 1.02 0.68 
RADIX PAEONIAE ALBA 691429 1752522 0.39 0.31 0.20 
RADIX ANGELICA SINENSIS 343710 1080792 0.32 0.25 0.10 
PORIA COCOS 569677 1796130 0.32 0.25 0.16 
CORTEX MOUTAN 1370641 1441104 0.95 0.76 0.39 
RADIX REHMANNIAE 
PREPARATA 
1064475 2356416 0.45 0.36 0.30 
RHIZOMA DIOSCOREAE 1905339 3409480 0.56 0.44 0.55 
FRUCTUS CORNI 4247146 2542768 1.67 1.33 1.22 
RHIZOMA ALISMATIS 2569921 2828628 0.91 0.72 0.74 
2      
Media 7074570 2555369 2.77 1 1.00 
GUI SHAO DI HUANG WAN 1197173 2385831 0.5 0.18 0.17 
RADIX PAEONIAE ALBA 2006739 1733028 1.16 0.42 0.28 
RADIX ANGELICA SINENSIS 4289481 2945475 1.46 0.53 0.61 
PORIA COCOS 5566449 3294866 1.69 0.61 0.79 
CORTEX MOUTAN 3048822 3903170 0.78 0.28 0.43 
RADIX REHMANNIAE 
PREPARATA 
5690265 4073239 1.4 0.5 0.80 
RHIZOMA DIOSCOREAE 6668193 3609144 1.85 0.67 0.94 
FRUCTUS CORNI 6437256 3597380 1.79 0.65 0.91 
RHIZOMA ALISMATIS 4575804 5684058 0.81 0.29 0.65 
3      
Media 6530223 3737431 1.75 1 1.00 
GUI SHAO DI HUANG WAN 3323727 1610466 2.06 1.18 0.51 
RADIX PAEONIAE ALBA 2345011 1565175 1.5 0.86 0.36 
RADIX ANGELICA SINENSIS 3360441 1577560 2.13 1.22 0.51 
PORIA COCOS 3859422 2437080 1.58 0.91 0.59 
CORTEX MOUTAN 2461640 2215260 1.11 0.64 0.38 
RADIX REHMANNIAE 
PREPARATA 
3146193 2355340 1.34 0.76 0.48 
RHIZOMA DIOSCOREAE 4907694 2605920 1.88 1.08 0.75 
FRUCTUS CORNI 6674822 3351400 1.99 1.14 1.02 
RHIZOMA ALISMATIS 5213964 4286540 1.22 0.7 0.80 
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ERβ 24 
 
  
1 ERβ 24 βA Ratio 
Normalised 
ratio 
Relative 
to media 
Media 347016 1208952 0.29 1 1.00 
GUI SHAO DI HUANG WAN 1070555 1753642 0.61 2.13 3.09 
RADIX PAEONIAE ALBA 4145405 2561562 1.62 5.64 11.95 
RADIX ANGELICA SINENSIS 4446646 2660310 1.67 5.82 12.81 
PORIA COCOS 1958767 3338154 0.59 2.04 5.64 
CORTEX MOUTAN 1515573 3949434 0.38 1.34 4.37 
RADIX REHMANNIAE PREPARATA 3258481 4980116 0.65 2.28 9.39 
RHIZOMA DIOSCOREAE 1831125 4630262 0.4 1.38 5.28 
FRUCTUS CORNI 1927664 4989894 0.39 1.35 5.55 
RHIZOMA ALISMATIS 2064720 6944328 0.3 1.04 5.95 
2      
Media 1311362 1460178 0.9 1 1.00 
GUI SHAO DI HUANG WAN 1795104 2258631 0.79 0.88 1.37 
RADIX PAEONIAE ALBA 3240925 1062666 3.05 3.4 2.47 
RADIX ANGELICA SINENSIS 1628460 1164108 1.4 1.56 1.24 
PORIA COCOS 1128096 1919918 0.59 0.65 0.86 
CORTEX MOUTAN 669114 2247520 0.3 0.33 0.51 
RADIX REHMANNIAE PREPARATA 2215188 1900382 1.17 1.3 1.69 
RHIZOMA DIOSCOREAE 1140660 2603898 0.44 0.49 0.87 
FRUCTUS CORNI 960280 4937240 0.19 0.22 0.73 
RHIZOMA ALISMATIS 1073512 7502456 0.14 0.16 0.82 
3      
Media 3683960 2429030 1.52 1 1.00 
GUI SHAO DI HUANG WAN 3199760 3119789 1.03 0.68 0.75 
RADIX PAEONIAE ALBA 2288660 3468078 0.66 0.44 1.06 
RADIX ANGELICA SINENSIS 3938500 5000407 0.79 0.52 0.95 
PORIA COCOS 2883020 3292491 0.88 0.58 0.96 
CORTEX MOUTAN 4084380 3396690 1.2 0.79 0.87 
RADIX REHMANNIAE PREPARATA 4775060 3194388 1.49 0.99 0.73 
RHIZOMA DIOSCOREAE 3232820 4974233 0.65 0.43 0.68 
FRUCTUS CORNI 2988900 2897463 1.03 0.68 0.21 
RHIZOMA ALISMATIS 3289680 5587873 0.59 0.39 0.77 
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ERβ 48 
 
  
1 ERβ 48 βA Ratio 
Normalised 
ratio 
Relative to 
media 
Media 4838027 4029025 1.2 1 1 
GUI SHAO DI HUANG WAN 3712082 3521300 1.05 0.88 0.767272 
RADIX PAEONIAE ALBA 3129000 3210563 0.97 0.81 0.646751 
RADIX ANGELICA SINENSIS 2900132 2474568 1.17 0.98 0.599445 
PORIA COCOS 3631659 3111714 1.17 0.97 0.750649 
CORTEX MOUTAN 2621315 1357740 1.93 1.61 0.541815 
RADIX REHMANNIAE PREPARATA 1221603 2829060 0.43 0.36 0.2525 
RHIZOMA DIOSCOREAE 1478728 3106962 0.48 0.4 0.305647 
FRUCTUS CORNI 746810 3202032 0.23 0.19 0.154363 
RHIZOMA ALISMATIS 1995239 4067080 0.49 0.41 0.412408 
2      
Media 3683960 2929407 1.26 1 1 
GUI SHAO DI HUANG WAN 3199760 4087120 0.78 0.62 0.868565 
RADIX PAEONIAE ALBA 2288660 4262422 0.54 0.43 0.62125 
RADIX ANGELICA SINENSIS 3938500 4475700 0.88 0.7 1.069094 
PORIA COCOS 2883020 3919120 0.74 0.58 0.782587 
CORTEX MOUTAN 4084380 3019455 1.35 1.08 1.108693 
RADIX REHMANNIAE PREPARATA 4775060 3324060 1.44 1.14 1.296176 
RHIZOMA DIOSCOREAE 3232820 3142736 1.03 0.82 0.877539 
FRUCTUS CORNI 2988900 3376353 0.89 0.7 0.811328 
RHIZOMA ALISMATIS 3289680 3802240 0.87 0.69 0.892974 
3      
Media 3683960 2429030 1.52 1 1 
GUI SHAO DI HUANG WAN 3199760 3119789 1.03 0.68 0.750303 
RADIX PAEONIAE ALBA 2288660 3468078 0.66 0.44 1.064833 
RADIX ANGELICA SINENSIS 3938500 5000407 0.79 0.52 0.949828 
PORIA COCOS 2883020 3292491 0.88 0.58 0.960325 
CORTEX MOUTAN 4084380 3396690 1.2 0.79 0.868447 
RADIX REHMANNIAE PREPARATA 4775060 3194388 1.49 0.99 0.733558 
RHIZOMA DIOSCOREAE 3232820 4974233 0.65 0.43 0.678695 
FRUCTUS CORNI 2988900 2897463 1.03 0.68 0.210855 
RHIZOMA ALISMATIS 3289680 5587873 0.59 0.39 0.770334 
Appendices 
 
254 
PRβ 24 
 
  
1 PRβ βA Ratio Normalised ratio 
Relative to 
media 
Media 582192 2270450 0.26 1 1 
GUI SHAO DI HUANG WAN 2133164 2476760 0.86 3.36 3.664021 
RADIX PAEONIAE ALBA 1790280 3490940 0.51 2 3.075068 
RADIX ANGELICA SINENSIS 1495662 3851190 0.39 1.51 2.569018 
PORIA COCOS 1592154 3621096 0.44 1.71 2.734758 
CORTEX MOUTAN 1582972 3312127 0.48 1.86 2.718986 
RADIX REHMANNIAE 
PREPARATA 
2076703 3267043 0.64 2.48 3.567041 
RHIZOMA DIOSCOREAE 1782140 4255220 0.42 1.63 3.061086 
FRUCTUS CORNI 2491880 4608700 0.54 2.11 4.280169 
RHIZOMA ALISMATIS 1570690 4254976 0.37 1.44 2.69789 
2      
Media 2023920 4100730 0.49 1 1 
GUI SHAO DI HUANG WAN 5198382 3771831 1.38 2.79 3.269301 
RADIX PAEONIAE ALBA 2826296 4050134 0.7 1.41 1.774698 
RADIX ANGELICA SINENSIS 1804740 5051718 0.36 0.72 1.132598 
PORIA COCOS 2541420 4235940 0.6 1.22 1.59467 
CORTEX MOUTAN 2477920 3274220 0.76 1.53 1.556257 
RADIX REHMANNIAE 
PREPARATA 
2053984 2469360 0.83 1.69 1.291766 
RHIZOMA DIOSCOREAE 1911080 3217960 0.59 1.2 1.199993 
FRUCTUS CORNI 2511160 3336980 0.75 1.52 1.579287 
RHIZOMA ALISMATIS 2508288 4038840 0.62 1.26 1.577481 
3      
Media 3958042 1546133 2.56 1 1 
GUI SHAO DI HUANG WAN 5123096 1472720 3.48 1.36 1.167674 
RADIX PAEONIAE ALBA 4989432 3682115 1.36 0.53 1.137209 
RADIX ANGELICA SINENSIS 4533606 2377348 1.91 0.74 1.033315 
PORIA COCOS 4007740 2686663 1.49 0.58 0.913458 
CORTEX MOUTAN 1726868 1931115 0.89 0.35 0.393594 
RADIX REHMANNIAE 
PREPARATA 
4845742 1239691 3.91 1.53 1.104458 
RHIZOMA DIOSCOREAE 5079404 1249619 4.06 1.59 1.157715 
FRUCTUS CORNI 5875452 1361581 4.32 1.69 1.339153 
RHIZOMA ALISMATIS 5590640 1724429 3.24 1.27 1.274238 
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PRβ 48 
  1 PRβ βA Normalised 
ratio 
Relative to 
media 
Media 4512784 1202026 1 1 
GUI SHAO DI HUANG WAN 3984942 1414530 0.75 0.883034 
RADIX PAEONIAE ALBA 5294400 1279450 1.1 1.1732 
RADIX ANGELICA SINENSIS 7338072 1224993 1.6 1.626063 
PORIA COCOS 6280764 1261428 1.33 1.391771 
CORTEX MOUTAN 3896739 1236963 0.84 0.863489 
RADIX REHMANNIAE PREPARATA 4418379 1063209 1.11 0.979081 
RHIZOMA DIOSCOREAE 3815574 1135806 0.89 0.845503 
FRUCTUS CORNI 3255315 1337574 0.65 0.721354 
RHIZOMA ALISMATIS 2678616 1160892 0.61 0.593562 
2     
Media 2482245 1536489 1 1 
GUI SHAO DI HUANG WAN 2204950 1275625 1.07 0.888289 
RADIX PAEONIAE ALBA 2868300 1133310 1.57 1.155527 
RADIX ANGELICA SINENSIS 2244585 962157 1.44 0.904256 
PORIA COCOS 3403974 1253868 1.68 1.371329 
CORTEX MOUTAN 2019780 1279383 0.98 0.813691 
RADIX REHMANNIAE PREPARATA 5237148 2916627 1.11 2.109843 
RHIZOMA DIOSCOREAE 1956864 1135344 1.07 0.788344 
FRUCTUS CORNI 2268147 1143702 1.23 0.913748 
RHIZOMA ALISMATIS 5600637 3056970 1.13 2.256279 
3     
Media 2097025 1272600 1 1 
GUI SHAO DI HUANG WAN 1960659 1469745 0.81 0.934972 
RADIX PAEONIAE ALBA 2453180 815143 1.83 1.169838 
RADIX ANGELICA SINENSIS 4560050 1325082 2.09 2.174533 
PORIA COCOS 5000200 1115160 2.72 2.384426 
CORTEX MOUTAN 2163060 732240 1.79 1.03149 
RADIX REHMANNIAE PREPARATA 3870480 1722020 1.36 1.8457 
RHIZOMA DIOSCOREAE 4468120 1879880 1.44 2.130695 
FRUCTUS CORNI 1965440 910840 1.31 0.937252 
RHIZOMA ALISMATIS 2147375 1484050 0.88 1.02401 
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XII. PT POST HOC TESTS (DUNN’S) FOR INDIVIDUAL HERB EXTRACTS  
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XIII. APTT POST HOC TESTS FOR INDIVIDUAL HERB EXTRACTS  
Games Howell post hoc tests 
(I) Herb (J) Herb 
Mean Difference (I-
J) 
Std. 
Error 
Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
dH2O 
Gui Shao Di Huang Wan -104.000000* 6.514461 .001 -139.78146 -68.21854 
Radix Paeoniae Alba -1.260000 .754718 .787 -4.41839 1.89839 
Radix Angelicae Sinensis -13.660000* 1.734532 .008 -22.37793 -4.94207 
Sclerotium Poria Cocos 6.640000* 1.098453 .012 1.67230 11.60770 
Cortex Moutan 1.060000 .838451 .937 -2.48429 4.60429 
Radix Rehmanniae 
Preparata 
1.060000 .838451 .937 -2.48429 4.60429 
Rhizoma Dioscoreae 2.540000 1.313621 .659 -3.68901 8.76901 
Fructus Corni -44.120000* 4.202523 .004 -66.96486 -21.27514 
Rhizoma Alismatis 4.620000 1.522498 .260 -2.84567 12.08567 
Gui Shao Di Huang 
Wan 
dH2O 104.000000* 6.514461 .001 68.21854 139.78146 
Radix Paeoniae Alba 102.740000* 6.514492 .001 66.95875 138.52125 
Radix Angelicae Sinensis 90.340000* 6.699075 .001 55.57126 125.10874 
Sclerotium Poria Cocos 110.640000* 6.563200 .001 75.16658 146.11342 
Cortex Moutan 105.060000* 6.524722 .001 69.34605 140.77395 
Radix Rehmanniae 
Preparata 
105.060000* 6.524722 .001 69.34605 140.77395 
Rhizoma Dioscoreae 106.540000* 6.602621 .001 71.29333 141.78667 
Fructus Corni 59.880000* 7.715582 .002 25.99897 93.76103 
Rhizoma Alismatis 108.620000* 6.647330 .001 73.60786 143.63214 
Radix Paeoniae Alba 
dH2O 1.260000 .754718 .787 -1.89839 4.41839 
Gui Shao Di Huang Wan -102.740000* 6.514492 .001 -138.52125 -66.95875 
Radix Angelicae Sinensis -12.400000* 1.734647 .012 -21.11756 -3.68244 
Sclerotium Poria Cocos 7.900000* 1.098636 .005 2.93222 12.86778 
Cortex Moutan 2.320000 .838689 .287 -1.22504 5.86504 
Radix Rehmanniae 
Preparata 
2.320000 .838689 .287 -1.22504 5.86504 
Rhizoma Dioscoreae 3.800000 1.313773 .286 -2.42883 10.02883 
Fructus Corni -42.860000* 4.202571 .005 -65.70456 -20.01544 
Rhizoma Alismatis 5.880000 1.522629 .122 -1.58536 13.34536 
Radix Angelicae 
Sinensis 
dH2O 13.660000* 1.734532 .008 4.94207 22.37793 
Gui Shao Di Huang Wan -90.340000* 6.699075 .001 -125.10874 -55.57126 
Radix Paeoniae Alba 12.400000* 1.734647 .012 3.68244 21.11756 
Sclerotium Poria Cocos 20.300000* 1.909450 .000 11.74780 28.85220 
Cortex Moutan 14.720000* 1.772682 .005 6.10217 23.33783 
Radix Rehmanniae 
Preparata 
14.720000* 1.772682 .005 6.10217 23.33783 
Rhizoma Dioscoreae 16.200000* 2.040833 .001 7.43124 24.96876 
Fructus Corni -30.460000* 4.483369 .012 -52.21353 -8.70647 
Rhizoma Alismatis 18.280000* 2.181146 .001 9.09863 27.46137 
Sclerotium Poria 
Cocos 
dH2O -6.640000* 1.098453 .012 -11.60770 -1.67230 
Gui Shao Di Huang Wan -110.640000* 6.563200 .001 -146.11342 -75.16658 
Radix Paeoniae Alba -7.900000* 1.098636 .005 -12.86778 -2.93222 
Radix Angelicae Sinensis -20.300000* 1.909450 .000 -28.85220 -11.74780 
Cortex Moutan -5.580000* 1.157756 .030 -10.61886 -.54114 
Radix Rehmanniae 
Preparata 
-5.580000* 1.157756 .030 -10.61886 -.54114 
Rhizoma Dioscoreae -4.100000 1.537205 .322 -10.61978 2.41978 
Fructus Corni -50.760000* 4.277686 .002 -73.19128 -28.32872 
Rhizoma Alismatis -2.020000 1.719128 .955 -9.50265 5.46265 
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Cortex Moutan 
dH2O -1.060000 .838451 .937 -4.60429 2.48429 
Gui Shao Di Huang Wan -105.060000* 6.524722 .001 -140.77395 -69.34605 
Radix Paeoniae Alba -2.320000 .838689 .287 -5.86504 1.22504 
Radix Angelicae Sinensis -14.720000* 1.772682 .005 -23.33783 -6.10217 
Sclerotium Poria Cocos 5.580000* 1.157756 .030 .54114 10.61886 
Radix Rehmanniae Preparata .000000 .914768 1.000 -3.82817 3.82817 
Rhizoma Dioscoreae 1.480000 1.363598 .969 -4.72710 7.68710 
Fructus Corni -45.180000* 4.218412 .004 -67.92844 -22.43156 
Rhizoma Alismatis 3.560000 1.565822 .504 -3.83348 10.95348 
Radix Rehmanniae Preparata 
dH2O -1.060000 .838451 .937 -4.60429 2.48429 
Gui Shao Di Huang Wan -105.060000* 6.524722 .001 -140.77395 -69.34605 
Radix Paeoniae Alba -2.320000 .838689 .287 -5.86504 1.22504 
Radix Angelicae Sinensis -14.720000* 1.772682 .005 -23.33783 -6.10217 
Sclerotium Poria Cocos 5.580000* 1.157756 .030 .54114 10.61886 
Cortex Moutan .000000 .914768 1.000 -3.82817 3.82817 
Rhizoma Dioscoreae 1.480000 1.363598 .969 -4.72710 7.68710 
Fructus Corni -45.180000* 4.218412 .004 -67.92844 -22.43156 
Rhizoma Alismatis 3.560000 1.565822 .504 -3.83348 10.95348 
Rhizoma Dioscoreae 
dH2O -2.540000 1.313621 .659 -8.76901 3.68901 
Gui Shao Di Huang Wan -106.540000* 6.602621 .001 -141.78667 -71.29333 
Radix Paeoniae Alba -3.800000 1.313773 .286 -10.02883 2.42883 
Radix Angelicae Sinensis -16.200000* 2.040833 .001 -24.96876 -7.43124 
Sclerotium Poria Cocos 4.100000 1.537205 .322 -2.41978 10.61978 
Cortex Moutan -1.480000 1.363598 .969 -7.68710 4.72710 
Radix Rehmanniae Preparata -1.480000 1.363598 .969 -7.68710 4.72710 
Fructus Corni -46.660000* 4.337926 .002 -68.83080 -24.48920 
Rhizoma Alismatis 2.080000 1.863974 .968 -5.78372 9.94372 
Fructus Corni 
dH2O 44.120000* 4.202523 .004 21.27514 66.96486 
Gui Shao Di Huang Wan -59.880000* 7.715582 .002 -93.76103 -25.99897 
Radix Paeoniae Alba 42.860000* 4.202571 .005 20.01544 65.70456 
Radix Angelicae Sinensis 30.460000* 4.483369 .012 8.70647 52.21353 
Sclerotium Poria Cocos 50.760000* 4.277686 .002 28.32872 73.19128 
Cortex Moutan 45.180000* 4.218412 .004 22.43156 67.92844 
Radix Rehmanniae Preparata 45.180000* 4.218412 .004 22.43156 67.92844 
Rhizoma Dioscoreae 46.660000* 4.337926 .002 24.48920 68.83080 
Rhizoma Alismatis 48.740000* 4.405678 .002 26.79747 70.68253 
Rhizoma Alismatis 
dH2O -4.620000 1.522498 .260 -12.08567 2.84567 
Gui Shao Di Huang Wan -108.620000* 6.647330 .001 -143.63214 -73.60786 
Radix Paeoniae Alba -5.880000 1.522629 .122 -13.34536 1.58536 
Radix Angelicae Sinensis -18.280000* 2.181146 .001 -27.46137 -9.09863 
Sclerotium Poria Cocos 2.020000 1.719128 .955 -5.46265 9.50265 
Cortex Moutan -3.560000 1.565822 .504 -10.95348 3.83348 
Radix Rehmanniae Preparata -3.560000 1.565822 .504 -10.95348 3.83348 
Rhizoma Dioscoreae -2.080000 1.863974 .968 -9.94372 5.78372 
Fructus Corni -48.740000* 4.405678 .002 -70.68253 -26.79747 
*. The mean difference is significant at the 0.05 level. 
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XIV. COMPLETE BLOT DATA 
 
Figure 8.1 ERα24-1 ERα and BA 
 
 
Figure 8.2 ERα24-2 ERα 
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Figure 8.3 ERα24-2 BA 
 
 
Figure 8.4 ERα24-3 ERα 
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Figure 8.5 ERα24-3 BA 
 
 
 
Figure 8.6 ERα48-1 ERα 
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Figure 8.7 ERα48-1 BA 
 
Figure 8.8 ERα48-2 ERα and BA 
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Figure 8.9 ERα48-3 ERα and BA 
 
 
 
Figure 8.10 ERβ 24-1 ERβ 
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Figure 8.11 ERβ 24-1 BA 
 
 
Figure 8.12 ERβ 24-2 ERβ 
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Figure 8.13 ERβ 24-2 BA 
 
 
Figure 8.14 ERβ 24-3 ERβ 
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Figure 8.15 ERβ 24-3 BA 
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Figure 8.16 ERβ 48-1 ERβ 
 
 
Figure 8.17  ERβ 48-1 BA 
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Figure 8.18 ERβ 48-2 ERβ 
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Figure 8.19 ERβ 48-2 BA 
 
 
 
Figure 8.20 ERβ 48-3 ERβ 
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Figure 8.21 ERβ 48-3 BA 
 
Figure 8.22 PRβ 24-1 PRβ +BA 
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Figure 8.23 PRβ 24-2 PRβ +BA 
 
Figure 8.24 PRβ 24-3 PRβ 
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Figure 8.25 PRβ 24-3 BA 
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Figure 8.26 PRβ 48-1 PRβ 
 
 
Figure 8.27  PRβ 48-1 BA 
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Figure 8.28  PRβ 48-2 PRβ 
 
 
Figure 8.29  PRβ 48-2 BA 
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Figure 8.30  PRβ 48-3 PRβ 
 
 
Figure 8.31  PRβ 48-3 BA 
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XV. UPR 16 
 
